Primary Care Center, Yale New Haven Hospital
789 Howard Avenue
New Haven, CT 06519
- Primary Care Center, Yale New Haven Hospital789 Howard AvenueNew Haven, CT 06519
Cary Gross, MD
Internal Medicine
Telehealth is available
Patient type treated
Adult
Accepting new patients
No
Referral required
Not Applicable
Titles
- Professor of Medicine (General Medicine) and of Epidemiology (Chronic Diseases)
- Founder and Director, Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center, Yale School of Medicine
- Director, National Clinician Scholars Program
Education & Training
- FellowJohns Hopkins School of Medicine (1999)
- Chief ResidentMemorial Sloan-Kettering Cancer Center (1997)
- ResidentNew York Hospital, Cornell Medical Center (1996)
- InternNew York Hospital, Cornell Medical Center (1994)
- MDNew York University School of Medicine (1993)
- BAJohns Hopkins University (1989)
Additional Information
Honors & Recognitions
- Elected Member: Association of American Physicians (2022)
- Yale Cancer Center Award for Mentorship Excellence: Yale New Haven Hospital (2021)
- Member: American Society for Clinical Investigation (2018)
- Visiting Professor: Johns Hopkins School of Medicine, Grand Rounds (2017)
- American Society for Radiation Oncology Annual Mtg Resident Digital Poster Discussion Recognition Award: American Society for Radiation Oncology (2013)
- Population Sciences Research Prize: Yale Cancer Center (2013)
- Mid-Career Research Mentorship Award: Society of General Internal Medicine (2012)
- Fellow: American College of Physicians (2010)
- Connecticut Quality Improvement Partnership Silver Innovation Prize: Connecticut Quality Improvement Partnership (2006)
- Joseph A. Zaccagnino Patient Safety and Clinical Quality Award: Yale-New Haven Hospital (2006)
Professional Service
- American Society of Clinical Oncology (ASCO) Quality Annual Meeting (2022): Planning Committee
- JAMA Internal Medicine (2022 - Present): Associate Editor
- Yale Cancer Center Diversity & Inclusion Committee (2020 - Present): Committee Member
- Society of General Internal Medicine, Scientific Abstract Selection Committee (Clinical Epi/Effectiveness) (2020 - Present): Co-Chair
- Medicare Contractor (2019 - Present): Advisor
- NCCN Institutional Representative for Young Investigator Award (2019): Reviewer
- Medicare (2019): Committee Member
- MedRxiv, Screening Affiliate (2019 - Present): Reviewer
- Yale School of Public Health Standing Appointments and Advisory Committee (2018 - 2020): Committee Member
- Yale Information Technology Services Advisory Committee (2018 - 2020): Committee Member
Publications
- Ajjawi I, Loeb S, Cooperberg M, Catalona W, Gross C, Ma X, Leapman M. Active Surveillance or Watchful Waiting for Intermediate-Risk Prostate Cancer, 2010-2020. JAMA 2024, 332: 2033-2036. PMID: 39565605, PMCID: PMC11579888, DOI: 10.1001/jama.2024.20580.
- Stall N, Gross C. Centering Patients and Evidence in Debates About Medical Assistance in Dying. JAMA Internal Medicine 2024, 185 PMID: 39652318, DOI: 10.1001/jamainternmed.2024.6650.
- Gross C, Gluck A, Corbie G. Physicians, the Homelessness Crisis, and Public Health—All Hands on Deck. JAMA Internal Medicine 2024, 184: 1414-1416. PMID: 39401048, DOI: 10.1001/jamainternmed.2024.5341.
- Moore C, Gross C, Hart L, Molinaro A, Rhodes D, Singh D, Baloescu C. Construction and performance of a clinical prediction rule for ureteral stone without the use of race or ethnicity: A new STONE score. Journal Of The American College Of Emergency Physicians Open 2024, 5: e13324. PMID: 39524039, PMCID: PMC11543628, DOI: 10.1002/emp2.13324.
- Paludo J, Dueck A, Bhatnagar V, Brown A, Cathcart-Rake E, Copley D, Diamond M, Faust L, Fiero M, Huntington S, Jeffery M, Jones L, Noble B, Power B, Ritchie J, Ross J, Ruddy K, Schellhorn S, Tarver M, Torre L, Wood W, Gross C, Kluetz P, Thanarajasingam G. Feasibility of Multi-Modal Physical Function Data Collection to Assess Treatment Tolerability in Patients with Lymphoma. Blood 2024, 144: 387-387. DOI: 10.1182/blood-2024-194607.
- Siddique S, Wang R, Gaddy J, Stempel J, Warren J, Gross C, Ma X. Disparities in Colorectal Cancer Screening Before and After the Onset of the COVID Pandemic. Journal Of General Internal Medicine 2024, 1-9. PMID: 39495455, DOI: 10.1007/s11606-024-09153-3.
- Chu L, Wang R, Gross C, Chen K, Ma X. Ambient Temperature and Stroke Risk Among Adults Aged 18-64 Years A Case-Crossover Study. Journal Of The American College Of Cardiology 2024, 84: 2327-2331. PMID: 39453364, DOI: 10.1016/j.jacc.2024.08.058.
- Kunst N, Long J, Westvold S, Sprenkle P, Kim I, Saperstein L, Rabil M, Ghaffar U, Karnes R, Ma X, Gross C, Wang S, Leapman M. Long-Term Outcomes of Prostate-Specific Membrane Antigen–PET Imaging of Recurrent Prostate Cancer. JAMA Network Open 2024, 7: e2440591. PMID: 39441595, PMCID: PMC11581571, DOI: 10.1001/jamanetworkopen.2024.40591.
- Siddique S, Wang R, Yasin F, Gaddy J, Zhang L, Gross C, Ma X. USPSTF Colorectal Cancer Screening Recommendation and Uptake for Individuals Aged 45 to 49 Years. JAMA Network Open 2024, 7: e2436358. PMID: 39361285, PMCID: PMC11450516, DOI: 10.1001/jamanetworkopen.2024.36358.
- Yabroff R, Blackford A, Fan Q, Hussaini S, Chen K, Polsky D, Katana Ogongo M, Warren J, Gross C, Pollack C. Is federal housing assistance associated with earlier-stage cancer diagnosis? Evidence from the new SEER-Medicare and US Department of Housing and Urban Development data linkage. Journal Of Clinical Oncology 2024, 20: 85-85. DOI: 10.1200/op.2024.20.10_suppl.85.
- Stackland S, Schnabel D, Dinan M, Presley C, Gross C. Strength of evidence underlying the CMS-FDA parallel review of comprehensive genomic profiling tests in the cancer setting. Journal Of The National Cancer Institute 2024, djae196. PMID: 39288939, DOI: 10.1093/jnci/djae196.
- Xu X, Chen L, Desai V, Gross C, Pollack C, Schwartz P, Wright J. Tubal Sterilization Rates by State Abortion Laws After the Dobbs Decision. JAMA 2024, 332: 1204-1206. PMID: 39259564, PMCID: PMC11391354, DOI: 10.1001/jama.2024.16862.
- Wang T, Corbie G, Allore H, Anderson T, Durant R, Ganguli I, Grady D, Gross C, Katz M, Mody L, Tripodis Y, Inouye S. Randomized Clinical Trials That Advance Health and Health Equity. JAMA Internal Medicine 2024, 184: 1011-1012. PMID: 39008289, DOI: 10.1001/jamainternmed.2024.3149.
- Forman R, Long J, Westvold S, Agnish K, McManus H, Leapman M, Hurwitz M, Spees L, Wheeler S, Gross C, Dinan M. Cost trends of metastatic renal cell carcinoma therapy: the impact of oral anticancer agents and immunotherapy. JNCI Cancer Spectrum 2024, 8: pkae067. PMID: 39133171, PMCID: PMC11376369, DOI: 10.1093/jncics/pkae067.
- Jain S, Long J, Rao V, Law A, Walkey A, Prsic E, Lindenauer P, Krumholz H, Gross C. Trends in use of intensive care during hospitalizations at the end‐of‐life among older adults with advanced cancer. Journal Of The American Geriatrics Society 2024, 72: 3840-3848. PMID: 39090970, PMCID: PMC11637920, DOI: 10.1111/jgs.19119.
- Richman I, Gross C. Progress in Lung Cancer Screening Adoption. JAMA Internal Medicine 2024, 184: 902-903. PMID: 38857025, DOI: 10.1001/jamainternmed.2024.1673.
- Yu J, DeStephano D, Horowitz D, Gross C, Cheng S. Reply to O. Saifi et al. Journal Of Clinical Oncology 2024, 42: 3763-3764. PMID: 39079081, DOI: 10.1200/jco-24-01228.
- Sundaresan V, Wang R, Long J, Sprenkle P, Seibert T, Loeb S, Cooperberg M, Catalona W, Ma X, Gross C, Leapman M. Associations Between Prostate Magnetic Resonance Imaging, Genomic Testing, and Treatment for Localized Prostate Cancer. Urology Practice 2024, 11: 965-973. PMID: 39196719, DOI: 10.1097/upj.0000000000000679.
- Miller J, Pelletiers W, Suttiratana S, Mensah M, Schwartz J, Ramachandran R, Gross C, Ross J. Harnessing policy to promote inclusive medical product evidence: development of a reference standard and structured audit of clinical trial diversity policies. BMJ Medicine 2024, 3: e000920. PMID: 39175919, PMCID: PMC11340651, DOI: 10.1136/bmjmed-2024-000920.
- Di M, Potnis K, Long J, Isufi I, Foss F, Seropian S, Gross C, Huntington S. Costs of care during chimeric antigen receptor T-cell therapy in relapsed or refractory B-cell lymphomas. JNCI Cancer Spectrum 2024, 8: pkae059. PMID: 39115391, PMCID: PMC11340641, DOI: 10.1093/jncics/pkae059.
- Canavan M, Wang X, Ascha M, Miksad R, Showalter T, Calip G, Gross C, Adelson K. Systemic Anticancer Therapy and Overall Survival in Patients With Very Advanced Solid Tumors. JAMA Oncology 2024, 10: 887-895. PMID: 38753341, PMCID: PMC11099840, DOI: 10.1001/jamaoncol.2024.1129.
- Gross C, Durant R. Tracking Physical Activity One Step at a Time. JAMA Internal Medicine 2024, 184: 726-726. PMID: 38767900, DOI: 10.1001/jamainternmed.2024.0898.
- Demkowicz P, Buck M, Nie J, Marks V, Wheeler S, Dinan M, Gross C, Leapman M. Changes in Facility Share of Medicaid-insured Patients With Urologic Cancers Following Implementation of the Patient Protection and Affordable Care Act. Urology 2024, 192: 19-27. PMID: 38901803, DOI: 10.1016/j.urology.2024.06.003.
- Dijk S, Krijkamp E, Kunst N, Labrecque J, Gross C, Pandit A, Lu C, Visser L, Wong J, Hunink M. Making Drug Approval Decisions in the Face of Uncertainty: Cumulative Evidence versus Value of Information. Medical Decision Making 2024, 44: 512-528. PMID: 38828516, PMCID: PMC11283736, DOI: 10.1177/0272989x241255047.
- Atre S, Soulos P, Kuderer N, Gross C, Baum L, Dinan M, Lustberg M. Characterization of time toxicity in older patients with metastatic breast cancer. Breast Cancer Research And Treatment 2024, 207: 541-550. PMID: 38816556, DOI: 10.1007/s10549-024-07379-7.
- Taylor M, Westvold S, Long J, Hyslop T, Wang S, Cecchini M, Leapman M, Leeds I, Lustberg M, Spees L, Wheeler S, Gross C, Oeffinger K, Dinan M. Personalized risk assessment of new onset depression in long-term cancer survivors. Journal Of Clinical Oncology 2024, 42: e13798-e13798. DOI: 10.1200/jco.2024.42.16_suppl.e13798.
- Opioid prescribing trends and pain scores among adult patients with cancer in a large health system.Baum L, Soulos P, KC M, Jeffery M, Ruddy K, Lerro C, Lee H, Graham D, Liberatore M, Rivera D, Leapman M, Jairam V, Dinan M, Gross C, Park H. Opioid prescribing trends and pain scores among adult patients with cancer in a large health system. Journal Of Clinical Oncology 2024, 42: 11059-11059. DOI: 10.1200/jco.2024.42.16_suppl.11059.
- Thanarajasingam G, Dueck A, Bhatnagar V, Brown A, Cathcart-Rake E, Diamond M, Faust L, Fiero M, Huntington S, Jeffery M, Jones L, Paludo J, Power B, Ross J, Ruddy K, Schellhorn S, Tarver M, Wood W, Gross C, Kluetz P. Integrating 4 Methods (In4M) to evaluate physical function in patients with cancer: Results of a comprehensive digital health study. Journal Of Clinical Oncology 2024, 42: 1564-1564. DOI: 10.1200/jco.2024.42.16_suppl.1564.
- Tarantino P, Lee D, Foldi J, Soulos P, Gross C, Grinda T, Winer E, Lin N, Krop I, Tolaney S, Lustberg M, Sammons S. Outcomes with trastuzumab deruxtecan (T-DXd) by HER2 status and line of treatment in a large real-world database of patients with metastatic breast cancer. Journal Of Clinical Oncology 2024, 42: 1077-1077. DOI: 10.1200/jco.2024.42.16_suppl.1077.
- Grady D, Allore H, Corbie G, Covinsky K, Durant R, Ganguli I, Gross C, Katz M, Mody L, Wang T, Tripodis Y, Inouye S. Improving Women’s Health Across the Life Span—JAMA Internal Medicine Call for Papers. JAMA Internal Medicine 2024, 184: 472-473. PMID: 38497973, PMCID: PMC11184509, DOI: 10.1001/jamainternmed.2024.0136.
- Richman I, Gross C, Wang E. Cancer and incarceration: a call for action. The Lancet Oncology 2024, 25: 530-531. PMID: 38697151, DOI: 10.1016/s1470-2045(24)00201-8.
- Leapman M, Long J, Westvold S, Rabil M, Sprenkle P, Kim I, Saperstein L, Fallah J, Suzman D, Lerro C, Xu J, Kluetz P, Karnes R, Kunst N, Wang S, Ma X, Gross C. PD45-11 TEMPORAL AND REGIONAL PATTERNS OF PROSTATE CANCER POSITRON EMISSION TOMOGRAPHY IMAGING AMONG COMMERCIAL INSURANCE BENEFICIARIES IN THE UNITED STATES. Journal Of Urology 2024, 211: e972. DOI: 10.1097/01.ju.0001008792.09108.b4.11.
- Kunst N, Long J, Westvold S, Sprenkle P, Rabil M, Ghaffar U, Kim I, Saperstein L, Wang S, Ma X, Gross C, Leapman M. MP57-08 COST EFFECTIVENESS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN POSITRON EMISSION TOMOGRAPHY (PSMA-PET) FOR THE EVALUATION OF BIOCHEMICAL RECURRENT PROSTATE CANCER IN THE UNITED STATES HEALTHCARE SYSTEM. Journal Of Urology 2024, 211: e940. DOI: 10.1097/01.ju.0001009420.83948.eb.08.
- Leapman M, Rabil M, Ghaffar U, Long J, Westvold S, Sprenkle P, Kim I, Saperstein L, Fallah J, Suzman D, Lerro C, Xu J, Kluetz P, Kunst N, Wang S, Ma X, Gross C, Karnes R. PD45-10 PROSTATE-SPECIFIC MEMBRANE ANTIGEN IMAGING FINDINGS AND SUBSEQUENT CLINICAL MANAGEMENT AMONG PATIENTS WITH BIOCHEMICAL RECURRENT PROSTATE CANCER: A RETROSPECTIVE COHORT STUDY. Journal Of Urology 2024, 211: e971. DOI: 10.1097/01.ju.0001008792.09108.b4.10.
- Kunst N, Long J, Westvold S, Sprenkle P, Rabil M, Ghaffar U, Kim I, Saperstein L, Wang S, Ma X, Gross C, Leapman M. PD08-10 EFFECTIVENESS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN POSITRON EMISSION TOMOGRAPHY AMONG PATIENTS WITH BIOCHEMICAL RECURRENT PROSTATE CANCER: RESULTS OF DECISION ANALYTIC MODELING. Journal Of Urology 2024, 211: e177. DOI: 10.1097/01.ju.0001008576.33217.96.10.
- Gross C, Corbie G. Physicians in Private Equity Practices—Canaries in a Coal Mine? JAMA Internal Medicine 2024, 184: 580-581. PMID: 38466292, DOI: 10.1001/jamainternmed.2024.0069.
- Sedrak M, Sun C, Bae M, Freedman R, Magnuson A, O’Connor T, Moy B, Wildes T, Klepin H, Chapman A, Tew W, Dotan E, Fenton M, Kim H, Katheria V, Muss H, Cohen H, Gross C, Ji J. Functional decline in older breast cancer survivors treated with and without chemotherapy and non-cancer controls: results from the Hurria Older PatiEnts (HOPE) prospective study. Journal Of Cancer Survivorship 2024, 18: 1131-1143. PMID: 38678525, PMCID: PMC11324395, DOI: 10.1007/s11764-024-01594-3.
- Li H, Huntington S, Gross C, Wang S. Immunotherapy utilization patterns in patients with advanced cancer and autoimmune disease. PLOS ONE 2024, 19: e0300789. PMID: 38625861, PMCID: PMC11020359, DOI: 10.1371/journal.pone.0300789.
- Sutherland R, Gross C, Ma X, Jeong F, Seibert T, Cooperberg M, Catalona W, Ellis S, Loeb S, Schulman‐Green D, Leapman M. ‘It Just Makes Sense to Me’: A qualitative study exploring patient decision‐making and experiences with prostate MRI during active surveillance for prostate cancer. BJUI Compass 2024, 5: 707-715. PMID: 38873351, PMCID: PMC11168777, DOI: 10.1002/bco2.351.
- Rahman S, Long J, Westvold S, Leapman M, Spees L, Hurwitz M, McManus H, Gross C, Wheeler S, Dinan M. Area Vulnerability and Disparities in Therapy for Patients With Metastatic Renal Cell Carcinoma. JAMA Network Open 2024, 7: e248747. PMID: 38687479, PMCID: PMC11061765, DOI: 10.1001/jamanetworkopen.2024.8747.
- Yu J, DeStephano D, Jeffers B, Horowitz D, Soulos P, Gross C, Cheng S. Updated Analysis of Comparative Toxicity of Proton and Photon Radiation for Prostate Cancer. Journal Of Clinical Oncology 2024, 42: 1943-1952. PMID: 38507655, DOI: 10.1200/jco.23.01604.
- Richman I, Gross C. Estimating Breast Cancer Overdiagnosis After Screening Mammography Among Older Women in the United States. Annals Of Internal Medicine 2024, 177: 403-404. PMID: 38498894, DOI: 10.7326/l23-0485.
- Zhang G, Gross C. Protecting Patients by Reducing Diagnostic Error. JAMA Internal Medicine 2024, 184: 173-173. PMID: 38190151, DOI: 10.1001/jamainternmed.2023.7334.
- Leapman M, Long J, Westvold S, Rabil M, Sprenkle P, Kim I, Saperstein L, Fallah J, Suzman D, Lerro C, Xu J, Kluetz P, Karnes R, Kunst N, Wang S, Ma X, Gross C. Temporal and regional patterns of prostate cancer positron emission tomography imaging among commercial insurance beneficiaries in the United States. Journal Of Clinical Oncology 2024, 42: 34-34. DOI: 10.1200/jco.2024.42.4_suppl.34.
- Thanarajasingam G, Kluetz P, Bhatnagar V, Brown A, Cathcart-Rake E, Diamond M, Faust L, Fiero M, Huntington S, Jeffery M, Jones L, Noble B, Paludo J, Powers B, Ross J, Ritchie J, Ruddy K, Schellhorn S, Tarver M, Dueck A, Gross C. Integrating 4 methods to evaluate physical function in patients with cancer (In4M): protocol for a prospective cohort study. BMJ Open 2024, 14: e074030. PMID: 38199641, PMCID: PMC10806877, DOI: 10.1136/bmjopen-2023-074030.
- Jairam V, Soulos P, Madhav K, Gross C, Slotman B, Chiang A, Park H. Differential Effect of Consolidative Thoracic Radiation Therapy in Extensive-Stage Small Cell Lung Cancer Based on Sex. Advances In Radiation Oncology 2023, 9: 101413. PMID: 38778819, PMCID: PMC11110031, DOI: 10.1016/j.adro.2023.101413.
- Habib A, Gross C. FDA Regulations of AI-Driven Clinical Decision Support Devices Fall Short. JAMA Internal Medicine 2023, 183: 1401-1402. PMID: 37812411, DOI: 10.1001/jamainternmed.2023.5006.
- Richman I, Soulos P, Lin H, Aminawung J, Oladeru O, Puglisi L, Wang E, Gross C. Incarceration and screen-detectable cancer diagnosis among adults in Connecticut. Journal Of The National Cancer Institute 2023, 116: 485-489. PMID: 37991935, PMCID: PMC10919339, DOI: 10.1093/jnci/djad242.
- Mitta S, Gross C, Simon M. Screening for Hypertensive Disorders of Pregnancy in the US—A New Hypertensive Urgency. JAMA Internal Medicine 2023, 183: 1185-1186. PMID: 37725383, DOI: 10.1001/jamainternmed.2023.4723.
- Li Y, Yang S, Chiang A, Gross C, Wang S. Using real world practice patterns to identify clinical equipoise in cancer treatment: Advanced non-small cell lung cancer as an exemplar. JCO Oncology Practice 2023, 19: 539-539. DOI: 10.1200/op.2023.19.11_suppl.539.
- Tan J, Yang S, Dinan M, Chiang A, Gross C, Wang S. Mutation-specific costs of advanced non-small cell lung cancer treatment. JCO Oncology Practice 2023, 19: 14-14. DOI: 10.1200/op.2023.19.11_suppl.14.
- Rahman S, Long J, Westvold S, Wheeler S, Spees L, Leapman M, Hurwitz M, McManus H, Gross C, Dinan M. Total and treatment-related costs of care associated with in patients with metastatic renal cell carcinoma receiving targeted or immune therapy. JCO Oncology Practice 2023, 19: 28-28. DOI: 10.1200/op.2023.19.11_suppl.28.
- Baum L, KC M, Soulos P, Jeffery M, Ruddy K, Lerro C, Lee H, Graham D, Rivera D, Leapman M, Jairam V, Dinan M, Gross C, Park H. Trends in new and persistent opioid use in older adults with and without cancer. Journal Of The National Cancer Institute 2023, 116: 316-323. PMID: 37802882, DOI: 10.1093/jnci/djad206.
- Kwan J, Gross C. Improving Support for Physician Scientists—Mind the (Funding) Gap. JAMA Network Open 2023, 6: e2332982. PMID: 37725379, DOI: 10.1001/jamanetworkopen.2023.32982.
- Ward E, Gross C. Evolving Methods to Assess Chatbot Performance in Health Sciences Research. JAMA Internal Medicine 2023, 183: 1030-1031. PMID: 37459112, DOI: 10.1001/jamainternmed.2023.2567.
- Patient experiences with tissue‐based genomic testing during active surveillance for prostate cancerLeapman M, Sutherland R, Gross C, Ma X, Seibert T, Cooperberg M, Catalona W, Loeb S, Schulman‐Green D. Patient experiences with tissue‐based genomic testing during active surveillance for prostate cancer. BJUI Compass 2023, 5: 142-149. PMID: 38179031, PMCID: PMC10764160, DOI: 10.1002/bco2.277.
- Rowhani-Farid A, Grewal M, Solar S, Eghrari A, Zhang A, Gross C, Krumholz H, Ross J. Clinical trial data sharing: a cross-sectional study of outcomes associated with two U.S. National Institutes of Health models. Scientific Data 2023, 10: 529. PMID: 37553403, PMCID: PMC10409750, DOI: 10.1038/s41597-023-02436-0.
- Richman I, Long J, Soulos P, Wang S, Gross C. Estimating Breast Cancer Overdiagnosis After Screening Mammography Among Older Women in the United States. Annals Of Internal Medicine 2023, 176: 1172-1180. PMID: 37549389, PMCID: PMC10623662, DOI: 10.7326/m23-0133.
- Voruganti T, Presley C, Gross C. Net Clinical Benefit as Measure of Treatment Benefit Among Older Adults With Advanced Incurable Non–Small Cell Lung Cancer—Reply. JAMA Oncology 2023, 9: 1154-1155. PMID: 37347467, DOI: 10.1001/jamaoncol.2023.1538.
- Kc M, Fan J, Hyslop T, Hassan S, Cecchini M, Wang S, Silber A, Leapman M, Leeds I, Wheeler S, Spees L, Gross C, Lustberg M, Greenup R, Justice A, Oeffinger K, Dinan M. Relative Burden of Cancer and Noncancer Mortality Among Long-Term Survivors of Breast, Prostate, and Colorectal Cancer in the US. JAMA Network Open 2023, 6: e2323115. PMID: 37436746, PMCID: PMC10339147, DOI: 10.1001/jamanetworkopen.2023.23115.
- Canavan M, Wang X, Ascha M, Miksad R, Showalter T, Calip G, Gross C, Adelson K. End-of-Life Systemic Oncologic Treatment in the Immunotherapy Era: The Role of Race, Insurance, and Practice Setting. Journal Of Clinical Oncology 2023, 41: 4729-4738. PMID: 37339389, PMCID: PMC10602547, DOI: 10.1200/jco.22.02180.
- Varma T, Gross C, Miller J. Clinical Trial Diversity—Will We Know It When We See It? JAMA Oncology 2023, 9: 765-767. PMID: 37022678, DOI: 10.1001/jamaoncol.2023.0143.
- Crosson F, Ostrer I, Gross C. Private Equity in US Health Care—Now Cradle to Grave? JAMA Internal Medicine 2023, 183: 511-512. PMID: 37126342, DOI: 10.1001/jamainternmed.2023.0324.
- Hassan S, Girgis A, Abramsohn E, Pinkerton E, Gross C. Opportunities and challenges to implementing a coordinated social care network for patients with cancer: Perspectives of local community based organizations. Journal Of Clinical Oncology 2023, 41: e18647-e18647. DOI: 10.1200/jco.2023.41.16_suppl.e18647.
- Ji J, Sun C, Wildes T, Freedman R, Magnuson A, O'Connor T, Moy B, Klepin H, Chapman A, Tew W, Dotan E, Fenton M, Kim H, Bae M, Katheria V, Gross C, Muss H, Cohen H, Sedrak M. Falls and hospitalization during chemotherapy in older women with early breast cancer. Journal Of Clinical Oncology 2023, 41: 12035-12035. DOI: 10.1200/jco.2023.41.16_suppl.12035.
- Canavan M, Wang X, Ascha M, Miksad R, Showalter T, Calip G, Gross C, Adelson K. Survival analysis of patients treated at oncology practices with more aggressive end-of-life practice patterns. Journal Of Clinical Oncology 2023, 41: 6562-6562. DOI: 10.1200/jco.2023.41.16_suppl.6562.
- Aminawung J, Soulos P, Oladeru O, Lin H, Gonsalves L, Puglisi L, Hassan S, Richman I, Wang E, Gross C. Cancer incidence among incarcerated and formerly incarcerated individuals: A statewide retrospective cohort study. Cancer Medicine 2023, 12: 15447-15454. PMID: 37248772, PMCID: PMC10417084, DOI: 10.1002/cam4.6162.
- Chow R, Long J, Hassan S, Wheeler S, Spees L, Leapman M, Hurwitz M, McManus H, Gross C, Dinan M. Disparities in immune and targeted therapy utilization for older US patients with metastatic renal cell carcinoma. JNCI Cancer Spectrum 2023, 7: pkad036. PMID: 37202354, PMCID: PMC10276895, DOI: 10.1093/jncics/pkad036.
- Miller S, Azar S, Farrelly J, Salzman G, Broderick M, Sanders K, Anto V, Patel N, Cordova A, Schuster K, Jones T, Kodadek L, Gross C, Morton J, Rosenthal R, Becher R. Current use of the National Surgical Quality Improvement Program surgical risk calculator in academic surgery: a mixed-methods study. Surgery In Practice And Science 2023, 13: 100173. PMID: 37502700, PMCID: PMC10373440, DOI: 10.1016/j.sipas.2023.100173.
- Ananth P, Lindsay M, Mun S, McCollum S, Shabanova V, de Oliveira S, Pitafi S, Kirch R, Ma X, Gross C, Boyden J, Feudtner C, Wolfe J. Parent Priorities in End-of-Life Care for Children With Cancer. JAMA Network Open 2023, 6: e2313503. PMID: 37184834, PMCID: PMC10878399, DOI: 10.1001/jamanetworkopen.2023.13503.
- Jain S, Long J, Rao V, Law A, Walkey A, Lindenauer P, Prsic E, Krumholz H, Gross C. Trends in Utilization of ICU for Older Adults With Cancer at the End-of-Life. 2023, a1398-a1398. DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a1398.
- Vu M, Boyd K, De Marchis E, Garnache B, Gottlieb L, Gross C, Lee N, Lindau S, Mun S, Winslow V, Makelarski J. Perceived appropriateness of assessing for health-related socioeconomic risks among adult patients with cancer. Cancer Research Communications 2023, 3: 521-531. PMID: 37020993, PMCID: PMC10069714, DOI: 10.1158/2767-9764.crc-22-0283.
- Gross C, Kraschel K, Emanuel E. Holding Medical Professional Society Scientific Meetings Only in States That Protect Abortion Rights—Clinical and Ethical Considerations. JAMA Internal Medicine 2023, 183: 283-284. PMID: 36848080, DOI: 10.1001/jamainternmed.2022.7073.
- Leapman M, Wang R, Long J, Sprenkle P, Ma X, Gross C. PD10-01 ASSOCIATIONS BETWEEN PROSTATE MRI AND GENOMIC TESTING AND TREATMENT INTENSIFICATION AMONG PATIENTS WITH LOCALIZED PROSTATE CANCER. Journal Of Urology 2023, 209: e326. DOI: 10.1097/ju.0000000000003250.01.
- Voruganti T, Soulos P, Mamtani R, Presley C, Gross C. Association Between Age and Survival Trends in Advanced Non–Small Cell Lung Cancer After Adoption of Immunotherapy. JAMA Oncology 2023, 9: 334-341. PMID: 36701150, PMCID: PMC9880865, DOI: 10.1001/jamaoncol.2022.6901.
- Chow R, Long J, Hassan S, Wheeler S, Spees L, Leapman M, Hurwitz M, McManus H, Gross C, Dinan M. Evolution of systemic therapy from 2015 to 2019 for older patients in the United States with metastatic renal cell carcinoma. Journal Of Clinical Oncology 2023, 41: 610-610. DOI: 10.1200/jco.2023.41.6_suppl.610.
- Sutherland R, Gross C, Ma X, Jeong F, Seibert T, Cooperberg M, Catalona W, Loeb S, Schulman-Green D, Leapman M. “It just makes sense to me”: Patient experiences with prostate MRI during prostate cancer active surveillance. Journal Of Clinical Oncology 2023, 41: 334-334. DOI: 10.1200/jco.2023.41.6_suppl.334.
- Leapman M, Sutherland R, Gross C, Ma X, Jeong F, Seibert T, Cooperberg M, Catalona W, Loeb S, Schulman-Green D. Patient experiences with tissue-based genomic testing during active surveillance for prostate cancer. Journal Of Clinical Oncology 2023, 41: 333-333. DOI: 10.1200/jco.2023.41.6_suppl.333.
- Leapman M, Wang R, Loeb S, Seibert T, Gaylis F, Lowentritt B, Brown G, Chen R, Lin D, Witte J, Cooperberg M, Catalona W, Gross C, Ma X. Use of Monitoring Tests Among Patients With Localized Prostate Cancer Managed With Observation. Journal Of Urology 2023, 209: 710-718. PMID: 36753746, DOI: 10.1097/ju.0000000000003159.
- Gross C, Dusetzina S. Stemming Medicare Spending on Discarded Drugs—Waste Not, Want Not? JAMA Internal Medicine 2023, 183: 93-93. PMID: 36534375, DOI: 10.1001/jamainternmed.2022.5895.
- Varma T, Mello M, Ross J, Gross C, Miller J. Metrics, baseline scores, and a tool to improve sponsor performance on clinical trial diversity: retrospective cross sectional study. BMJ Medicine 2023, 2: e000395. PMID: 36936269, PMCID: PMC9951369, DOI: 10.1136/bmjmed-2022-000395.
- Shultz B, Oladele C, Leeds I, Gluck A, Gross C. Targeting Health-Related Social Risks in the Clinical Setting: New Policy Momentum and Practice Considerations. The Journal Of Law, Medicine & Ethics 2023, 51: 777-785. PMID: 38477272, DOI: 10.1017/jme.2024.25.
- Dinan M, Pitafi S, Greenup R, Long J, Gross C. Genetic testing in privately insured women with surgically treated breast cancer. Breast Cancer Research And Treatment 2022, 198: 177-181. PMID: 36542252, DOI: 10.1007/s10549-022-06829-4.
- Boatright D, Anderson N, Kim J, Holmboe E, McDade W, Fancher T, Gross C, Chaudhry S, Nguyen M, Tiako M, Colson E, Xu Y, Li F, Dziura J, Saha S. Racial and Ethnic Differences in Internal Medicine Residency Assessments. JAMA Network Open 2022, 5: e2247649. PMID: 36580337, PMCID: PMC9857126, DOI: 10.1001/jamanetworkopen.2022.47649.
- Sedrak M, Sun C, Ji J, Cohen H, Gross C, Tew W, Klepin H, Wildes T, Dotan E, Freedman R, O'Connor T, Chow S, Fenton M, Moy B, Chapman A, Dale W, Katheria V, Kuderer N, Lyman G, Magnuson A, Muss H. Low-Intensity Adjuvant Chemotherapy for Breast Cancer in Older Women: Results From the Prospective Multicenter HOPE Trial. Journal Of Clinical Oncology 2022, 41: 316-326. PMID: 36455189, PMCID: PMC9839299, DOI: 10.1200/jco.22.01440.
- Potnis K, Ross J, Aneja S, Gross C, Richman I. Artificial Intelligence in Breast Cancer Screening. JAMA Internal Medicine 2022, 182: 1306-1312. PMID: 36342705, PMCID: PMC10623674, DOI: 10.1001/jamainternmed.2022.4969.
- Dzimitrowicz H, Wilson L, Jackson B, Spees L, Baggett C, Greiner M, Kaye D, Zhang T, George D, Scales C, Pritchard J, Leapman M, Gross C, Dinan M, Wheeler S. End-of-Life Care for Patients With Metastatic Renal Cell Carcinoma in the Era of Oral Anticancer Therapy. JCO Oncology Practice 2022, 19: e213-e227. PMID: 36413741, PMCID: PMC9970274, DOI: 10.1200/op.22.00401.
- Gao S, Jin L, Meadows H, Shafman T, Gross C, Yu J, Aerts H, Miccio J, Stahl J, Mak R, Decker R, Kann B. Prediction of Distant Metastases After Stereotactic Body Radiation Therapy for Early Stage NSCLC: Development and External Validation of a Multi-Institutional Model. Journal Of Thoracic Oncology 2022, 18: 339-349. PMID: 36396062, DOI: 10.1016/j.jtho.2022.11.007.
- Leapman M, Long J, Wang R, Sprenkle P, Ma X, Gross C. MP53-11 FOUR KALLIKREIN PANEL TESTING AMONG MEDICARE BENEFICIARIES UNDERGOING PROSTATE CANCER SCREENING. Journal Of Urology 2022, 207: e899. DOI: 10.1097/ju.0000000000002628.11.
- Ananth P, Mun S, Lindsay M, De Oliveira S, Pitafi S, Ma X, Gross C, Boyden J, Feudtner C, Wolfe J. Parent Priorities in End-of-Life Care for Children with Cancer. Journal Of Pain And Symptom Management 2022, 63: 885. DOI: 10.1016/j.jpainsymman.2022.02.087.
- Dzimitrowicz H, Wilson L, Jackson B, Spees L, Baggett C, Greiner M, Kaye D, Zhang T, George D, Scales C, Pritchard J, Leapman M, Gross C, Dinan M, Wheeler S. Factors associated with the quality of end-of-life care for patients with metastatic renal cell carcinoma. Journal Of Clinical Oncology 2022, 40: 300-300. DOI: 10.1200/jco.2022.40.6_suppl.300.
- Spees L, Wheeler S, Jackson B, Baggett C, Wilson L, Greiner M, Kaye D, Zhang T, George D, Scales C, Pritchard J, Leapman M, Gross C, Dinan M. Provider- and patient-level predictors of oral anticancer agent initiation and adherence in patients with metastatic renal cell carcinoma. Journal Of Clinical Oncology 2021, 39: 87-87. DOI: 10.1200/jco.2020.39.28_suppl.87.
- Spees L, Dinan M, Jackson B, Baggett C, Wilson L, Greiner M, Kaye D, Zhang T, George D, Scales C, Pritchard J, Leapman M, Gross C, Wheeler S. Patient- and provider-level predictors of mortality among patients with metastatic renal cell carcinoma receiving oral anticancer agents. Journal Of Clinical Oncology 2021, 39: 116-116. DOI: 10.1200/jco.2020.39.28_suppl.116.
- Canavan M, Wang X, Ascha M, Miksad R, Showalter T, Calip G, Gross C, Adelson K. Trends in end-of- life (EOL) systemic oncologic treatment in contemporary clinical practice: Insights from real-world data. Journal Of Clinical Oncology 2021, 39: 253-253. DOI: 10.1200/jco.2020.39.28_suppl.253.
- Adelson K, Wang X, Ascha M, Miksad R, Showalter T, Calip G, Gross C, Canavan M. Differences by race in systemic oncologic end-of-life (EOL) care among patients with cancer. Journal Of Clinical Oncology 2021, 39: 137-137. DOI: 10.1200/jco.2020.39.28_suppl.137.
- Leapman M, Wang R, Gross C, Ma X. PD50-11 CHANGES IN PSA SCREENING RELATIVE TO THE REVISED USPSTF GUIDANCE FOR PROSTATE CANCER SCREENING. Journal Of Urology 2021, 206: e856-e856. DOI: 10.1097/ju.0000000000002072.11.
- Leapman M, Dinan M, Pasha S, Washington S, Ma X, Gross C. PD46-08 MEDIATORS OF RACIAL DISPARITY IN THE USE OF PROSTATE MRI. Journal Of Urology 2021, 206: e751-e751. DOI: 10.1097/ju.0000000000002060.08.
- Axson S, Mello MM, Lincow D, Yang C, Gross C, Ross JS, Miller J. Clinical trial transparency and data sharing among biopharmaceutical companies and the role of company size, location and product type: a cross-sectional descriptive analysis. BMJ Open 2021, 11: e053248. PMID: 34281933, PMCID: PMC8291313, DOI: 10.1136/bmjopen-2021-053248.
- Abujarad F, Wang S, Ulrich D, Mougalian S, Killelea B, Fraenkel L, Gross C, Evans S. Building a Digital Health Risk Calculator for Older Women with Early-Stage Breast Cancer. Lecture Notes In Computer Science 2021, 12780: 389-402. DOI: 10.1007/978-3-030-78224-5_27.
- Hsu SH, Chang SH, Gross C, Wang SY. Relative risks of COVID-19 fatality between the first and second waves of the pandemic in Ontario, Canada. International Journal Of Infectious Diseases 2021, 109: 189-191. PMID: 34216734, PMCID: PMC8245301, DOI: 10.1016/j.ijid.2021.06.059.
- Xu X, Desai V, Schwartz P, Gross C, Lin H, Wright J. MT4 Safety Warnings about Power Morcellation in Hysterectomy: A Simulation of National Impact. Value In Health 2021, 24: s12. DOI: 10.1016/j.jval.2021.04.062.
- Puglisi L, Halberstam AA, Aminawung J, Gallagher C, Gonsalves L, Schulman-Green D, Lin HJ, Metha R, Mun S, Oladeru OT, Gross C, Wang EA. Incarceration and Cancer-Related Outcomes (ICRO) study protocol: using a mixed-methods approach to investigate the role of incarceration on cancer incidence, mortality and quality of care. BMJ Open 2021, 11: e048863. PMID: 34035109, PMCID: PMC8154989, DOI: 10.1136/bmjopen-2021-048863.
- Parikh R, Min E, Wileyto E, Riaz F, Gross C, Cohen R, Hubbard R, Long Q, Mamtani R. Uptake and effectiveness of checkpoint inhibitor therapy among trial-ineligible patients with advanced solid malignancies. Journal Of Clinical Oncology 2021, 39: e18595-e18595. DOI: 10.1200/jco.2021.39.15_suppl.e18595.
- Takvorian S, Parikh R, Vader D, Wileyto E, Clark A, Lee D, Goyal G, Rocque G, Dotan E, Geynisman D, Phull P, Spiess P, Kim R, Davidoff A, Gross C, Miksad R, Calip G, Shulman L, Mamtani R, Hubbard R. Impact of COVID-19 pandemic on time to treatment initiation for patients with advanced cancer. Journal Of Clinical Oncology 2021, 39: 1528-1528. DOI: 10.1200/jco.2021.39.15_suppl.1528.
- Leapman M, Dinan M, Pasha S, Washington S, Ma X, Gross C. Mediators of racial disparity in the use of prostate MRI. Journal Of Clinical Oncology 2021, 39: 6554-6554. DOI: 10.1200/jco.2021.39.15_suppl.6554.
- Jairam V, Pasha S, Soulos P, Goldberg S, Yu J, Decker R, Gross C, Park H. Adoption of consolidative durvalumab among patients with locally advanced non-small cell lung cancer. Journal Of Clinical Oncology 2021, 39: e20550-e20550. DOI: 10.1200/jco.2021.39.15_suppl.e20550.
- Chagpar A, Lannin D, Mougalian S, Berger E, Gross C, Horowitz N, Sanft T, DiGiovanna M, Golshan M, Pusztai L. How did the COVID crisis affect use of neoadjuvant therapy for patients with breast cancer? Journal Of Clinical Oncology 2021, 39: e18708-e18708. DOI: 10.1200/jco.2021.39.15_suppl.e18708.
- Samuels EA, Boatright DH, Wong AH, Cramer LD, Desai MM, Solotke MT, Latimore D, Gross CP. Association Between Sexual Orientation, Mistreatment, and Burnout Among US Medical Students. JAMA Network Open 2021, 4: e2036136. PMID: 33528552, PMCID: PMC7856540, DOI: 10.1001/jamanetworkopen.2020.36136.
- Jairam V, Pasha S, Soulos P, Gross C, Yu J, Park H, Decker R. Post-Operative Radiation Therapy for Non-Small Cell Lung Cancer: A Comparison of Radiation Therapy Techniques. International Journal Of Radiation Oncology • Biology • Physics 2020, 108: e130. DOI: 10.1016/j.ijrobp.2020.07.1276.
- Gao S, Dosoretz A, Shafman T, Gross C, Yu J, Meadows H, Decker R, Mak R, Kann B. Development and External Validation of a Nomogram to Predict Distant Metastases after Stereotactic Body Radiation Therapy in Early Stage Non-Small Cell Lung Cancer Patients. International Journal Of Radiation Oncology • Biology • Physics 2020, 108: e90. DOI: 10.1016/j.ijrobp.2020.07.1190.
- Yang D, Park H, Jairam V, Decker R, Chiang A, Gross C, Yu J. Association Between Prophylactic Cranial Irradiation and Improved Overall Survival in Small Cell Lung Cancer. International Journal Of Radiation Oncology • Biology • Physics 2020, 108: e106. DOI: 10.1016/j.ijrobp.2020.07.1223.
- Wong W, Sheinson D, Ogale S, Flores C, Gross C. The association between Medicare’s next generation sequencing (NGS), national coverage decision (NCD), and NGS utilization. Journal Of Clinical Oncology 2020, 38: 98-98. DOI: 10.1200/jco.2020.38.29_suppl.98.
- Gross C, Meyer C, Ogale S, Kent M, Wong W. The association between Medicaid insurance, biomarker testing, and outcomes in patients with advanced non-small cell lung cancer (aNSCLC). Journal Of Clinical Oncology 2020, 38: 89-89. DOI: 10.1200/jco.2020.38.29_suppl.89.
- Adelson K, Canavan M, Mun S, Gross C, Sinanis N, Davidoff A. The association between clinical trial (CT) participation, pharmaceutical costs, and savings performance in the Oncology Care Model (OCM). Journal Of Clinical Oncology 2020, 38: 2-2. DOI: 10.1200/jco.2020.38.29_suppl.2.
- Bongiovanni T, Kim SP, Kim A, Killelea B, Gross C. Is there variation in private payor payments to cancer surgeons? A cross-sectional study in the USA. BMJ Open 2020, 10: e035438. PMID: 33020076, PMCID: PMC7537435, DOI: 10.1136/bmjopen-2019-035438.
- Parikh R, Cohen R, Min E, Wileyto E, Riaz F, Gross C, Long Q, Mamtani R. Uptake of first-line immune checkpoint inhibitors among medically frail patients with advanced solid malignancies. Journal Of Clinical Oncology 2020, 38: e19316-e19316. DOI: 10.1200/jco.2020.38.15_suppl.e19316.
- Yang D, Leapman M, Gross C, Yu J. Utilization of next-generation sequencing and associated systemic therapy initiation in metastatic prostate cancer. Journal Of Clinical Oncology 2020, 38: e19308-e19308. DOI: 10.1200/jco.2020.38.15_suppl.e19308.
- Jairam V, Yang D, Pasha S, Soulos P, Gross C, Yu J, Park H. Temporal trends in opioid prescribing patterns among oncologists in the Medicare population. Journal Of Clinical Oncology 2020, 38: 12022-12022. DOI: 10.1200/jco.2020.38.15_suppl.12022.
- Yang D, Jairam V, Park H, Decker R, Chiang A, Gross C, Yu J. Use of prophylactic cranial irradiation in patients with extensive-stage small cell lung cancer receiving immunotherapy. Journal Of Clinical Oncology 2020, 38: e19309-e19309. DOI: 10.1200/jco.2020.38.15_suppl.e19309.
- Riaz F, Gan G, Li F, Davidoff A, Adelson K, Presley C, Adamson B, Shaw P, Parikh R, Mamtani R, Gross C. The adoption of immune checkpoint inhibitors and patterns of care at the end of life. Journal Of Clinical Oncology 2020, 38: 12027-12027. DOI: 10.1200/jco.2020.38.15_suppl.12027.
- Adelson K, Canavan M, Mun S, Gross C, Sinanis N, Davidoff A. The impact of clinical trial (CTr) participation on savings performance in the oncology care model (OCM). Journal Of Clinical Oncology 2020, 38: e19367-e19367. DOI: 10.1200/jco.2020.38.15_suppl.e19367.
- Hill KA, Samuels EA, Gross CP, Desai MM, Zelin N, Latimore D, Huot SJ, Cramer LD, Wong AH, Boatright D. Assessment of the Prevalence of Medical Student Mistreatment by Sex, Race/Ethnicity, and Sexual Orientation. JAMA Internal Medicine 2020, 180: 653-665. PMID: 32091540, PMCID: PMC7042809, DOI: 10.1001/jamainternmed.2020.0030.
- Leapman* M, Wang R, Ma X, Gross C. MP23-17 ASSOCIATIONS OF REGIONAL-LEVEL ADOPTION OF PROSTATE MRI AND GENOMIC TESTING AND OBSERVATION FOR PROSTATE CANCER. Journal Of Urology 2020, 203 DOI: 10.1097/ju.0000000000000856.017.
- Wang SY, Abujarad F, Chen T, Evans SB, Killelea BK, Mougalian SS, Fraenkel L, Gross C. “Radiotherapy for older women (ROW)”: A risk calculator for women with early-stage breast cancer. Journal Of Geriatric Oncology 2019, 11: 850-859. PMID: 31899199, PMCID: PMC7263974, DOI: 10.1016/j.jgo.2019.12.010.
- Huntington S, Soulos P, Barr P, Jacobs R, Lansigan F, Odejide O, Schwartzberg L, Davidoff A, Gross C. Utilization and Early Discontinuation of First-Line Ibrutinib for Patients with Chronic Lymphocytic Leukemia Treated in the Community Oncology Setting in the United States. Blood 2019, 134: 797. DOI: 10.1182/blood-2019-122054.
- Cohen A, Neri B, Adamson B, Scanlon C, Gross C, Meropol N, Miksad R. 1558P Biomarker status as a mediator of age-related overall survival (OS) in advanced non-small cell lung cancer (aNSCLC). Annals Of Oncology 2019, 30: v642. DOI: 10.1093/annonc/mdz260.080.
- Bongiovanni T, Jean R, Xu X, Soulos P, Herrin J, Kim A, Gross C. Moving to Bundled Payments: Costs of Lung Cancer Resections. Journal Of The American College Of Surgeons 2019, 229: e209. DOI: 10.1016/j.jamcollsurg.2019.08.1434.
- Kunst N, Long J, Xu X, Busch S, Richman I, Kyanko K, Gross C. Utilization and costs of breast cancer screening for women in their 40s in a privately insured U.S. population. Journal Of Clinical Oncology 2019, 37: 105-105. DOI: 10.1200/jco.2019.37.27_suppl.105.
- Adelson K, Canavan M, Supalla S, Sedghi T, Chaudhry B, Sinanis N, Gross C. Effects of rising drug costs on efforts to control overall cost at a large academic cancer center. Journal Of Clinical Oncology 2019, 37: 2-2. DOI: 10.1200/jco.2019.37.27_suppl.2.
- Mahal A, Mahal B, Kim S, Singh R, Green A, Nguyen P, Gross C, Yu J. The Effect of Race and Decision Aids on Provider Recommendation for Prostate Cancer Treatment Planning: A Randomized Study. International Journal Of Radiation Oncology • Biology • Physics 2019, 105: s220. DOI: 10.1016/j.ijrobp.2019.06.306.
- Chang E, Decker R, Hu X, Yu J, Gross C, Lester-Coll N. Predictors of Toxicity from Stereotactic Body Radiotherapy (SBRT) for Lung Tumors Ultra-Central or Central to Heart, Esophagus, or Proximal Bronchial Tree. International Journal Of Radiation Oncology • Biology • Physics 2019, 105: e499-e500. DOI: 10.1016/j.ijrobp.2019.06.1413.
- Gao S, Kann B, Dosoretz A, Shafman T, Gross C, Yu J, Decker R. An Externally Validated Nomogram to Predict Distant Metastases after Stereotactic Body Radiation Therapy in Early Stage Non-Small Cell Lung Cancer Patients. International Journal Of Radiation Oncology • Biology • Physics 2019, 105: s145-s146. DOI: 10.1016/j.ijrobp.2019.06.146.
- Richman IB, Hoag JR, Xu X, Forman HP, Hooley R, Busch SH, Gross CP. Adoption of Digital Breast Tomosynthesis in Clinical Practice. JAMA Internal Medicine 2019, 179: 1292-1295. PMID: 31233086, PMCID: PMC6593646, DOI: 10.1001/jamainternmed.2019.1058.
- Adamson B, Cohen A, Estevez M, Magee K, Williams E, Gross C, Meropol N, Davidoff A. Affordable Care Act (ACA) Medicaid expansion impact on racial disparities in time to cancer treatment. Journal Of Clinical Oncology 2019, 37: lba1-lba1. DOI: 10.1200/jco.2019.37.18_suppl.lba1.
- Yang D, Makarov D, Gross C, Yu J. Contemporary changes in localized and metastatic prostate cancer incidence by geographic area following decreased PSA screening. Journal Of Clinical Oncology 2019, 37: 1567-1567. DOI: 10.1200/jco.2019.37.15_suppl.1567.
- Abandonment trajectories of conventionally fractionated adjuvant radiotherapy in breast cancer care.Xu X, Soulos P, Herrin J, Wang S, Pollack C, Evans S, Gross C, Yu J. Abandonment trajectories of conventionally fractionated adjuvant radiotherapy in breast cancer care. Journal Of Clinical Oncology 2019, 37: 531-531. DOI: 10.1200/jco.2019.37.15_suppl.531.
- Leapman M, Presley C, Zhu W, Soulos P, Adelson K, Boffa D, Gross C. Real-world practice patterns and impact of PD-L1 expression testing in patients with advanced non-small cell lung cancer. Journal Of Clinical Oncology 2019, 37: 9059-9059. DOI: 10.1200/jco.2019.37.15_suppl.9059.
- Giri S, Huntington S, Wang R, Zeidan A, Podoltsev N, Gore S, Ma X, Gross C, Davidoff A, Neparidze N. Chromosome 1 abnormalities and clinical outcomes in multiple myeloma in the era of novel agents. Journal Of Clinical Oncology 2019, 37: 8044-8044. DOI: 10.1200/jco.2019.37.15_suppl.8044.
- Canavan M, Sedghi T, Gross C, Lane S, Bogdan J, Adelson K. Understanding cancer care coordination: Opening the black box. Journal Of Clinical Oncology 2019, 37: e18310-e18310. DOI: 10.1200/jco.2019.37.15_suppl.e18310.
- Sedghi T, Canavan M, Gross C, Davidoff A, Gould Rothberg BE, Strait M, Sinanis N, Adelson K. Impact of an oncology urgent care clinic on emergency department rates. Journal Of Clinical Oncology 2019, 37: 6615-6615. DOI: 10.1200/jco.2019.37.15_suppl.6615.
- Hooley I, Cohen A, Gross C, Williams E, Adamson B. PCN200 MEDICAID EXPANSION AND RACIAL INEQUITIES IN NEXT GENERATION SEQUENCING TESTING IN ONCOLOGY. Value In Health 2019, 22: s93. DOI: 10.1016/j.jval.2019.04.322.
- Johnson S, Park H, Gross C, Yu J. Complementary Medicine, Refusal of Conventional Cancer Therapy, and Survival Among Patients With Curable Cancers. Obstetrical & Gynecological Survey 2019, 74: 217-219. DOI: 10.1097/01.ogx.0000554438.70661.56.
- Hsiang W, Jemal A, Nguyen K, Shuch B, Park H, Yu J, Gross C, Davidoff A, Leapman* M. MP29-16 THE ASSOCIATION BETWEEN THE AFFORDABLE CARE ACT, INSURANCE STATUS, AND TREATMENT AMONG PATIENTS WITH TESTICULAR CANCER. Journal Of Urology 2019, 201 DOI: 10.1097/01.ju.0000557551.36748.5c.
- Jairam V, Lee V, Park H, Thomas C, Melnick E, Gross C, Presley C, Adelson K, Yu J. P78 Treatment-Related Complications of Chemotherapy and Radiotherapy: An Analysis of the Nationwide Emergency Department Sample. International Journal Of Radiation Oncology • Biology • Physics 2019, 103: e51-e52. DOI: 10.1016/s0360-3016(19)30528-0.
- Desai VB, Wright J, Gross C, Lin H, Boscoe F, Schwartz P, Xu X. Risk of unexpected uterine Cancer in women undergoing myomectomy: A population-based study. European Journal Of Obstetrics & Gynecology And Reproductive Biology 2019, 238: 188-190. PMID: 31103353, DOI: 10.1016/j.ejogrb.2019.03.021.
- Parikh R, Galsky M, Gyawali B, Riaz F, Kaufmann T, Cohen A, Adamson B, Gross C, Meropol N, Mamtani R. Trends in checkpoint inhibitor therapy for advanced urothelial cell carcinoma (aUC) at the end of life: Insights from real-world practice. Journal Of Clinical Oncology 2019, 37: 395-395. DOI: 10.1200/jco.2019.37.7_suppl.395.
- Schulman-Green D, Cherlin E, Capasso R, Mougalian S, Wang S, Gross C, Bajaj P, Eakle K, Adelson K, Patel S. Finding the Path: Incorporating Patient Preferences into an Interactive Clinical Pathway Platform (S867). Journal Of Pain And Symptom Management 2019, 57: 517. DOI: 10.1016/j.jpainsymman.2018.12.317.
- Huntington S, Zhu W, Hoag J, Wang R, Zeidan A, Giri S, Podoltsev N, Gore S, Ma X, Gross C, Davidoff A. Association between Oncologist Ownership of Imaging Facilities and Utilization: An Analysis of Positron-Emission Tomography (PET) Use in Lymphoma Settings with Variable PET Utility. Blood 2018, 132: 3538. DOI: 10.1182/blood-2018-99-115140.
- Yu J, Pollack C, Herrin J, Zhu W, Soulos P, Xu X, Gross C. Persistent Use of Extended Fractionation Palliative Radiation Therapy for Medicare Beneficiaries with Metastatic Breast Cancer: 2011-2014. International Journal Of Radiation Oncology • Biology • Physics 2018, 102: e425. DOI: 10.1016/j.ijrobp.2018.07.1241.
- Kann B, Miccio J, Stahl J, Verma V, Dosoretz A, Park H, Shafman T, Gross C, Yu J, Decker R. Systemic Therapy with Stereotactic Body Radiation Therapy (SBRT) for Early-Stage Non-Small Cell Lung Carcinoma (NSCLC): A Multi-institutional Analysis. International Journal Of Radiation Oncology • Biology • Physics 2018, 102: s10-s11. DOI: 10.1016/j.ijrobp.2018.06.119.
- Johnson S, Park H, Gross C, Yu J. Complementary Medicine, Refusal of Conventional Cancer Therapy, and Survival among Patients with Curable Cancers. International Journal Of Radiation Oncology • Biology • Physics 2018, 102: e399-e400. DOI: 10.1016/j.ijrobp.2018.07.1180.
- O’Connor J, Sedghi T, Dhodapkar M, Kane MJ, Gross CP. Factors Associated With Cancer Disparities Among Low-, Medium-, and High-Income US Counties. JAMA Network Open 2018, 1: e183146. PMID: 30646225, PMCID: PMC6324449, DOI: 10.1001/jamanetworkopen.2018.3146.
- Zhou Y, Abel G, Hamilton W, Pritchard-Jones K, Gross C, Walter F, Renzi C, Johnson S, McPhail S, Elliss-Brookes L, Lyratzopoulos G. Defining, Measuring and Preventing the Diagnosis of Cancer as an Emergency: A Critical Review of Current Evidence. Journal Of Global Oncology 2018, 4: 48s-48s. DOI: 10.1200/jgo.18.45300.
- Wang S, Lin Y, Lin C, Sedghi T, Hsu S, Kim H, Chou T, Chiu Y, Gross C, Wang J. Treatment patterns and survival for hepatocellular carcinoma in USA and Taiwan. Journal Of Clinical Oncology 2018, 36: e16120-e16120. DOI: 10.1200/jco.2018.36.15_suppl.e16120.
- Wang S, Hung P, Killelea B, Mougalian S, Evans S, Sedghi T, Gross C. Comparative effectiveness of sentinel lymph node biopsy for patients with ductal carcinoma in situ. Journal Of Clinical Oncology 2018, 36: e12602-e12602. DOI: 10.1200/jco.2018.36.15_suppl.e12602.
- Richman I, Hoag J, Busch S, Gross C. Early adoption of digital breast tomosynthesis in the United States. Journal Of Clinical Oncology 2018, 36: e13543-e13543. DOI: 10.1200/jco.2018.36.15_suppl.e13543.
- Gross C, Hoag J, Xu X, Richman I, Aminawung J, Soulos P, Busch S. State breast density inform mandate laws and utilization of adjunctive screening tests and cancer detection following screening mammography. Journal Of Clinical Oncology 2018, 36: 6579-6579. DOI: 10.1200/jco.2018.36.15_suppl.6579.
- Pariser A, Mougalian S, Sedghi T, Gross C, Killelea B. Treatment effect of neoadjuvant endocrine therapy compared to neoadjuvant chemotherapy on breast cancer outcomes. Journal Of Clinical Oncology 2018, 36: e12630-e12630. DOI: 10.1200/jco.2018.36.15_suppl.e12630.
- Huntington S, Von Keudell G, Davidoff A, Gross C, Prasad S. Cost-effectiveness analysis of brentuximab vedotin with chemotherapy in newly diagnosed stage III/IV Hodgkin lymphoma. Journal Of Clinical Oncology 2018, 36: 6609-6609. DOI: 10.1200/jco.2018.36.15_suppl.6609.
- Ruddy KJ, Sangaralingham L, Freedman RA, Mougalian S, Neuman H, Greenberg C, Jemal A, Duma N, Haddad TC, Lemaine V, Ghosh K, Hieken TJ, Hunt K, Vachon C, Gross C, Shah ND. Adherence to Guidelines for Breast Surveillance in Breast Cancer Survivors. Journal Of The National Comprehensive Cancer Network 2018, 16: 526-534. PMID: 29752327, DOI: 10.6004/jnccn.2018.7001.
- Kim S, Karnes J, Bukavina L, Van Houten H, Gross C, Mwangi R, Shah N. MP12-15 NATIONAL TRENDS IN THE MANAGEMENT OF LOCALIZED PROSTATE CANCER FROM A POPULATION-BASED COHORT OF PRIVATELY INSURED PATIENTS. Journal Of Urology 2018, 199: e141-e142. DOI: 10.1016/j.juro.2018.02.402.
- Leapman M, Wang R, Park H, Yu J, Gross C, Ma X. MP53-08 USE OF PROSTATE MAGNETIC RESONANCE IMAGING AMONG MEDICARE BENEFICIARIES WITH LOW-RISK PROSTATE CANCER IS ASSOCIATED WITH A HIGHER LIKELIHOOD OF DEFINITIVE TREATMENT. Journal Of Urology 2018, 199: e707. DOI: 10.1016/j.juro.2018.02.1679.
- Andreano A, Peake M, Valsecchi M, Janes S, Pritchard-Jones K, Hoag J, Gross C. 128 The care and outcomes of older persons with lung cancer in England and US, 2008–2012. Lung Cancer 2018, 115: s54-s55. DOI: 10.1016/s0169-5002(18)30154-5.
- Bui D, Magnuson W, Lester-Coll N, Qian J, Ross R, Soulos P, Shafman T, Dosoretz A, Evans S, Yu J, Gross C, Decker R. Stereotactic Body Radiation Therapy for Oligometastatic Disease: A Multi-Institutional Retrospective Survival Analysis. International Journal Of Radiation Oncology • Biology • Physics 2017, 99: e443. DOI: 10.1016/j.ijrobp.2017.06.1664.
- Johnson S, Park H, Gross C, Yu J. Use of Alternative Medicine for Cancer and Its Impact on Survival. International Journal Of Radiation Oncology • Biology • Physics 2017, 99: e401. DOI: 10.1016/j.ijrobp.2017.06.1562.
- Johnson SB, Park HS, Gross CP, Yu JB. Use of Alternative Medicine for Cancer and Its Impact on Survival. Journal Of The National Cancer Institute 2017, 110: djx145. PMID: 28922780, DOI: 10.1093/jnci/djx145.
- Presley C, Han L, O'leary J, Chao H, Shamas T, Kerin A, Rose M, Gross C. Concurrent Care and Aggressive End-of-Life Lung Cancer Care. Journal Of Thoracic Oncology 2017, 12: s1545. DOI: 10.1016/j.jtho.2017.06.058.
- Li D, Sun C, Levi A, Klepin H, Elias R, Mohile S, Tew W, Lim D, Chung V, Chao J, Owusu C, Muss H, Lichtman S, Gross C, Chapman A, Gajra A, Cohen H, Katheria V, Hurria A. Risk factors for hospitalizations (HOS) among older adults with gastrointestinal (GI) cancers receiving chemotherapy. Journal Of Clinical Oncology 2017, 35: e21523-e21523. DOI: 10.1200/jco.2017.35.15_suppl.e21523.
- Soto Perez De Celis E, Sun C, Tew W, Mohile S, Gajra A, Klepin H, Owusu C, Gross C, Muss H, Lichtman S, Chapman A, Cohen H, Dale W, Kim H, Katheria V, Hurria A. Impact of hearing and visual impairment in older adults with cancer. Journal Of Clinical Oncology 2017, 35: 10036-10036. DOI: 10.1200/jco.2017.35.15_suppl.10036.
- O'Connor J, Seidl-Rathkopf K, You P, Nussbaum N, Torres A, Fessele K, Darius K, Adelson K, Yin E, Presley C, Chiang A, Ross J, Abernethy A, Gross C. Adoption of immunotherapy into real-world practice: Insights from the use of checkpoint inhibitors. Journal Of Clinical Oncology 2017, 35: e14583-e14583. DOI: 10.1200/jco.2017.35.15_suppl.e14583.
- Presley C, Soulos P, Chiang A, Longtine J, Adelson K, Herbst R, Nussbaum N, Sorg R, Abernethy A, Agarwala V, Gross C. Disparities in next generation sequencing in a population-based community cohort of patients with advanced non-small cell lung cancer. Journal Of Clinical Oncology 2017, 35: 6563-6563. DOI: 10.1200/jco.2017.35.15_suppl.6563.
- O'Connor J, Seidl-Rathkopf K, Torres A, You P, Nussbaum N, Fessele K, Darius K, Adelson K, Yin E, Presley C, Chiang A, Ross J, Abernethy A, Gross C. Racial disparities in the use of programmed death-1 checkpoint inhibitors. Journal Of Clinical Oncology 2017, 35: 3068-3068. DOI: 10.1200/jco.2017.35.15_suppl.3068.
- Ruddy K, Sangaralingham L, Neuman H, Greenberg C, Freedman R, Jemal A, Mougalian S, Hunt K, Haddad T, Lemaine V, Ghosh K, Hieken T, Vachon C, Gross C, Shah N. Mammography use in breast cancer survivors: An administrative claims study. Journal Of Clinical Oncology 2017, 35: 6531-6531. DOI: 10.1200/jco.2017.35.15_suppl.6531.
- Johnson S, Gross C, Park H, Yu J. Use of alternative medicine for cancer and its impact on survival. Journal Of Clinical Oncology 2017, 35: e18175-e18175. DOI: 10.1200/jco.2017.35.15_suppl.e18175.
- Huntington S, Long J, Hoag J, Wang R, Zeidan A, Giri S, Gore S, Ma X, Gross C, Davidoff A. Physician volume and discontinuation of rituximab during lymphoma treatment. Journal Of Clinical Oncology 2017, 35: 6593-6593. DOI: 10.1200/jco.2017.35.15_suppl.6593.
- Mougalian S, Soulos P, Lannin D, Pusztai L, Gross C, Killelea B. Duration of neoadjuvant endocrine therapy and breast cancer outcomes. Journal Of Clinical Oncology 2017, 35: e12129-e12129. DOI: 10.1200/jco.2017.35.15_suppl.e12129.
- Scarberry K, Scarberry K, Abouassaly R, Gonzalez C, Gross C, Shah N, Meropol N, Psutka S, Prasad S, Bukavina L, Kim S. PD09-02 RACIAL VARIATION IN THE REFUSAL OF INITIAL TREATMENT PLAN AMONG MEN DIAGNOSED WITH LOCALIZED PROSTATE CANCER. Journal Of Urology 2017, 197: e194. DOI: 10.1016/j.juro.2017.02.552.
- Nguyen K, Gross C, Cooperberg M, Katz M, Hittelman A, Syed J, Schulam P, Leapman M. MP69-07 HASHTAG PEER-REVIEW: DOES EARLY SOCIAL MEDIA SUCCESS CORRELATE WITH CONVENTIONAL METRICS OF PUBLICATION IMPACT? Journal Of Urology 2017, 197: e928-e929. DOI: 10.1016/j.juro.2017.02.2303.
- Pollack CE, Soulos PR, Herrin J, Xu X, Christakis NA, Forman HP, Yu JB, Killelea BK, Wang SY, Gross CP. The Impact of Social Contagion on Physician Adoption of Advanced Imaging Tests in Breast Cancer. Journal Of The National Cancer Institute 2017, 109: djw330. PMID: 28376191, PMCID: PMC6059114, DOI: 10.1093/jnci/djw330.
- Davis BA, Aminawung JA, Abu-Khalaf MM, Evans SB, Su K, Mehta R, Wang SY, Gross CP. Racial and Ethnic Disparities in Oncotype DX Test Receipt in a Statewide Population-Based Study. Journal Of The National Comprehensive Cancer Network 2017, 15: 346-354. PMID: 28275035, DOI: 10.6004/jnccn.2017.0034.
- Wang S, Cramer L, Pollack C, Gross C. Primary care physician continuity and end-of-life care intensity among Medicare cancer decedents. Journal Of Clinical Oncology 2017, 35: 38-38. DOI: 10.1200/jco.2017.35.5_suppl.38.
- Bongiovanni T, Kim S, Gross C, Kim A, Killelea B. Variation in Private Payer Payments to Cancer Surgeons. Journal Of The American College Of Surgeons 2016, 223: s121-s122. DOI: 10.1016/j.jamcollsurg.2016.06.252.
- Stahl J, Ross R, Harder E, Mancini B, Soulos P, Dosoretz A, Finkelstein S, Shafman T, Husain Z, Evans S, Yu J, Gross C, Decker R. A Biologically Effective Dose of ≥105 Gy Is Associated With Improved Overall Survival in Stage I Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy. International Journal Of Radiation Oncology • Biology • Physics 2016, 96: s174-s175. DOI: 10.1016/j.ijrobp.2016.06.438.
- Jairam V, Gross C, Yu J. Examining Trends in the CMS Medicare Provider Utilization and Payment Database for Radiation Oncologists. International Journal Of Radiation Oncology • Biology • Physics 2016, 96: e404-e405. DOI: 10.1016/j.ijrobp.2016.06.1646.
- Johnson S, Soulos P, Shafman T, Mantz C, Dosoretz A, Ross R, Finkelstein S, Collins S, Suy S, Brower J, Ritter M, King C, Kupelian P, Horwitz E, Pollack A, Abramowitz M, Hallman M, Faria S, Gross C, Yu J. Patient-Reported Quality of Life After Stereotactic Body Radiation Therapy Versus Moderate Hypofractionation for Clinically Localized Prostate Cancer. International Journal Of Radiation Oncology • Biology • Physics 2016, 96: e242. DOI: 10.1016/j.ijrobp.2016.06.1232.
- Hong J, Gross C, Shafman T, Hu X, Yu J, Ross R, Dosoretz A, Park H, Finkelstein S, Soulos P, Evans S. Modern Radiation Therapy for Left-Sided Breast Cancer: An Analysis of Mean Heart Dose Within Diverse Practice Settings. International Journal Of Radiation Oncology • Biology • Physics 2016, 96: s209. DOI: 10.1016/j.ijrobp.2016.06.520.
- Wang E, Wang S, Soulos P, Chen R, Kim S, Gross C, Yu J. Changes in quality of life after radiation therapy for localized prostate cancer after dissemination of intensity modulated radiation therapy. Journal Of Radiation Oncology 2016, 6: 295-300. DOI: 10.1007/s13566-016-0269-0.
- Klepin H, Sun C, Smith D, Elias R, Trevino K, Bryant A, Nelson C, Tew W, Mohile S, Owusu C, Gross C, Gajra A, Lichtman S, Katheria V, Hurria A. Predictors of unplanned hospitalizations among older adults receiving cancer chemotherapy. Journal Of Clinical Oncology 2016, 34: 10057-10057. DOI: 10.1200/jco.2016.34.15_suppl.10057.
- Shahrokni A, Sun C, Tew W, Mohile S, Owusu C, Klepin H, Gross C, Lichtman S, Gajra A, Katheria V, Cohen H, Hurria A. Complex association between social support and chemotherapy-related toxicities in older cancer patients. Journal Of Clinical Oncology 2016, 34: 10036-10036. DOI: 10.1200/jco.2016.34.15_suppl.10036.
- Wang S, Huang S, Hsu S, Gross C. Association of length of hospice enrollment with regional variation in end-of-life care expenditures. Journal Of Clinical Oncology 2016, 34: 10030-10030. DOI: 10.1200/jco.2016.34.15_suppl.10030.
- Epstein L, Jhaveri A, Han G, Abu-Khalaf M, Hofstatter E, Sanft T, DiGiovanna M, Silber A, Adelson K, Chung G, Gross C, Pusztai L, Mougalian S. Onset of side effects and adherence to endocrine therapy in the Breast Cancer Endocrine Therapy Adherence (BETA) pilot study. Journal Of Clinical Oncology 2016, 34: e18136-e18136. DOI: 10.1200/jco.2016.34.15_suppl.e18136.
- Ruddy K, Sangaralingham L, Freedman R, Jemal A, Thompson C, Hashmi S, Mougalian S, Gross C, Shah N. Acute care use among women receiving adjuvant chemotherapy for breast cancer. Journal Of Clinical Oncology 2016, 34: 6543-6543. DOI: 10.1200/jco.2016.34.15_suppl.6543.
- Gross C, Ross W, Rotatori J, Mitchell H, Ma X, Kadan-Lottick N. Randomized trial assessing the impact of survivorship care plans on the quality of care for childhood cancer survivors. Journal Of Clinical Oncology 2016, 34: 10007-10007. DOI: 10.1200/jco.2016.34.15_suppl.10007.
- Stratton J, Hu X, Soulos P, Davidoff A, Pusztai L, Gross C, Mougalian S. Bone density screening in postmenopausal women with early-stage breast cancer on aromatase inhibitors. Journal Of Clinical Oncology 2016, 34: 6599-6599. DOI: 10.1200/jco.2016.34.15_suppl.6599.
- Presley C, Harrington E, Gippetti J, Agarwala V, Bowser B, Adelson K, Herbst R, Abernethy A, Gross C. Contemporary management of advanced non-small cell lung cancer (aNSCLC) in a large, real-world cohort. Journal Of Clinical Oncology 2016, 34: e20621-e20621. DOI: 10.1200/jco.2016.34.15_suppl.e20621.
- Mahal A, Cramer L, Wang E, Wang S, Davidoff A, Gross C, Yu J. The benefit of modern cancer therapy for older patients. Journal Of Clinical Oncology 2016, 34: e18141-e18141. DOI: 10.1200/jco.2016.34.15_suppl.e18141.
- Doan K, Levy B, Gross C, Wang S. Associations of pre- and post-cancer depression with end-of-life cancer care intensity. Journal Of Clinical Oncology 2016, 34: 10031-10031. DOI: 10.1200/jco.2016.34.15_suppl.10031.
- Thomas G, Cartmel B, Harrigan M, Fiellin M, Capozza S, Zhou Y, Ercolano E, Gross C, Hershman D, Ligibel J, Schmitz K, Li F, Sanft T, Irwin M. Randomized Trial Of Exercise On Body Composition In Breast Cancer Survivors Taking Aromatase Inhibitors. Medicine & Science In Sports & Exercise 2016, 48: 334. DOI: 10.1249/01.mss.0000486010.57056.60.
- Zeidan A, Long J, Hall J, Wang R, Huntington S, Abel G, Prebet T, Podoltsev N, Gross C, Gore S, Ma X, Davidoff A. Comparative Effectiveness of Azacitidine Versus Decitabine Among Older Adults Diagnosed with Higher-Risk Myelodysplastic Syndromes (HR-MDS). Blood 2015, 126: 3285. DOI: 10.1182/blood.v126.23.3285.3285.
- Zeidan A, Long J, Wang R, Yu J, Hall J, Abel G, Gore S, Gross C, Ma X, Davidoff A. Secondary Myeloid Neoplasms in Older Women with Breast Cancer after Radiotherapy: A Population-Based Study. Blood 2015, 126: 1676. DOI: 10.1182/blood.v126.23.1676.1676.
- Wang R, Zeidan A, Soulos P, Yu J, Davidoff A, Gore S, Gross C, Ma X. Myelodysplastic Syndromes and Acute Myeloid Leukemia in Prostate Cancer Patients after Radiotherapy, a Population-Based Study. Blood 2015, 126: 3295. DOI: 10.1182/blood.v126.23.3295.3295.
- Zeidan A, Wang R, Davidoff A, Gore S, Soulos P, Huntington S, Gross C, Ma X. Lack of Association Between Costs of Care and Overall Survival (OS) Among Medicare Beneficiaries with Myelodysplastic Syndromes (MDS) in the United States (US). Blood 2015, 126: 873. DOI: 10.1182/blood.v126.23.873.873.
- Aneja S, Smith B, Gross C, Haffty B, Wilson L, Yu J. Trends in Hospital Owned Practices Within Radiation Oncology. International Journal Of Radiation Oncology • Biology • Physics 2015, 93: e371-e372. DOI: 10.1016/j.ijrobp.2015.07.1495.
- Park H, Wang E, Corso C, Rutter C, Wilson L, Kim A, Gross C, Yu J, Decker R. Higher Facility Case Volume of Stereotactic Body Radiation Therapy Is Associated With Improved Overall Survival in Clinical Stage I Non-Small Cell Lung Cancer. International Journal Of Radiation Oncology • Biology • Physics 2015, 93: s186-s187. DOI: 10.1016/j.ijrobp.2015.07.447.
- Aneja S, Gross C, Glazer P, Yu J. Genomic Predictors of Biochemical Failure Following Radical Prostatectomy. International Journal Of Radiation Oncology • Biology • Physics 2015, 93: e251-e252. DOI: 10.1016/j.ijrobp.2015.07.1180.
- Bledsoe T, Rutter C, Corso C, Aneja S, Lester-Coll N, Wang E, Potosky A, Gross C, Yu J, Park H. Stereotactic Body Radiation Therapy for Prostate Cancer: Adoption in the United States From 2005 to 2012. International Journal Of Radiation Oncology • Biology • Physics 2015, 93: e359. DOI: 10.1016/j.ijrobp.2015.07.1462.
- Lester-Coll N, Park H, Rutter C, Corso C, Mancini B, Yeboa D, Kim S, Gross C, Yu J. Evaluation at Academic Centers Increases the Likelihood of Active Surveillance in Low-Risk Prostate Cancer. International Journal Of Radiation Oncology • Biology • Physics 2015, 93: s118. DOI: 10.1016/j.ijrobp.2015.07.281.
- Fox J, Bauder A, Gross C, Killelea B, Butler P, Kovach S. The Relationship Between Geographic Access to Plastic Surgeons and Immediate Breast Reconstruction Rates Among Women Undergoing Mastectomy for Cancer. Plastic & Reconstructive Surgery 2015, 136: 91-92. DOI: 10.1097/01.prs.0000472391.73232.70.
- Zeidan A, Wang R, Davidoff A, Gore S, Gross C, Ma X. Disease-specific costs of care and survival among Medicare-enrolled patients with myelodysplastic syndromes (MDS). Clinical Lymphoma Myeloma & Leukemia 2015, 15: s44-s45. DOI: 10.1016/j.clml.2015.07.094.
- Wildes T, Tew W, Maggiore R, Edwards B, Cohen H, Smith D, Mohile S, Owusu C, Klepin H, Gross C, Lichtman S, Gajra A, Katheria V, Akiba C, Hurria A. Association of geriatric assessment factors with falls in older adults initiating chemotherapy. Journal Of Clinical Oncology 2015, 33: 9542-9542. DOI: 10.1200/jco.2015.33.15_suppl.9542.
- Peterson L, Hurria A, Feng T, Mohile S, Owusu C, Klepin H, Gross C, Lichtman S, Gajra A, Glezerman I, Katheria V, Zavala L, Smith D, Tew W. Association between renal function and chemotherapy-related toxicity in older adults with cancer. Journal Of Clinical Oncology 2015, 33: 9509-9509. DOI: 10.1200/jco.2015.33.15_suppl.9509.
- Presley C, Soulos P, Yu J, Gross C. “The burden upon me”: The complexity of healthcare utilization among Medicare patients undergoing curative lung cancer treatment. Journal Of Clinical Oncology 2015, 33: 7533-7533. DOI: 10.1200/jco.2015.33.15_suppl.7533.
- Bongiovanni T, Kim A, Killelea B, Kim S, Gross C. Variation in surgeon payment for cancer resection. Journal Of Clinical Oncology 2015, 33: e17802-e17802. DOI: 10.1200/jco.2015.33.15_suppl.e17802.
- Kim S, Karnes J, Gross C, Meropol N, Van Houten H, Abouassaly R, Shah N. Contemporary national trends of prostate cancer screening among privately insured patients in the United States. Journal Of Clinical Oncology 2015, 33: 5065-5065. DOI: 10.1200/jco.2015.33.15_suppl.5065.
- Su K, Yu J, Shafman T, Evans S, Decker R, Dosoretz A, Dosoretz D, Ross R, Salenius S, Finkelstein S, Hall J, Soulos P, Gross C. Changes in prostate cancer presentation for radiation oncology care after USPSTF recommendations, 2007-2013. Journal Of Clinical Oncology 2015, 33: e16070-e16070. DOI: 10.1200/jco.2015.33.15_suppl.e16070.
- Mougalian S, Long J, Hall J, Adelson K, Abu-Khalaf M, Pusztai L, Gross C. Outcomes of adjuvant ACT vs. TC chemotherapy in older women with breast cancer. Journal Of Clinical Oncology 2015, 33: 1009-1009. DOI: 10.1200/jco.2015.33.15_suppl.1009.
- Wang S, Hall J, Long J, Pollack C, Bradley E, Adelson K, Gross C. Trends and regional variation of end-of-life cancer care in the Medicare program. Journal Of Clinical Oncology 2015, 33: 9526-9526. DOI: 10.1200/jco.2015.33.15_suppl.9526.
- Makarov DV, Soulos PR, Gold HT, Yu JB, Sen S, Ross JS, Gross CP. Regional-Level Correlations in Inappropriate Imaging Rates for Prostate and Breast Cancers: Potential Implications for the Choosing Wisely Campaign. JAMA Oncology 2015, 1: 185-194. PMID: 26181021, PMCID: PMC4707944, DOI: 10.1001/jamaoncol.2015.37.
- Kiechle J, Wang E, Yu J, Gross C, Abouassaly R, Cherullo E, Smaldone M, Shah N, Trinh Q, Sun M, Kim S. MP56-06 ASSOCIATION BETWEEN PROVIDER-LEVEL FACTORS AND LYMPH NODE DISSECTION OUTCOMES DURING RADICAL PROSTATECTOMY: A NATIONAL CANCER DATABASE ANALYSIS. Journal Of Urology 2015, 193: e683. DOI: 10.1016/j.juro.2015.02.2070.
- Makarov D, Gold H, Walter D, Eugenio E, Sherman S, Gross C, Zeliadt S. MP9-03 THE EFFECT OF HEALTHCARE SYSTEM ON APPROPRIATENESS OF PROSTATE CANCER IMAGING: DO PATIENTS GET BETTER CARE IN VA OR FEE-FOR-SERVICE MEDICARE? Journal Of Urology 2015, 193: e102-e103. DOI: 10.1016/j.juro.2015.02.363.
- Wane R, Zeidan A, Soulos P, Yu J, Davidoff A, Gore S, Gross C, Ma X. 80 SUBSEQUENT MYELODYSPLASTIC SYNDROMES IN PROSTATE CANCER PATIENTS AFTER RADIOTHERAPY, A POPULATION-BASED STUDY. Leukemia Research 2015, 39: s39. DOI: 10.1016/s0145-2126(15)30081-3.
- Han Y, Wietsma A, Gross C, Shah N, Abouassaly R, Smaldone M, Boorjian S, Hoimes C, Cooney M, Kim S. MP69-08 SYSTEMATIC REVIEW AND META-ANALYSIS OF TARGETED THERAPY FOR OVERALL SURVIVAL, COMPLETE RESPONSE AND QUALITY OF LIFE FOR METASTATIC RENAL CELL CARCINOMA. Journal Of Urology 2015, 193: e869-e870. DOI: 10.1016/j.juro.2015.02.2512.
- Kim S, Karnes R, Gross C, Van Houten H, Abouassaly R, Shah N. PD44-05 CONTEMPORARY NATIONAL TRENDS OF PROSTATE CANCER SCREENING AMONG PRIVATELY INSURED PATIENTS IN THE UNITED STATES. Journal Of Urology 2015, 193: e899. DOI: 10.1016/j.juro.2015.02.2551.
- Kiechle J, Abouassaly R, Tabayoyong W, Dong S, Smaldone M, Cherullo E, Gross C, Shah N, Zhu H, Kim S. MP84-05 VARIATION IN SURGICAL MARGIN STATUS BY SURGICAL APPROACH AMONG PATIENTS UNDERGOING PARTIAL NEPHRECTOMY FOR SMALL RENAL MASSES. Journal Of Urology 2015, 193: e1059. DOI: 10.1016/j.juro.2015.02.1972.
- Dong S, Kiechle J, Kim S, Abouassaly R, Cherullo E, Ponsky L, Gross C, Shah N, Zhu H. MP44-10 TREATMENT TRENDS OF SMALL RENAL MASSES IN PATIENTS OF ADVANCED AGE. Journal Of Urology 2015, 193: e530. DOI: 10.1016/j.juro.2015.02.1552.
- Kiechle J, Wang E, Yu J, Gross C, Abouassaly R, Cherullo E, Smaldone M, Shah N, Trinh Q, Sun M, Kim S. Association between provider-level factors and lymph node dissection outcomes during radical prostatectomy: A national cancer database analysis. Journal Of Clinical Oncology 2015, 33: 89-89. DOI: 10.1200/jco.2015.33.7_suppl.89.
- Gajra A, Feng T, CARG, Mohile S, Owusu C, Klepin H, Gross C, Katheria V, Tew W, Hurria A, Group C. Assessing the validity of the CARG (Cancer and Aging Research Group) chemotherapy toxicity score for reduced models. Journal Of Geriatric Oncology 2014, 5: s64. DOI: 10.1016/j.jgo.2014.09.116.
- Erb C, Soulos P, Tanoue L, Gross C. Surveillance Practice Patterns After Curative Intent Therapy for Stage I Non-small Cell Lung Cancer in the Medicare Population. CHEST Journal 2014, 146: 607a. DOI: 10.1378/chest.1992085.
- Lott J, Soulos P, Aminawung J, Gross C. PS1-44: Time to Surgery for Melanoma. Clinical Medicine & Research 2014, 12: 78-78. PMCID: PMC4453318, DOI: 10.3121/cmr.2014.1250.ps1-44.
- Yu J, Soulos P, Cramer L, Decker R, Kim A, Gross C. Comparative Effectiveness of Stereotactic Body Radiation Therapy Versus Surgery for Stage I Non-small Cell Lung Cancer. International Journal Of Radiation Oncology • Biology • Physics 2014, 90: s138. DOI: 10.1016/j.ijrobp.2014.05.596.
- Yang D, Pamela S, Brigette D, Gross C, Yu J. Impact of 3 Decades of Screening on Racial Disparities in Cervical Cancer Incidence. International Journal Of Radiation Oncology • Biology • Physics 2014, 90: s579-s580. DOI: 10.1016/j.ijrobp.2014.05.1745.
- Killelea BK, Long JB, Chagpar AB, Ma X, Wang R, Ross JS, Gross CP. Evolution of Breast Cancer Screening in the Medicare Population: Clinical and Economic Implications. Journal Of The National Cancer Institute 2014, 106: dju159. PMID: 25031307, PMCID: PMC4155428, DOI: 10.1093/jnci/dju159.
- Kim S, Gross C, Abouassaly R, Psutka S, Van Houten H, Thompson R, Smaldone M, Trinh Q, Sun M, Han L, Shah N. Out-of-pockets costs for patients receiving targeted agents for metastatic renal cell carcinoma. Journal Of Clinical Oncology 2014, 32: e15598-e15598. DOI: 10.1200/jco.2014.32.15_suppl.e15598.
- Yang D, Soulos P, Davis B, Gross C, Yu J. Estimating the impact of screening on three decades of cervical cancer incidence. Journal Of Clinical Oncology 2014, 32: 1518-1518. DOI: 10.1200/jco.2014.32.15_suppl.1518.
- Yu J, Soulos P, Cramer L, Decker R, Kim A, Gross C. Diffusion of stereotactic body radiotherapy (SBRT) for early-stage non-small cell lung cancer (NSCLC) in the Medicare population, 2007-2009. Journal Of Clinical Oncology 2014, 32: 7575-7575. DOI: 10.1200/jco.2014.32.15_suppl.7575.
- Graham-Steed T, Soulos P, Dearing N, Concato J, Tinetti M, Gross C. Development and validation of a prognostic index for fracture risk in older men undergoing prostate cancer treatment. Journal Of Clinical Oncology 2014, 32: 5056-5056. DOI: 10.1200/jco.2014.32.15_suppl.5056.
- Kim S, Gross C, Nguyen P, Smaldone M, Thompson R, Shah N, Kutikov A, Han L, Karnes R, Ziegenfuss J, Tilburt J. Erratum: Specialty bias in treatment recommendations and quality of life among radiation oncologists and urologists for localized prostate cancer. Prostate Cancer And Prostatic Diseases 2014, 17: 212-212. DOI: 10.1038/pcan.2014.14.
- Sivarajan G, Taksler G, Walter D, Bjurlin M, Gross C, Makarov D. PD17-08 THE EFFECT OF THE SURGICAL ROBOT ON THE HOSPITAL-LEVEL UTILIZATION OF PARTIAL NEPHRECTOMY. Journal Of Urology 2014, 191: e543. DOI: 10.1016/j.juro.2014.02.1515.
- Psutka S, Kim S, Gross C, Van Houten H, Thompson R, Abouassaly R, Weight C, Leibovich B, Shah N. MP6-06 POPULATION-LEVEL TRENDS IN THE ADOPTION OF NOVEL TARGETED AGENTS FOR SYSTEMIC THERAPY AND IMPACT ON RATES OF CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA. Journal Of Urology 2014, 191: e58. DOI: 10.1016/j.juro.2014.02.240.
- Delpe S, Shah N, Tilburt J, Karnes R, Nguyen P, Shuch B, Gross C, Schulam P, Yu J, Ziegenfuss J, Kim S. Perceptions of radiation oncologists and urologists on the type of evidence that informs and changes the clinical practice of prostate cancer. Journal Of Clinical Oncology 2014, 32: 167-167. DOI: 10.1200/jco.2014.32.4_suppl.167.
- Yu J, Cramer L, Herrin J, Soulos P, Potosky A, Gross C. Stereotactic body radiosurgery versus intensity modulated radiotherapy for prostate cancer: Comparison of toxicity. Journal Of Clinical Oncology 2014, 32: 89-89. DOI: 10.1200/jco.2014.32.4_suppl.89.
- Presley C, Gross C. Trends in Radiotherapy After Breast-Conserving Surgery in Elderly Patients with Early-Stage Breast Cancer Luu C, Goldstein L, Goldner B, et al (Harbor-UCLA Med Ctr, Torrance, CA; City of Hope Natl Cancer Ctr, Duarte, CA) Ann Surg Oncol 20:3266-3273, 2013§. Breast Diseases A Year Book Quarterly 2014, 25: 85-87. DOI: 10.1016/j.breastdis.2014.01.005.
- Gavankar C, Gross C, Lilenbaum R, Chagpar A. Factors associated with unplanned breast cancer readmissions. Journal Of Clinical Oncology 2013, 31: 131-131. DOI: 10.1200/jco.2013.31.31_suppl.131.
- Raldow A, Presley C, Yu J, Cramer L, Soulos P, Long J, Makarov D, Gross C. The Dissemination of New Technologies and Temporal Trends in Curative Therapy for Prostate Cancer Patients With Low Likelihood of Clinical Benefit. International Journal Of Radiation Oncology • Biology • Physics 2013, 87: s177-s178. DOI: 10.1016/j.ijrobp.2013.06.459.
- Yu J, Cramer L, Herrin J, Soulos P, Potosky A, Gross C. Stereotactic Radiosurgery Versus Intensity Modulated Radiation Therapy for Prostate Cancer: Comparison of Early Toxicity. International Journal Of Radiation Oncology • Biology • Physics 2013, 87: s153-s154. DOI: 10.1016/j.ijrobp.2013.06.396.
- Herbst M, Rosenberg G, Daniels B, Gross C, Singh D, Molinaro A, Luty S, Moore C. Accuracy of Point-of-Care Ultrasound for Hydronephrosis in Patients With Suspected Renal Colic: A Look at Emergency Providers With Variable Ultrasound Experience. Annals Of Emergency Medicine 2013, 62: s32-s33. DOI: 10.1016/j.annemergmed.2013.07.369.
- Yang D, Gross C, Yu J. Changes in Early- and Late-Stage Colorectal Cancer Incidence During the Era of Screening: 1976-2009. International Journal Of Radiation Oncology • Biology • Physics 2013, 87: s331. DOI: 10.1016/j.ijrobp.2013.06.872.
- Maggiore R, Feng T, Dale W, Gross C, Tew W, Mohile S, Owusu C, Klepin H, Lichtman S, Gajra A, McKoy J, Katheria V, Ramani R, Jayani R, Brown J, Hurria A. Measures of polypharmacy and chemotherapy toxicity in older adults with cancer. Journal Of Clinical Oncology 2013, 31: 9545-9545. DOI: 10.1200/jco.2013.31.15_suppl.9545.
- Changes in early- and late-stage colorectal cancer incidence during the era of screening: 1976-2009.Yang D, Gross C, Yu J. Changes in early- and late-stage colorectal cancer incidence during the era of screening: 1976-2009. Journal Of Clinical Oncology 2013, 31: 1522-1522. DOI: 10.1200/jco.2013.31.15_suppl.1522.
- Iyer N, Mitchell H, Gross C, Ma X, Kadan-Lottick N. Health practices and behaviors of childhood cancer survivors not attending a comprehensive survivor clinic. Journal Of Clinical Oncology 2013, 31: 10063-10063. DOI: 10.1200/jco.2013.31.15_suppl.10063.
- Gross CP, Long JB, Ross JS, Abu-Khalaf MM, Wang R, Killelea BK, Gold HT, Chagpar AB, Ma X. The Cost of Breast Cancer Screening in the Medicare Population. JAMA Internal Medicine 2013, 173: 220-226. PMID: 23303200, PMCID: PMC3638736, DOI: 10.1001/jamainternmed.2013.1397.
- Vashi AA, Fox JP, Carr BG, D’Onofrio G, Pines JM, Ross JS, Gross CP. Use of Hospital-Based Acute Care Among Patients Recently Discharged From the Hospital. JAMA 2013, 309: 364-371. PMID: 23340638, PMCID: PMC3598620, DOI: 10.1001/jama.2012.216219.
- Yu JB, Soulos PR, Herrin J, Cramer LD, Potosky AL, Roberts KB, Gross CP. Proton Versus Intensity-Modulated Radiotherapy for Prostate Cancer: Patterns of Care and Early Toxicity. Journal Of The National Cancer Institute 2012, 105: 25-32. PMID: 23243199, PMCID: PMC3536640, DOI: 10.1093/jnci/djs463.
- Yu J, Soulos P, Herrin J, Cramer L, Potosky A, Roberts K, Gross C. Proton Radiation Therapy for Prostate Cancer in the Medicare Population: Patterns of Care and Comparison of Early Toxicity With Intensity Modulated Radiation Therapy. International Journal Of Radiation Oncology • Biology • Physics 2012, 84: s13. DOI: 10.1016/j.ijrobp.2012.07.040.
- Lloyd S, Buscariollo D, Gross C, Makarov D, Yu J, Aneja S. The Funding of Phase III Clinical Trials Examining Radiation Compared With That of Other Modalities. International Journal Of Radiation Oncology • Biology • Physics 2012, 84: s44-s45. DOI: 10.1016/j.ijrobp.2012.07.326.
- Buscariollo D, Lloyd S, Gross C, Makarov D, Yu J. Comparison of the Level of Evidence Supporting Practice Guidelines in Cancer Care Between Therapeutic Modalities. International Journal Of Radiation Oncology • Biology • Physics 2012, 84: s43. DOI: 10.1016/j.ijrobp.2012.07.324.
- Roberts K, Soulos P, Yu J, Evans S, Long J, Gross C. Temporal Trends in Radiation Modalities Among Older Women With Favorable Risk Breast Cancer. International Journal Of Radiation Oncology • Biology • Physics 2012, 84: s34. DOI: 10.1016/j.ijrobp.2012.07.093.
- Sen S, Soulos P, Frick K, Long J, Roberts K, Yu J, Evans S, Chagpar A, Gross C. Understanding Costs and Value of Newer Radiation Modalities Among Older Women With Breast Cancer. International Journal Of Radiation Oncology • Biology • Physics 2012, 84: s35. DOI: 10.1016/j.ijrobp.2012.07.096.
- Hansen D, Fox J, Gross C, Bruun J. Laparoscopic colon resection for cancer is not associated with fewer hospital-based encounters following discharge. Journal Of The American College Of Surgeons 2012, 215: s99. DOI: 10.1016/j.jamcollsurg.2012.06.264.
- Gajra A, Tew W, Hardt M, Mohile S, Owusu C, Klepin H, Gross C, Lichtman S, Katheria V, Hurria A. Predictors of early discontinuation of chemotherapy (EDC) in patients (pts) age 65 or older with stage IV non-small cell lung cancer (NSCLC). Journal Of Clinical Oncology 2012, 30: e18133-e18133. DOI: 10.1200/jco.2012.30.15_suppl.e18133.
- Quon J, Yu J, Soulos P, Gross C. The relations between age and androgen deprivation therapy use among men receiving radiation therapy for prostate cancer in the Medicare population. Journal Of Clinical Oncology 2012, 30: e15150-e15150. DOI: 10.1200/jco.2012.30.15_suppl.e15150.
- Weiss T, Nelson C, Tew W, Hardt M, Mohile S, Owusu C, Klepin H, Gross C, Gajra A, Lichtman S, Ramani R, Katheria V, Zavala L, Hurria A. The relationship among age, anxiety, and depression in older adults with cancer. Journal Of Clinical Oncology 2012, 30: 9123-9123. DOI: 10.1200/jco.2012.30.15_suppl.9123.
- Owusu C, Tew W, Hardt M, Mohile S, Klepin H, Gross C, Gajra A, Lichtman S, Ramani R, Katheria V, Zavala L, Hurria A. Anemia and functional disability in older adults with cancer. Journal Of Clinical Oncology 2012, 30: 9109-9109. DOI: 10.1200/jco.2012.30.15_suppl.9109.
- Hurria A, Hardt M, Tew W, Mohile S, Owusu C, Gross C, Gajra A, Lichtman S, Katheria V, Ramani R, Zavala L, Klepin H. Factors associated with life expectancy (LE) < 3 months (mo) among older adults receiving palliative chemotherapy (chemo). Journal Of Clinical Oncology 2012, 30: 9034-9034. DOI: 10.1200/jco.2012.30.15_suppl.9034.
- Lloyd S, Buscariollo D, Gross C, Makarov D, Yu J. An assessment of the collective efforts of clinical trials to provide evidence-based practice guidelines in cancer care. Journal Of Clinical Oncology 2012, 30: 6019-6019. DOI: 10.1200/jco.2012.30.15_suppl.6019.
- Yu J, Soulos P, Cramer L, Roberts K, Herrin J, Potosky A, Gross C. Proton radiotherapy for prostate cancer in the Medicare population: Patterns of care and comparison of early toxicity with IMRT. Journal Of Clinical Oncology 2012, 30: 4651-4651. DOI: 10.1200/jco.2012.30.15_suppl.4651.
- Presley C, Soulos P, Herrin J, Roberts K, Yu J, Killelea B, Lesnikoski B, Long J, Gross C. Short-term complications and use of breast brachytherapy in the national Medicare population in 2008-2009. Journal Of Clinical Oncology 2012, 30: 1030-1030. DOI: 10.1200/jco.2012.30.15_suppl.1030.
- Makarov D, Li H, Yu J, Makary M, Braithwaite S, Sherman S, Taneja S, Penson D, Lepor H, Desai R, Blustein J, Gross C. 419 FACTORS ASSOCIATED WITH THE EARLY ACQUISITION OF THE SURGICAL ROBOT BY HOSPITALS IN THE UNITED STATES. Journal Of Urology 2012, 187: e172. DOI: 10.1016/j.juro.2012.02.485.
- Soulos PR, Yu JB, Roberts KB, Raldow AC, Herrin J, Long JB, Gross CP. Assessing the Impact of a Cooperative Group Trial on Breast Cancer Care in the Medicare Population. Journal Of Clinical Oncology 2012, 30: 1601-1607. PMID: 22393088, PMCID: PMC3383112, DOI: 10.1200/jco.2011.39.4890.
- Chen J, Long J, Steingart R, Gross C. RISK OF HEART FAILURE OR CARDIOMYOPATHY ASSOCIATED WITH ADJUVANT TRASTUZUMAB OR CHEMOTHERAPY IN OLDER WOMEN WITH BREAST CANCER. Journal Of The American College Of Cardiology 2012, 59: e996. DOI: 10.1016/s0735-1097(12)60997-8.
- Hurria A, Togawa K, Mohile S, Owusu C, Klepin H, Gross C, Lichtman S, Gajra A, Bhatia S, Katheria V, Klapper S, Hansen K, Ramani R, Lachs M, Wong F, Tew W. Reply to J. Lagro et al. Journal Of Clinical Oncology 2012, 30: 561-562. DOI: 10.1200/jco.2011.39.5319.
- Yu J, Aneja S, Makarov D, Roberts K, Gross C. The influence of regional radiation oncologist and urologist capacities on treatment choice for prostate cancer management. Journal Of Clinical Oncology 2012, 30: 108-108. DOI: 10.1200/jco.2012.30.5_suppl.108.
- Yu J, Aneja S, Makarov D, Roberts K, Gross C. The influence of physician densities and patient characteristics on the decision to treat prostate cancer patients with varying clinical benefit. Journal Of Clinical Oncology 2012, 30: 19-19. DOI: 10.1200/jco.2012.30.5_suppl.19.
- Aneja S, Makarov D, Gross C, Roberts K, Yu J. The Influence of Physician Densities and Patient Characteristics on the Decision to Treat Prostate Cancer Patients with Varying Clinical Benefit. International Journal Of Radiation Oncology • Biology • Physics 2011, 81: s553. DOI: 10.1016/j.ijrobp.2011.06.871.
- Lloyd S, Gross C, Makarov D, Yu J. Are the Efforts of Current Clinical Trials Involving Radiation Therapy Focused on the Evidence Gaps in Cancer Treatment? International Journal Of Radiation Oncology • Biology • Physics 2011, 81: s139-s140. DOI: 10.1016/j.ijrobp.2011.06.286.
- Aneja S, Gross C, Makarov D, Roberts K, Yu J. The Influence of Regional Radiation Oncologist and Urologist Capacities on Treatment Choice for Prostate Cancer. International Journal Of Radiation Oncology • Biology • Physics 2011, 81: s552. DOI: 10.1016/j.ijrobp.2011.06.869.
- Maggiore R, Gross C, Hardt M, Tew W, Mohile S, Klepin H, Lichtman S, Owusu C, Gajra A, Ramani R, Katheria V, Brown J, Jayani R, Hurria A. Polypharmacy, potentially inappropriate medications, and chemotherapy-related adverse events among older adults with cancer. Journal Of Clinical Oncology 2011, 29: e19501-e19501. DOI: 10.1200/jco.2011.29.15_suppl.e19501.
- Gajra A, Hardt M, Tew W, Mohile S, Owusu C, Klepin H, Gross C, Lichtman S, Ramani R, Brown J, Katheria V, Jayani R, Hansen K, Togawa K, Klapper S, Hurria A. Primary dose reduction (PDR) of chemotherapy (chemo) in patients (Pts) older than age 65 with advanced cancer (Ca) and toxicity outcomes. Journal Of Clinical Oncology 2011, 29: 9037-9037. DOI: 10.1200/jco.2011.29.15_suppl.9037.
- Klepin H, Gajra A, Hardt M, Tew W, Mohile S, Owusu C, Gross C, Lichtman S, Ramani R, Katheria V, Brown J, Jayani R, Hansen K, Togawa K, Klapper S, Wong F, Hurria A. Predictors of primary dose reduction (PDR) among patients (pts) age 65 and older receiving adjuvant chemotherapy (chemo). Journal Of Clinical Oncology 2011, 29: 9003-9003. DOI: 10.1200/jco.2011.29.15_suppl.9003.
- Presley C, Raldow A, Cramer L, Soulos P, Long J, Makarov D, Yu J, Gross C. Racial disparities in prostate cancer treatment: The contribution of inappropriate care. Journal Of Clinical Oncology 2011, 29: 4544-4544. DOI: 10.1200/jco.2011.29.15_suppl.4544.
- Chagpar A, Sanft T, Gross C. Do cancer survivors follow screening guidelines better? Journal Of Clinical Oncology 2011, 29: 1597-1597. DOI: 10.1200/jco.2011.29.15_suppl.1597.
- Vest M, Tanoue L, Soulos P, Kim A, Gross C. Adoption Of Invasive Clinical Staging Techniques In Stage IIIA Non-Small Cell Lung Cancer Lags Adoption Of Positron Emission Tomography. 2011, a5380-a5380. DOI: 10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a5380.
- Hemani M, Huang W, Blustein J, Braithwaite S, Sherman S, Gross C, Taneja S, Penson D, Desai R, Makarov D. 443 REGIONAL VARIATION IN THE COST OF RADICAL CYSTECTOMY: EVIDENCE FROM THE HEALTHCARE COST AND UTILIZATION PROJECT NATIONWIDE INPATIENT SAMPLE. Journal Of Urology 2011, 185: e180-e181. DOI: 10.1016/j.juro.2011.02.534.
- Makarov D, Yu J, Desai R, Penson D, Gross C. 439 THE ASSOCIATION BETWEEN DIFFUSION OF THE SURGICAL ROBOT AND RADICAL PROSTATECTOMY RATES. Journal Of Urology 2011, 185: e178-e179. DOI: 10.1016/j.juro.2011.02.530.
- Yu J, Soulos P, Sharma R, Makarov D, Decker R, Smith B, Desai R, Cramer L, Gross C. Head and Neck Cancer (HNC) Patients Undergoing Primary Radiation with Intensity Modulated Radiation Therapy (IMRT) Demonstrate Improved Overall Survival (OS) Compared to Those Undergoing Conventional Radiation Therapy (CRT) in the SEER-Medicare Linked Database. International Journal Of Radiation Oncology • Biology • Physics 2010, 78: s459. DOI: 10.1016/j.ijrobp.2010.07.1077.
- Gross C, Soulos P, Sharma R, Makarov D, Decker R, Smith B, Desai R, Cramer L, Yu J. Head and Neck Cancer (HNC) Patients Undergoing Intensity Modulated Radiation Therapy (IMRT) Have Fewer Subsequent Days of Hospitalization (DOH) than Do Patients Undergoing Conventional Radiation Therapy (CRT) in the SEER-Medicare Linked Database. International Journal Of Radiation Oncology • Biology • Physics 2010, 78: s445. DOI: 10.1016/j.ijrobp.2010.07.1045.
- Raldow A, Sharma R, Presley C, Cramer L, Yu J, Soulos P, Gross C. Temporal Trends in the Treatment of Elderly Men with Low and Moderate Risk Prostate Cancer: The Effect of Life Expectancy on the Administration of Curative Therapy. International Journal Of Radiation Oncology • Biology • Physics 2010, 78: s562. DOI: 10.1016/j.ijrobp.2010.07.1312.
- Rao M, Lerro C, Gross C. 221: Current Strategies and Future Solutions to On-Call Care Shortages. Annals Of Emergency Medicine 2010, 56: s73. DOI: 10.1016/j.annemergmed.2010.06.269.
- Gibney G, Elfiky A, Hoimes C, Burns A, Rowen E, McDonough J, Lampert R, Gross C, Kelly W. Assessing cardiac risk using heart rate variability in a phase II study of androgen-deprivation therapy and bevacizumab in noncastrate metastatic prostate cancer patients. Journal Of Clinical Oncology 2010, 28: tps244-tps244. DOI: 10.1200/jco.2010.28.15_suppl.tps244.
- Hurria A, Togawa K, Mohile S, Owusu C, Klepin H, Gross C, Lichtman S, Katheria V, Klapper S, Tew W. Predicting chemotherapy toxicity in older adults with cancer: A prospective 500 patient multicenter study. Journal Of Clinical Oncology 2010, 28: 9001-9001. DOI: 10.1200/jco.2010.28.15_suppl.9001.
- Makarov D, Sharma R, Yu J, Abraham N, Desai R, Albertsen P, Penson D, Gross C. 270 INAPPROPRIATE USE OF IMAGING TO STAGE INCIDENT PROSTATE CANCER IN THE MEDICARE POPULATION. Journal Of Urology 2010, 183: e106-e107. DOI: 10.1016/j.juro.2010.02.330.
- Yu J, Makarov D, Gross C. Predicting the Extent of Prostate Cancer. International Journal Of Radiation Oncology • Biology • Physics 2009, 75: s313-s314. DOI: 10.1016/j.ijrobp.2009.07.719.
- Geriatric assessment of older adults with cancer: Baseline data from a 500 patient multicenter studyHurria A, Mohile S, Lichtman S, Owusu C, Klepin H, Gross C, Hansen K, Klapper S, Togawa K, Tew W. Geriatric assessment of older adults with cancer: Baseline data from a 500 patient multicenter study. Journal Of Clinical Oncology 2009, 27: 9546-9546. DOI: 10.1200/jco.2009.27.15_suppl.9546.
- Yu J, Makarov D, Sharma R, Peschel R, Partin A, Gross C. VALIDATING THE PARTIN TABLES USING THE NCI SEER DATABASE. Journal Of Urology 2009, 181: 170. DOI: 10.1016/s0022-5347(09)60487-0.
- Knisely J, Gross C, Castrucci W, Chiang V. Survey of Radiosurgery Practitioner Attitudes on the use of Stereotactic Radiosurgery Alone for Oligometastatic Brain Metastases. International Journal Of Radiation Oncology • Biology • Physics 2008, 72: s241-s242. DOI: 10.1016/j.ijrobp.2008.06.625.
- Gross C, McAvay G, Tinetti M. Life Expectancy and Colorectal Cancer Screening. Annals Of Internal Medicine 2007, 146: 758. DOI: 10.7326/0003-4819-146-10-200705150-00018.
- Gross CP, McAvay GJ, Krumholz HM, Paltiel AD, Bhasin D, Tinetti ME. The effect of age and chronic illness on life expectancy after a diagnosis of colorectal cancer: implications for screening. Annals Of Internal Medicine 2006, 145: 646-53. PMID: 17088577, DOI: 10.7326/0003-4819-145-9-200611070-00006.
- Gross C, Filardo G, Singh H, Freedman A, Farrell M. The relation between projected breast cancer risk, perceived cancer risk, and mammography use. Journal Of General Internal Medicine 2006, 21: 158-164. DOI: 10.1007/s11606-006-0251-4.
- Gross C, Murthy V, Li Y, Kaluzny A, Krumholz H. Cancer Trial Enrollment After State-Mandated Reimbursement. Journal Of Urology 2006, 175: 265. DOI: 10.1016/s0022-5347(05)00074-1.
- Wendler D, Kington R, Madans J, Van Wye G, Christ-Schmidt H, Pratt LA, Brawley OW, Gross CP, Emanuel E. Are Racial and Ethnic Minorities Less Willing to Participate in Health Research? PLOS Medicine 2005, 3: e19. PMID: 16318411, PMCID: PMC1298944, DOI: 10.1371/journal.pmed.0030019.
- Murthy V, Krumholz H, Gross C. Disparities in Participation in Cancer Clinical Trials—Reply. JAMA 2004, 292: 922-922. DOI: 10.1001/jama.292.8.922-b.
- Murthy VH, Krumholz HM, Gross CP. Participation in Cancer Clinical Trials: Race-, Sex-, and Age-Based Disparities. JAMA 2004, 291: 2720-2726. PMID: 15187053, DOI: 10.1001/jama.291.22.2720.
- Masoudi F, Gross C, Wang Y, Havranek E, Rathore S, Foody J, Krumholz H. 838-1 National patterns of spironolactone prescription for older patients with heart failure and left ventricular systolic dysfunction before and after RALES. Journal Of The American College Of Cardiology 2004, 43: a415. DOI: 10.1016/s0735-1097(04)91750-0.
- Bekelman JE, Li Y, Gross CP. Scope and Impact of Financial Conflicts of Interest in Biomedical Research: A Systematic Review. JAMA 2003, 289: 454-465. PMID: 12533125, DOI: 10.1001/jama.289.4.454.
- Cruz-Correa M, Gross C, F M, McNeil C, R N. The impact of practice guidelines on management of Barrett's esophagus: a prospective cohort. The American Journal Of Gastroenterology 2000, 95: 2627. DOI: 10.1111/j.1572-0241.2000.03106.x.
- Gross C, Nicholson W, Powe N. Factors Affecting Prophylactic Oophorectomy in Postmenopausal Women. Obstetrical & Gynecological Survey 2000, 55: 147-148. DOI: 10.1097/00006254-200003000-00015.
- Management of Barrett's esophagus: a national study of practice patterns and their cost implicationsGross C, Canto M, Hixson J, Powe N. Management of Barrett's esophagus: a national study of practice patterns and their cost implications. The American Journal Of Gastroenterology 1999, 94: ajg1999806. PMID: 10606300, DOI: 10.1111/j.1572-0241.1999.01606.x.
- GROSS C, NICHOLSON W, POWE N. Factors Affecting Prophylactic Oophorectomy in Postmenopausal Women. Obstetrics And Gynecology 1999, 94: 962-968. DOI: 10.1097/00006250-199912000-00011.
- Gross C, Anderson G, Powe N. The Relation between Funding by the National Institutes of Health and the Burden of Disease. New England Journal Of Medicine 1999, 340: 1881-1887. PMID: 10369852, DOI: 10.1056/nejm199906173402406.
- Gross C, Sepkowitz K. The myth of the medical breakthrough: Smallpox, vaccination, and Jenner reconsidered. International Journal Of Infectious Diseases 1998, 3: 54-60. PMID: 9831677, DOI: 10.1016/s1201-9712(98)90096-0.
- Gross C, Reisman A, Schwartz M. The Physician as Ambivalent Samaritan. Journal Of General Internal Medicine 1998, 13: 491-494. PMID: 9686718, PMCID: PMC1496980, DOI: 10.1046/j.1525-1497.1998.00141.x.
- Gross C, Callahan M, Mele J. Will Commercial Managed Care Patients Accept Residents as Their Primary Care Providers? Journal Of General Internal Medicine 1998, 13: 331-334. PMID: 9613890, PMCID: PMC1496953, DOI: 10.1046/j.1525-1497.1998.00100.x.
Departments and Programs
Locations
Primary Care Center, Yale New Haven Hospital
789 Howard Avenue
New Haven, CT 06519
- Primary Care Center, Yale New Haven Hospital789 Howard AvenueNew Haven, CT 06519
Titles
- Professor of Medicine (General Medicine) and of Epidemiology (Chronic Diseases)
- Founder and Director, Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center, Yale School of Medicine
- Director, National Clinician Scholars Program
Education & Training
- FellowJohns Hopkins School of Medicine (1999)
- Chief ResidentMemorial Sloan-Kettering Cancer Center (1997)
- ResidentNew York Hospital, Cornell Medical Center (1996)
- InternNew York Hospital, Cornell Medical Center (1994)
- MDNew York University School of Medicine (1993)
- BAJohns Hopkins University (1989)
Additional Information
Honors & Recognitions
- Elected Member: Association of American Physicians (2022)
- Yale Cancer Center Award for Mentorship Excellence: Yale New Haven Hospital (2021)
- Member: American Society for Clinical Investigation (2018)
- Visiting Professor: Johns Hopkins School of Medicine, Grand Rounds (2017)
- American Society for Radiation Oncology Annual Mtg Resident Digital Poster Discussion Recognition Award: American Society for Radiation Oncology (2013)
- Population Sciences Research Prize: Yale Cancer Center (2013)
- Mid-Career Research Mentorship Award: Society of General Internal Medicine (2012)
- Fellow: American College of Physicians (2010)
- Connecticut Quality Improvement Partnership Silver Innovation Prize: Connecticut Quality Improvement Partnership (2006)
- Joseph A. Zaccagnino Patient Safety and Clinical Quality Award: Yale-New Haven Hospital (2006)
Professional Service
- American Society of Clinical Oncology (ASCO) Quality Annual Meeting (2022): Planning Committee
- JAMA Internal Medicine (2022 - Present): Associate Editor
- Yale Cancer Center Diversity & Inclusion Committee (2020 - Present): Committee Member
- Society of General Internal Medicine, Scientific Abstract Selection Committee (Clinical Epi/Effectiveness) (2020 - Present): Co-Chair
- Medicare Contractor (2019 - Present): Advisor
- NCCN Institutional Representative for Young Investigator Award (2019): Reviewer
- Medicare (2019): Committee Member
- MedRxiv, Screening Affiliate (2019 - Present): Reviewer
- Yale School of Public Health Standing Appointments and Advisory Committee (2018 - 2020): Committee Member
- Yale Information Technology Services Advisory Committee (2018 - 2020): Committee Member
Publications
- Ajjawi I, Loeb S, Cooperberg M, Catalona W, Gross C, Ma X, Leapman M. Active Surveillance or Watchful Waiting for Intermediate-Risk Prostate Cancer, 2010-2020. JAMA 2024, 332: 2033-2036. PMID: 39565605, PMCID: PMC11579888, DOI: 10.1001/jama.2024.20580.
- Stall N, Gross C. Centering Patients and Evidence in Debates About Medical Assistance in Dying. JAMA Internal Medicine 2024, 185 PMID: 39652318, DOI: 10.1001/jamainternmed.2024.6650.
- Gross C, Gluck A, Corbie G. Physicians, the Homelessness Crisis, and Public Health—All Hands on Deck. JAMA Internal Medicine 2024, 184: 1414-1416. PMID: 39401048, DOI: 10.1001/jamainternmed.2024.5341.
- Moore C, Gross C, Hart L, Molinaro A, Rhodes D, Singh D, Baloescu C. Construction and performance of a clinical prediction rule for ureteral stone without the use of race or ethnicity: A new STONE score. Journal Of The American College Of Emergency Physicians Open 2024, 5: e13324. PMID: 39524039, PMCID: PMC11543628, DOI: 10.1002/emp2.13324.
- Paludo J, Dueck A, Bhatnagar V, Brown A, Cathcart-Rake E, Copley D, Diamond M, Faust L, Fiero M, Huntington S, Jeffery M, Jones L, Noble B, Power B, Ritchie J, Ross J, Ruddy K, Schellhorn S, Tarver M, Torre L, Wood W, Gross C, Kluetz P, Thanarajasingam G. Feasibility of Multi-Modal Physical Function Data Collection to Assess Treatment Tolerability in Patients with Lymphoma. Blood 2024, 144: 387-387. DOI: 10.1182/blood-2024-194607.
- Siddique S, Wang R, Gaddy J, Stempel J, Warren J, Gross C, Ma X. Disparities in Colorectal Cancer Screening Before and After the Onset of the COVID Pandemic. Journal Of General Internal Medicine 2024, 1-9. PMID: 39495455, DOI: 10.1007/s11606-024-09153-3.
- Chu L, Wang R, Gross C, Chen K, Ma X. Ambient Temperature and Stroke Risk Among Adults Aged 18-64 Years A Case-Crossover Study. Journal Of The American College Of Cardiology 2024, 84: 2327-2331. PMID: 39453364, DOI: 10.1016/j.jacc.2024.08.058.
- Kunst N, Long J, Westvold S, Sprenkle P, Kim I, Saperstein L, Rabil M, Ghaffar U, Karnes R, Ma X, Gross C, Wang S, Leapman M. Long-Term Outcomes of Prostate-Specific Membrane Antigen–PET Imaging of Recurrent Prostate Cancer. JAMA Network Open 2024, 7: e2440591. PMID: 39441595, PMCID: PMC11581571, DOI: 10.1001/jamanetworkopen.2024.40591.
- Siddique S, Wang R, Yasin F, Gaddy J, Zhang L, Gross C, Ma X. USPSTF Colorectal Cancer Screening Recommendation and Uptake for Individuals Aged 45 to 49 Years. JAMA Network Open 2024, 7: e2436358. PMID: 39361285, PMCID: PMC11450516, DOI: 10.1001/jamanetworkopen.2024.36358.
- Yabroff R, Blackford A, Fan Q, Hussaini S, Chen K, Polsky D, Katana Ogongo M, Warren J, Gross C, Pollack C. Is federal housing assistance associated with earlier-stage cancer diagnosis? Evidence from the new SEER-Medicare and US Department of Housing and Urban Development data linkage. Journal Of Clinical Oncology 2024, 20: 85-85. DOI: 10.1200/op.2024.20.10_suppl.85.
- Stackland S, Schnabel D, Dinan M, Presley C, Gross C. Strength of evidence underlying the CMS-FDA parallel review of comprehensive genomic profiling tests in the cancer setting. Journal Of The National Cancer Institute 2024, djae196. PMID: 39288939, DOI: 10.1093/jnci/djae196.
- Xu X, Chen L, Desai V, Gross C, Pollack C, Schwartz P, Wright J. Tubal Sterilization Rates by State Abortion Laws After the Dobbs Decision. JAMA 2024, 332: 1204-1206. PMID: 39259564, PMCID: PMC11391354, DOI: 10.1001/jama.2024.16862.
- Wang T, Corbie G, Allore H, Anderson T, Durant R, Ganguli I, Grady D, Gross C, Katz M, Mody L, Tripodis Y, Inouye S. Randomized Clinical Trials That Advance Health and Health Equity. JAMA Internal Medicine 2024, 184: 1011-1012. PMID: 39008289, DOI: 10.1001/jamainternmed.2024.3149.
- Forman R, Long J, Westvold S, Agnish K, McManus H, Leapman M, Hurwitz M, Spees L, Wheeler S, Gross C, Dinan M. Cost trends of metastatic renal cell carcinoma therapy: the impact of oral anticancer agents and immunotherapy. JNCI Cancer Spectrum 2024, 8: pkae067. PMID: 39133171, PMCID: PMC11376369, DOI: 10.1093/jncics/pkae067.
- Jain S, Long J, Rao V, Law A, Walkey A, Prsic E, Lindenauer P, Krumholz H, Gross C. Trends in use of intensive care during hospitalizations at the end‐of‐life among older adults with advanced cancer. Journal Of The American Geriatrics Society 2024, 72: 3840-3848. PMID: 39090970, PMCID: PMC11637920, DOI: 10.1111/jgs.19119.
- Richman I, Gross C. Progress in Lung Cancer Screening Adoption. JAMA Internal Medicine 2024, 184: 902-903. PMID: 38857025, DOI: 10.1001/jamainternmed.2024.1673.
- Yu J, DeStephano D, Horowitz D, Gross C, Cheng S. Reply to O. Saifi et al. Journal Of Clinical Oncology 2024, 42: 3763-3764. PMID: 39079081, DOI: 10.1200/jco-24-01228.
- Sundaresan V, Wang R, Long J, Sprenkle P, Seibert T, Loeb S, Cooperberg M, Catalona W, Ma X, Gross C, Leapman M. Associations Between Prostate Magnetic Resonance Imaging, Genomic Testing, and Treatment for Localized Prostate Cancer. Urology Practice 2024, 11: 965-973. PMID: 39196719, DOI: 10.1097/upj.0000000000000679.
- Miller J, Pelletiers W, Suttiratana S, Mensah M, Schwartz J, Ramachandran R, Gross C, Ross J. Harnessing policy to promote inclusive medical product evidence: development of a reference standard and structured audit of clinical trial diversity policies. BMJ Medicine 2024, 3: e000920. PMID: 39175919, PMCID: PMC11340651, DOI: 10.1136/bmjmed-2024-000920.
- Di M, Potnis K, Long J, Isufi I, Foss F, Seropian S, Gross C, Huntington S. Costs of care during chimeric antigen receptor T-cell therapy in relapsed or refractory B-cell lymphomas. JNCI Cancer Spectrum 2024, 8: pkae059. PMID: 39115391, PMCID: PMC11340641, DOI: 10.1093/jncics/pkae059.
- Canavan M, Wang X, Ascha M, Miksad R, Showalter T, Calip G, Gross C, Adelson K. Systemic Anticancer Therapy and Overall Survival in Patients With Very Advanced Solid Tumors. JAMA Oncology 2024, 10: 887-895. PMID: 38753341, PMCID: PMC11099840, DOI: 10.1001/jamaoncol.2024.1129.
- Gross C, Durant R. Tracking Physical Activity One Step at a Time. JAMA Internal Medicine 2024, 184: 726-726. PMID: 38767900, DOI: 10.1001/jamainternmed.2024.0898.
- Demkowicz P, Buck M, Nie J, Marks V, Wheeler S, Dinan M, Gross C, Leapman M. Changes in Facility Share of Medicaid-insured Patients With Urologic Cancers Following Implementation of the Patient Protection and Affordable Care Act. Urology 2024, 192: 19-27. PMID: 38901803, DOI: 10.1016/j.urology.2024.06.003.
- Dijk S, Krijkamp E, Kunst N, Labrecque J, Gross C, Pandit A, Lu C, Visser L, Wong J, Hunink M. Making Drug Approval Decisions in the Face of Uncertainty: Cumulative Evidence versus Value of Information. Medical Decision Making 2024, 44: 512-528. PMID: 38828516, PMCID: PMC11283736, DOI: 10.1177/0272989x241255047.
- Atre S, Soulos P, Kuderer N, Gross C, Baum L, Dinan M, Lustberg M. Characterization of time toxicity in older patients with metastatic breast cancer. Breast Cancer Research And Treatment 2024, 207: 541-550. PMID: 38816556, DOI: 10.1007/s10549-024-07379-7.
- Taylor M, Westvold S, Long J, Hyslop T, Wang S, Cecchini M, Leapman M, Leeds I, Lustberg M, Spees L, Wheeler S, Gross C, Oeffinger K, Dinan M. Personalized risk assessment of new onset depression in long-term cancer survivors. Journal Of Clinical Oncology 2024, 42: e13798-e13798. DOI: 10.1200/jco.2024.42.16_suppl.e13798.
- Opioid prescribing trends and pain scores among adult patients with cancer in a large health system.Baum L, Soulos P, KC M, Jeffery M, Ruddy K, Lerro C, Lee H, Graham D, Liberatore M, Rivera D, Leapman M, Jairam V, Dinan M, Gross C, Park H. Opioid prescribing trends and pain scores among adult patients with cancer in a large health system. Journal Of Clinical Oncology 2024, 42: 11059-11059. DOI: 10.1200/jco.2024.42.16_suppl.11059.
- Thanarajasingam G, Dueck A, Bhatnagar V, Brown A, Cathcart-Rake E, Diamond M, Faust L, Fiero M, Huntington S, Jeffery M, Jones L, Paludo J, Power B, Ross J, Ruddy K, Schellhorn S, Tarver M, Wood W, Gross C, Kluetz P. Integrating 4 Methods (In4M) to evaluate physical function in patients with cancer: Results of a comprehensive digital health study. Journal Of Clinical Oncology 2024, 42: 1564-1564. DOI: 10.1200/jco.2024.42.16_suppl.1564.
- Tarantino P, Lee D, Foldi J, Soulos P, Gross C, Grinda T, Winer E, Lin N, Krop I, Tolaney S, Lustberg M, Sammons S. Outcomes with trastuzumab deruxtecan (T-DXd) by HER2 status and line of treatment in a large real-world database of patients with metastatic breast cancer. Journal Of Clinical Oncology 2024, 42: 1077-1077. DOI: 10.1200/jco.2024.42.16_suppl.1077.
- Grady D, Allore H, Corbie G, Covinsky K, Durant R, Ganguli I, Gross C, Katz M, Mody L, Wang T, Tripodis Y, Inouye S. Improving Women’s Health Across the Life Span—JAMA Internal Medicine Call for Papers. JAMA Internal Medicine 2024, 184: 472-473. PMID: 38497973, PMCID: PMC11184509, DOI: 10.1001/jamainternmed.2024.0136.
- Richman I, Gross C, Wang E. Cancer and incarceration: a call for action. The Lancet Oncology 2024, 25: 530-531. PMID: 38697151, DOI: 10.1016/s1470-2045(24)00201-8.
- Leapman M, Long J, Westvold S, Rabil M, Sprenkle P, Kim I, Saperstein L, Fallah J, Suzman D, Lerro C, Xu J, Kluetz P, Karnes R, Kunst N, Wang S, Ma X, Gross C. PD45-11 TEMPORAL AND REGIONAL PATTERNS OF PROSTATE CANCER POSITRON EMISSION TOMOGRAPHY IMAGING AMONG COMMERCIAL INSURANCE BENEFICIARIES IN THE UNITED STATES. Journal Of Urology 2024, 211: e972. DOI: 10.1097/01.ju.0001008792.09108.b4.11.
- Kunst N, Long J, Westvold S, Sprenkle P, Rabil M, Ghaffar U, Kim I, Saperstein L, Wang S, Ma X, Gross C, Leapman M. MP57-08 COST EFFECTIVENESS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN POSITRON EMISSION TOMOGRAPHY (PSMA-PET) FOR THE EVALUATION OF BIOCHEMICAL RECURRENT PROSTATE CANCER IN THE UNITED STATES HEALTHCARE SYSTEM. Journal Of Urology 2024, 211: e940. DOI: 10.1097/01.ju.0001009420.83948.eb.08.
- Leapman M, Rabil M, Ghaffar U, Long J, Westvold S, Sprenkle P, Kim I, Saperstein L, Fallah J, Suzman D, Lerro C, Xu J, Kluetz P, Kunst N, Wang S, Ma X, Gross C, Karnes R. PD45-10 PROSTATE-SPECIFIC MEMBRANE ANTIGEN IMAGING FINDINGS AND SUBSEQUENT CLINICAL MANAGEMENT AMONG PATIENTS WITH BIOCHEMICAL RECURRENT PROSTATE CANCER: A RETROSPECTIVE COHORT STUDY. Journal Of Urology 2024, 211: e971. DOI: 10.1097/01.ju.0001008792.09108.b4.10.
- Kunst N, Long J, Westvold S, Sprenkle P, Rabil M, Ghaffar U, Kim I, Saperstein L, Wang S, Ma X, Gross C, Leapman M. PD08-10 EFFECTIVENESS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN POSITRON EMISSION TOMOGRAPHY AMONG PATIENTS WITH BIOCHEMICAL RECURRENT PROSTATE CANCER: RESULTS OF DECISION ANALYTIC MODELING. Journal Of Urology 2024, 211: e177. DOI: 10.1097/01.ju.0001008576.33217.96.10.
- Gross C, Corbie G. Physicians in Private Equity Practices—Canaries in a Coal Mine? JAMA Internal Medicine 2024, 184: 580-581. PMID: 38466292, DOI: 10.1001/jamainternmed.2024.0069.
- Sedrak M, Sun C, Bae M, Freedman R, Magnuson A, O’Connor T, Moy B, Wildes T, Klepin H, Chapman A, Tew W, Dotan E, Fenton M, Kim H, Katheria V, Muss H, Cohen H, Gross C, Ji J. Functional decline in older breast cancer survivors treated with and without chemotherapy and non-cancer controls: results from the Hurria Older PatiEnts (HOPE) prospective study. Journal Of Cancer Survivorship 2024, 18: 1131-1143. PMID: 38678525, PMCID: PMC11324395, DOI: 10.1007/s11764-024-01594-3.
- Li H, Huntington S, Gross C, Wang S. Immunotherapy utilization patterns in patients with advanced cancer and autoimmune disease. PLOS ONE 2024, 19: e0300789. PMID: 38625861, PMCID: PMC11020359, DOI: 10.1371/journal.pone.0300789.
- Sutherland R, Gross C, Ma X, Jeong F, Seibert T, Cooperberg M, Catalona W, Ellis S, Loeb S, Schulman‐Green D, Leapman M. ‘It Just Makes Sense to Me’: A qualitative study exploring patient decision‐making and experiences with prostate MRI during active surveillance for prostate cancer. BJUI Compass 2024, 5: 707-715. PMID: 38873351, PMCID: PMC11168777, DOI: 10.1002/bco2.351.
- Rahman S, Long J, Westvold S, Leapman M, Spees L, Hurwitz M, McManus H, Gross C, Wheeler S, Dinan M. Area Vulnerability and Disparities in Therapy for Patients With Metastatic Renal Cell Carcinoma. JAMA Network Open 2024, 7: e248747. PMID: 38687479, PMCID: PMC11061765, DOI: 10.1001/jamanetworkopen.2024.8747.
- Yu J, DeStephano D, Jeffers B, Horowitz D, Soulos P, Gross C, Cheng S. Updated Analysis of Comparative Toxicity of Proton and Photon Radiation for Prostate Cancer. Journal Of Clinical Oncology 2024, 42: 1943-1952. PMID: 38507655, DOI: 10.1200/jco.23.01604.
- Richman I, Gross C. Estimating Breast Cancer Overdiagnosis After Screening Mammography Among Older Women in the United States. Annals Of Internal Medicine 2024, 177: 403-404. PMID: 38498894, DOI: 10.7326/l23-0485.
- Zhang G, Gross C. Protecting Patients by Reducing Diagnostic Error. JAMA Internal Medicine 2024, 184: 173-173. PMID: 38190151, DOI: 10.1001/jamainternmed.2023.7334.
- Leapman M, Long J, Westvold S, Rabil M, Sprenkle P, Kim I, Saperstein L, Fallah J, Suzman D, Lerro C, Xu J, Kluetz P, Karnes R, Kunst N, Wang S, Ma X, Gross C. Temporal and regional patterns of prostate cancer positron emission tomography imaging among commercial insurance beneficiaries in the United States. Journal Of Clinical Oncology 2024, 42: 34-34. DOI: 10.1200/jco.2024.42.4_suppl.34.
- Thanarajasingam G, Kluetz P, Bhatnagar V, Brown A, Cathcart-Rake E, Diamond M, Faust L, Fiero M, Huntington S, Jeffery M, Jones L, Noble B, Paludo J, Powers B, Ross J, Ritchie J, Ruddy K, Schellhorn S, Tarver M, Dueck A, Gross C. Integrating 4 methods to evaluate physical function in patients with cancer (In4M): protocol for a prospective cohort study. BMJ Open 2024, 14: e074030. PMID: 38199641, PMCID: PMC10806877, DOI: 10.1136/bmjopen-2023-074030.
- Jairam V, Soulos P, Madhav K, Gross C, Slotman B, Chiang A, Park H. Differential Effect of Consolidative Thoracic Radiation Therapy in Extensive-Stage Small Cell Lung Cancer Based on Sex. Advances In Radiation Oncology 2023, 9: 101413. PMID: 38778819, PMCID: PMC11110031, DOI: 10.1016/j.adro.2023.101413.
- Habib A, Gross C. FDA Regulations of AI-Driven Clinical Decision Support Devices Fall Short. JAMA Internal Medicine 2023, 183: 1401-1402. PMID: 37812411, DOI: 10.1001/jamainternmed.2023.5006.
- Richman I, Soulos P, Lin H, Aminawung J, Oladeru O, Puglisi L, Wang E, Gross C. Incarceration and screen-detectable cancer diagnosis among adults in Connecticut. Journal Of The National Cancer Institute 2023, 116: 485-489. PMID: 37991935, PMCID: PMC10919339, DOI: 10.1093/jnci/djad242.
- Mitta S, Gross C, Simon M. Screening for Hypertensive Disorders of Pregnancy in the US—A New Hypertensive Urgency. JAMA Internal Medicine 2023, 183: 1185-1186. PMID: 37725383, DOI: 10.1001/jamainternmed.2023.4723.
- Li Y, Yang S, Chiang A, Gross C, Wang S. Using real world practice patterns to identify clinical equipoise in cancer treatment: Advanced non-small cell lung cancer as an exemplar. JCO Oncology Practice 2023, 19: 539-539. DOI: 10.1200/op.2023.19.11_suppl.539.
- Tan J, Yang S, Dinan M, Chiang A, Gross C, Wang S. Mutation-specific costs of advanced non-small cell lung cancer treatment. JCO Oncology Practice 2023, 19: 14-14. DOI: 10.1200/op.2023.19.11_suppl.14.
- Rahman S, Long J, Westvold S, Wheeler S, Spees L, Leapman M, Hurwitz M, McManus H, Gross C, Dinan M. Total and treatment-related costs of care associated with in patients with metastatic renal cell carcinoma receiving targeted or immune therapy. JCO Oncology Practice 2023, 19: 28-28. DOI: 10.1200/op.2023.19.11_suppl.28.
- Baum L, KC M, Soulos P, Jeffery M, Ruddy K, Lerro C, Lee H, Graham D, Rivera D, Leapman M, Jairam V, Dinan M, Gross C, Park H. Trends in new and persistent opioid use in older adults with and without cancer. Journal Of The National Cancer Institute 2023, 116: 316-323. PMID: 37802882, DOI: 10.1093/jnci/djad206.
- Kwan J, Gross C. Improving Support for Physician Scientists—Mind the (Funding) Gap. JAMA Network Open 2023, 6: e2332982. PMID: 37725379, DOI: 10.1001/jamanetworkopen.2023.32982.
- Ward E, Gross C. Evolving Methods to Assess Chatbot Performance in Health Sciences Research. JAMA Internal Medicine 2023, 183: 1030-1031. PMID: 37459112, DOI: 10.1001/jamainternmed.2023.2567.
- Patient experiences with tissue‐based genomic testing during active surveillance for prostate cancerLeapman M, Sutherland R, Gross C, Ma X, Seibert T, Cooperberg M, Catalona W, Loeb S, Schulman‐Green D. Patient experiences with tissue‐based genomic testing during active surveillance for prostate cancer. BJUI Compass 2023, 5: 142-149. PMID: 38179031, PMCID: PMC10764160, DOI: 10.1002/bco2.277.
- Rowhani-Farid A, Grewal M, Solar S, Eghrari A, Zhang A, Gross C, Krumholz H, Ross J. Clinical trial data sharing: a cross-sectional study of outcomes associated with two U.S. National Institutes of Health models. Scientific Data 2023, 10: 529. PMID: 37553403, PMCID: PMC10409750, DOI: 10.1038/s41597-023-02436-0.
- Richman I, Long J, Soulos P, Wang S, Gross C. Estimating Breast Cancer Overdiagnosis After Screening Mammography Among Older Women in the United States. Annals Of Internal Medicine 2023, 176: 1172-1180. PMID: 37549389, PMCID: PMC10623662, DOI: 10.7326/m23-0133.
- Voruganti T, Presley C, Gross C. Net Clinical Benefit as Measure of Treatment Benefit Among Older Adults With Advanced Incurable Non–Small Cell Lung Cancer—Reply. JAMA Oncology 2023, 9: 1154-1155. PMID: 37347467, DOI: 10.1001/jamaoncol.2023.1538.
- Kc M, Fan J, Hyslop T, Hassan S, Cecchini M, Wang S, Silber A, Leapman M, Leeds I, Wheeler S, Spees L, Gross C, Lustberg M, Greenup R, Justice A, Oeffinger K, Dinan M. Relative Burden of Cancer and Noncancer Mortality Among Long-Term Survivors of Breast, Prostate, and Colorectal Cancer in the US. JAMA Network Open 2023, 6: e2323115. PMID: 37436746, PMCID: PMC10339147, DOI: 10.1001/jamanetworkopen.2023.23115.
- Canavan M, Wang X, Ascha M, Miksad R, Showalter T, Calip G, Gross C, Adelson K. End-of-Life Systemic Oncologic Treatment in the Immunotherapy Era: The Role of Race, Insurance, and Practice Setting. Journal Of Clinical Oncology 2023, 41: 4729-4738. PMID: 37339389, PMCID: PMC10602547, DOI: 10.1200/jco.22.02180.
- Varma T, Gross C, Miller J. Clinical Trial Diversity—Will We Know It When We See It? JAMA Oncology 2023, 9: 765-767. PMID: 37022678, DOI: 10.1001/jamaoncol.2023.0143.
- Crosson F, Ostrer I, Gross C. Private Equity in US Health Care—Now Cradle to Grave? JAMA Internal Medicine 2023, 183: 511-512. PMID: 37126342, DOI: 10.1001/jamainternmed.2023.0324.
- Hassan S, Girgis A, Abramsohn E, Pinkerton E, Gross C. Opportunities and challenges to implementing a coordinated social care network for patients with cancer: Perspectives of local community based organizations. Journal Of Clinical Oncology 2023, 41: e18647-e18647. DOI: 10.1200/jco.2023.41.16_suppl.e18647.
- Ji J, Sun C, Wildes T, Freedman R, Magnuson A, O'Connor T, Moy B, Klepin H, Chapman A, Tew W, Dotan E, Fenton M, Kim H, Bae M, Katheria V, Gross C, Muss H, Cohen H, Sedrak M. Falls and hospitalization during chemotherapy in older women with early breast cancer. Journal Of Clinical Oncology 2023, 41: 12035-12035. DOI: 10.1200/jco.2023.41.16_suppl.12035.
- Canavan M, Wang X, Ascha M, Miksad R, Showalter T, Calip G, Gross C, Adelson K. Survival analysis of patients treated at oncology practices with more aggressive end-of-life practice patterns. Journal Of Clinical Oncology 2023, 41: 6562-6562. DOI: 10.1200/jco.2023.41.16_suppl.6562.
- Aminawung J, Soulos P, Oladeru O, Lin H, Gonsalves L, Puglisi L, Hassan S, Richman I, Wang E, Gross C. Cancer incidence among incarcerated and formerly incarcerated individuals: A statewide retrospective cohort study. Cancer Medicine 2023, 12: 15447-15454. PMID: 37248772, PMCID: PMC10417084, DOI: 10.1002/cam4.6162.
- Chow R, Long J, Hassan S, Wheeler S, Spees L, Leapman M, Hurwitz M, McManus H, Gross C, Dinan M. Disparities in immune and targeted therapy utilization for older US patients with metastatic renal cell carcinoma. JNCI Cancer Spectrum 2023, 7: pkad036. PMID: 37202354, PMCID: PMC10276895, DOI: 10.1093/jncics/pkad036.
- Miller S, Azar S, Farrelly J, Salzman G, Broderick M, Sanders K, Anto V, Patel N, Cordova A, Schuster K, Jones T, Kodadek L, Gross C, Morton J, Rosenthal R, Becher R. Current use of the National Surgical Quality Improvement Program surgical risk calculator in academic surgery: a mixed-methods study. Surgery In Practice And Science 2023, 13: 100173. PMID: 37502700, PMCID: PMC10373440, DOI: 10.1016/j.sipas.2023.100173.
- Ananth P, Lindsay M, Mun S, McCollum S, Shabanova V, de Oliveira S, Pitafi S, Kirch R, Ma X, Gross C, Boyden J, Feudtner C, Wolfe J. Parent Priorities in End-of-Life Care for Children With Cancer. JAMA Network Open 2023, 6: e2313503. PMID: 37184834, PMCID: PMC10878399, DOI: 10.1001/jamanetworkopen.2023.13503.
- Jain S, Long J, Rao V, Law A, Walkey A, Lindenauer P, Prsic E, Krumholz H, Gross C. Trends in Utilization of ICU for Older Adults With Cancer at the End-of-Life. 2023, a1398-a1398. DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a1398.
- Vu M, Boyd K, De Marchis E, Garnache B, Gottlieb L, Gross C, Lee N, Lindau S, Mun S, Winslow V, Makelarski J. Perceived appropriateness of assessing for health-related socioeconomic risks among adult patients with cancer. Cancer Research Communications 2023, 3: 521-531. PMID: 37020993, PMCID: PMC10069714, DOI: 10.1158/2767-9764.crc-22-0283.
- Gross C, Kraschel K, Emanuel E. Holding Medical Professional Society Scientific Meetings Only in States That Protect Abortion Rights—Clinical and Ethical Considerations. JAMA Internal Medicine 2023, 183: 283-284. PMID: 36848080, DOI: 10.1001/jamainternmed.2022.7073.
- Leapman M, Wang R, Long J, Sprenkle P, Ma X, Gross C. PD10-01 ASSOCIATIONS BETWEEN PROSTATE MRI AND GENOMIC TESTING AND TREATMENT INTENSIFICATION AMONG PATIENTS WITH LOCALIZED PROSTATE CANCER. Journal Of Urology 2023, 209: e326. DOI: 10.1097/ju.0000000000003250.01.
- Voruganti T, Soulos P, Mamtani R, Presley C, Gross C. Association Between Age and Survival Trends in Advanced Non–Small Cell Lung Cancer After Adoption of Immunotherapy. JAMA Oncology 2023, 9: 334-341. PMID: 36701150, PMCID: PMC9880865, DOI: 10.1001/jamaoncol.2022.6901.
- Chow R, Long J, Hassan S, Wheeler S, Spees L, Leapman M, Hurwitz M, McManus H, Gross C, Dinan M. Evolution of systemic therapy from 2015 to 2019 for older patients in the United States with metastatic renal cell carcinoma. Journal Of Clinical Oncology 2023, 41: 610-610. DOI: 10.1200/jco.2023.41.6_suppl.610.
- Sutherland R, Gross C, Ma X, Jeong F, Seibert T, Cooperberg M, Catalona W, Loeb S, Schulman-Green D, Leapman M. “It just makes sense to me”: Patient experiences with prostate MRI during prostate cancer active surveillance. Journal Of Clinical Oncology 2023, 41: 334-334. DOI: 10.1200/jco.2023.41.6_suppl.334.
- Leapman M, Sutherland R, Gross C, Ma X, Jeong F, Seibert T, Cooperberg M, Catalona W, Loeb S, Schulman-Green D. Patient experiences with tissue-based genomic testing during active surveillance for prostate cancer. Journal Of Clinical Oncology 2023, 41: 333-333. DOI: 10.1200/jco.2023.41.6_suppl.333.
- Leapman M, Wang R, Loeb S, Seibert T, Gaylis F, Lowentritt B, Brown G, Chen R, Lin D, Witte J, Cooperberg M, Catalona W, Gross C, Ma X. Use of Monitoring Tests Among Patients With Localized Prostate Cancer Managed With Observation. Journal Of Urology 2023, 209: 710-718. PMID: 36753746, DOI: 10.1097/ju.0000000000003159.
- Gross C, Dusetzina S. Stemming Medicare Spending on Discarded Drugs—Waste Not, Want Not? JAMA Internal Medicine 2023, 183: 93-93. PMID: 36534375, DOI: 10.1001/jamainternmed.2022.5895.
- Varma T, Mello M, Ross J, Gross C, Miller J. Metrics, baseline scores, and a tool to improve sponsor performance on clinical trial diversity: retrospective cross sectional study. BMJ Medicine 2023, 2: e000395. PMID: 36936269, PMCID: PMC9951369, DOI: 10.1136/bmjmed-2022-000395.
- Shultz B, Oladele C, Leeds I, Gluck A, Gross C. Targeting Health-Related Social Risks in the Clinical Setting: New Policy Momentum and Practice Considerations. The Journal Of Law, Medicine & Ethics 2023, 51: 777-785. PMID: 38477272, DOI: 10.1017/jme.2024.25.
- Dinan M, Pitafi S, Greenup R, Long J, Gross C. Genetic testing in privately insured women with surgically treated breast cancer. Breast Cancer Research And Treatment 2022, 198: 177-181. PMID: 36542252, DOI: 10.1007/s10549-022-06829-4.
- Boatright D, Anderson N, Kim J, Holmboe E, McDade W, Fancher T, Gross C, Chaudhry S, Nguyen M, Tiako M, Colson E, Xu Y, Li F, Dziura J, Saha S. Racial and Ethnic Differences in Internal Medicine Residency Assessments. JAMA Network Open 2022, 5: e2247649. PMID: 36580337, PMCID: PMC9857126, DOI: 10.1001/jamanetworkopen.2022.47649.
- Sedrak M, Sun C, Ji J, Cohen H, Gross C, Tew W, Klepin H, Wildes T, Dotan E, Freedman R, O'Connor T, Chow S, Fenton M, Moy B, Chapman A, Dale W, Katheria V, Kuderer N, Lyman G, Magnuson A, Muss H. Low-Intensity Adjuvant Chemotherapy for Breast Cancer in Older Women: Results From the Prospective Multicenter HOPE Trial. Journal Of Clinical Oncology 2022, 41: 316-326. PMID: 36455189, PMCID: PMC9839299, DOI: 10.1200/jco.22.01440.
- Potnis K, Ross J, Aneja S, Gross C, Richman I. Artificial Intelligence in Breast Cancer Screening. JAMA Internal Medicine 2022, 182: 1306-1312. PMID: 36342705, PMCID: PMC10623674, DOI: 10.1001/jamainternmed.2022.4969.
- Dzimitrowicz H, Wilson L, Jackson B, Spees L, Baggett C, Greiner M, Kaye D, Zhang T, George D, Scales C, Pritchard J, Leapman M, Gross C, Dinan M, Wheeler S. End-of-Life Care for Patients With Metastatic Renal Cell Carcinoma in the Era of Oral Anticancer Therapy. JCO Oncology Practice 2022, 19: e213-e227. PMID: 36413741, PMCID: PMC9970274, DOI: 10.1200/op.22.00401.
- Gao S, Jin L, Meadows H, Shafman T, Gross C, Yu J, Aerts H, Miccio J, Stahl J, Mak R, Decker R, Kann B. Prediction of Distant Metastases After Stereotactic Body Radiation Therapy for Early Stage NSCLC: Development and External Validation of a Multi-Institutional Model. Journal Of Thoracic Oncology 2022, 18: 339-349. PMID: 36396062, DOI: 10.1016/j.jtho.2022.11.007.
- Leapman M, Long J, Wang R, Sprenkle P, Ma X, Gross C. MP53-11 FOUR KALLIKREIN PANEL TESTING AMONG MEDICARE BENEFICIARIES UNDERGOING PROSTATE CANCER SCREENING. Journal Of Urology 2022, 207: e899. DOI: 10.1097/ju.0000000000002628.11.
- Ananth P, Mun S, Lindsay M, De Oliveira S, Pitafi S, Ma X, Gross C, Boyden J, Feudtner C, Wolfe J. Parent Priorities in End-of-Life Care for Children with Cancer. Journal Of Pain And Symptom Management 2022, 63: 885. DOI: 10.1016/j.jpainsymman.2022.02.087.
- Dzimitrowicz H, Wilson L, Jackson B, Spees L, Baggett C, Greiner M, Kaye D, Zhang T, George D, Scales C, Pritchard J, Leapman M, Gross C, Dinan M, Wheeler S. Factors associated with the quality of end-of-life care for patients with metastatic renal cell carcinoma. Journal Of Clinical Oncology 2022, 40: 300-300. DOI: 10.1200/jco.2022.40.6_suppl.300.
- Spees L, Wheeler S, Jackson B, Baggett C, Wilson L, Greiner M, Kaye D, Zhang T, George D, Scales C, Pritchard J, Leapman M, Gross C, Dinan M. Provider- and patient-level predictors of oral anticancer agent initiation and adherence in patients with metastatic renal cell carcinoma. Journal Of Clinical Oncology 2021, 39: 87-87. DOI: 10.1200/jco.2020.39.28_suppl.87.
- Spees L, Dinan M, Jackson B, Baggett C, Wilson L, Greiner M, Kaye D, Zhang T, George D, Scales C, Pritchard J, Leapman M, Gross C, Wheeler S. Patient- and provider-level predictors of mortality among patients with metastatic renal cell carcinoma receiving oral anticancer agents. Journal Of Clinical Oncology 2021, 39: 116-116. DOI: 10.1200/jco.2020.39.28_suppl.116.
- Canavan M, Wang X, Ascha M, Miksad R, Showalter T, Calip G, Gross C, Adelson K. Trends in end-of- life (EOL) systemic oncologic treatment in contemporary clinical practice: Insights from real-world data. Journal Of Clinical Oncology 2021, 39: 253-253. DOI: 10.1200/jco.2020.39.28_suppl.253.
- Adelson K, Wang X, Ascha M, Miksad R, Showalter T, Calip G, Gross C, Canavan M. Differences by race in systemic oncologic end-of-life (EOL) care among patients with cancer. Journal Of Clinical Oncology 2021, 39: 137-137. DOI: 10.1200/jco.2020.39.28_suppl.137.
- Leapman M, Wang R, Gross C, Ma X. PD50-11 CHANGES IN PSA SCREENING RELATIVE TO THE REVISED USPSTF GUIDANCE FOR PROSTATE CANCER SCREENING. Journal Of Urology 2021, 206: e856-e856. DOI: 10.1097/ju.0000000000002072.11.
- Leapman M, Dinan M, Pasha S, Washington S, Ma X, Gross C. PD46-08 MEDIATORS OF RACIAL DISPARITY IN THE USE OF PROSTATE MRI. Journal Of Urology 2021, 206: e751-e751. DOI: 10.1097/ju.0000000000002060.08.
- Axson S, Mello MM, Lincow D, Yang C, Gross C, Ross JS, Miller J. Clinical trial transparency and data sharing among biopharmaceutical companies and the role of company size, location and product type: a cross-sectional descriptive analysis. BMJ Open 2021, 11: e053248. PMID: 34281933, PMCID: PMC8291313, DOI: 10.1136/bmjopen-2021-053248.
- Abujarad F, Wang S, Ulrich D, Mougalian S, Killelea B, Fraenkel L, Gross C, Evans S. Building a Digital Health Risk Calculator for Older Women with Early-Stage Breast Cancer. Lecture Notes In Computer Science 2021, 12780: 389-402. DOI: 10.1007/978-3-030-78224-5_27.
- Hsu SH, Chang SH, Gross C, Wang SY. Relative risks of COVID-19 fatality between the first and second waves of the pandemic in Ontario, Canada. International Journal Of Infectious Diseases 2021, 109: 189-191. PMID: 34216734, PMCID: PMC8245301, DOI: 10.1016/j.ijid.2021.06.059.
- Xu X, Desai V, Schwartz P, Gross C, Lin H, Wright J. MT4 Safety Warnings about Power Morcellation in Hysterectomy: A Simulation of National Impact. Value In Health 2021, 24: s12. DOI: 10.1016/j.jval.2021.04.062.
- Puglisi L, Halberstam AA, Aminawung J, Gallagher C, Gonsalves L, Schulman-Green D, Lin HJ, Metha R, Mun S, Oladeru OT, Gross C, Wang EA. Incarceration and Cancer-Related Outcomes (ICRO) study protocol: using a mixed-methods approach to investigate the role of incarceration on cancer incidence, mortality and quality of care. BMJ Open 2021, 11: e048863. PMID: 34035109, PMCID: PMC8154989, DOI: 10.1136/bmjopen-2021-048863.
- Parikh R, Min E, Wileyto E, Riaz F, Gross C, Cohen R, Hubbard R, Long Q, Mamtani R. Uptake and effectiveness of checkpoint inhibitor therapy among trial-ineligible patients with advanced solid malignancies. Journal Of Clinical Oncology 2021, 39: e18595-e18595. DOI: 10.1200/jco.2021.39.15_suppl.e18595.
- Takvorian S, Parikh R, Vader D, Wileyto E, Clark A, Lee D, Goyal G, Rocque G, Dotan E, Geynisman D, Phull P, Spiess P, Kim R, Davidoff A, Gross C, Miksad R, Calip G, Shulman L, Mamtani R, Hubbard R. Impact of COVID-19 pandemic on time to treatment initiation for patients with advanced cancer. Journal Of Clinical Oncology 2021, 39: 1528-1528. DOI: 10.1200/jco.2021.39.15_suppl.1528.
- Leapman M, Dinan M, Pasha S, Washington S, Ma X, Gross C. Mediators of racial disparity in the use of prostate MRI. Journal Of Clinical Oncology 2021, 39: 6554-6554. DOI: 10.1200/jco.2021.39.15_suppl.6554.
- Jairam V, Pasha S, Soulos P, Goldberg S, Yu J, Decker R, Gross C, Park H. Adoption of consolidative durvalumab among patients with locally advanced non-small cell lung cancer. Journal Of Clinical Oncology 2021, 39: e20550-e20550. DOI: 10.1200/jco.2021.39.15_suppl.e20550.
- Chagpar A, Lannin D, Mougalian S, Berger E, Gross C, Horowitz N, Sanft T, DiGiovanna M, Golshan M, Pusztai L. How did the COVID crisis affect use of neoadjuvant therapy for patients with breast cancer? Journal Of Clinical Oncology 2021, 39: e18708-e18708. DOI: 10.1200/jco.2021.39.15_suppl.e18708.
- Samuels EA, Boatright DH, Wong AH, Cramer LD, Desai MM, Solotke MT, Latimore D, Gross CP. Association Between Sexual Orientation, Mistreatment, and Burnout Among US Medical Students. JAMA Network Open 2021, 4: e2036136. PMID: 33528552, PMCID: PMC7856540, DOI: 10.1001/jamanetworkopen.2020.36136.
- Jairam V, Pasha S, Soulos P, Gross C, Yu J, Park H, Decker R. Post-Operative Radiation Therapy for Non-Small Cell Lung Cancer: A Comparison of Radiation Therapy Techniques. International Journal Of Radiation Oncology • Biology • Physics 2020, 108: e130. DOI: 10.1016/j.ijrobp.2020.07.1276.
- Gao S, Dosoretz A, Shafman T, Gross C, Yu J, Meadows H, Decker R, Mak R, Kann B. Development and External Validation of a Nomogram to Predict Distant Metastases after Stereotactic Body Radiation Therapy in Early Stage Non-Small Cell Lung Cancer Patients. International Journal Of Radiation Oncology • Biology • Physics 2020, 108: e90. DOI: 10.1016/j.ijrobp.2020.07.1190.
- Yang D, Park H, Jairam V, Decker R, Chiang A, Gross C, Yu J. Association Between Prophylactic Cranial Irradiation and Improved Overall Survival in Small Cell Lung Cancer. International Journal Of Radiation Oncology • Biology • Physics 2020, 108: e106. DOI: 10.1016/j.ijrobp.2020.07.1223.
- Wong W, Sheinson D, Ogale S, Flores C, Gross C. The association between Medicare’s next generation sequencing (NGS), national coverage decision (NCD), and NGS utilization. Journal Of Clinical Oncology 2020, 38: 98-98. DOI: 10.1200/jco.2020.38.29_suppl.98.
- Gross C, Meyer C, Ogale S, Kent M, Wong W. The association between Medicaid insurance, biomarker testing, and outcomes in patients with advanced non-small cell lung cancer (aNSCLC). Journal Of Clinical Oncology 2020, 38: 89-89. DOI: 10.1200/jco.2020.38.29_suppl.89.
- Adelson K, Canavan M, Mun S, Gross C, Sinanis N, Davidoff A. The association between clinical trial (CT) participation, pharmaceutical costs, and savings performance in the Oncology Care Model (OCM). Journal Of Clinical Oncology 2020, 38: 2-2. DOI: 10.1200/jco.2020.38.29_suppl.2.
- Bongiovanni T, Kim SP, Kim A, Killelea B, Gross C. Is there variation in private payor payments to cancer surgeons? A cross-sectional study in the USA. BMJ Open 2020, 10: e035438. PMID: 33020076, PMCID: PMC7537435, DOI: 10.1136/bmjopen-2019-035438.
- Parikh R, Cohen R, Min E, Wileyto E, Riaz F, Gross C, Long Q, Mamtani R. Uptake of first-line immune checkpoint inhibitors among medically frail patients with advanced solid malignancies. Journal Of Clinical Oncology 2020, 38: e19316-e19316. DOI: 10.1200/jco.2020.38.15_suppl.e19316.
- Yang D, Leapman M, Gross C, Yu J. Utilization of next-generation sequencing and associated systemic therapy initiation in metastatic prostate cancer. Journal Of Clinical Oncology 2020, 38: e19308-e19308. DOI: 10.1200/jco.2020.38.15_suppl.e19308.
- Jairam V, Yang D, Pasha S, Soulos P, Gross C, Yu J, Park H. Temporal trends in opioid prescribing patterns among oncologists in the Medicare population. Journal Of Clinical Oncology 2020, 38: 12022-12022. DOI: 10.1200/jco.2020.38.15_suppl.12022.
- Yang D, Jairam V, Park H, Decker R, Chiang A, Gross C, Yu J. Use of prophylactic cranial irradiation in patients with extensive-stage small cell lung cancer receiving immunotherapy. Journal Of Clinical Oncology 2020, 38: e19309-e19309. DOI: 10.1200/jco.2020.38.15_suppl.e19309.
- Riaz F, Gan G, Li F, Davidoff A, Adelson K, Presley C, Adamson B, Shaw P, Parikh R, Mamtani R, Gross C. The adoption of immune checkpoint inhibitors and patterns of care at the end of life. Journal Of Clinical Oncology 2020, 38: 12027-12027. DOI: 10.1200/jco.2020.38.15_suppl.12027.
- Adelson K, Canavan M, Mun S, Gross C, Sinanis N, Davidoff A. The impact of clinical trial (CTr) participation on savings performance in the oncology care model (OCM). Journal Of Clinical Oncology 2020, 38: e19367-e19367. DOI: 10.1200/jco.2020.38.15_suppl.e19367.
- Hill KA, Samuels EA, Gross CP, Desai MM, Zelin N, Latimore D, Huot SJ, Cramer LD, Wong AH, Boatright D. Assessment of the Prevalence of Medical Student Mistreatment by Sex, Race/Ethnicity, and Sexual Orientation. JAMA Internal Medicine 2020, 180: 653-665. PMID: 32091540, PMCID: PMC7042809, DOI: 10.1001/jamainternmed.2020.0030.
- Leapman* M, Wang R, Ma X, Gross C. MP23-17 ASSOCIATIONS OF REGIONAL-LEVEL ADOPTION OF PROSTATE MRI AND GENOMIC TESTING AND OBSERVATION FOR PROSTATE CANCER. Journal Of Urology 2020, 203 DOI: 10.1097/ju.0000000000000856.017.
- Wang SY, Abujarad F, Chen T, Evans SB, Killelea BK, Mougalian SS, Fraenkel L, Gross C. “Radiotherapy for older women (ROW)”: A risk calculator for women with early-stage breast cancer. Journal Of Geriatric Oncology 2019, 11: 850-859. PMID: 31899199, PMCID: PMC7263974, DOI: 10.1016/j.jgo.2019.12.010.
- Huntington S, Soulos P, Barr P, Jacobs R, Lansigan F, Odejide O, Schwartzberg L, Davidoff A, Gross C. Utilization and Early Discontinuation of First-Line Ibrutinib for Patients with Chronic Lymphocytic Leukemia Treated in the Community Oncology Setting in the United States. Blood 2019, 134: 797. DOI: 10.1182/blood-2019-122054.
- Cohen A, Neri B, Adamson B, Scanlon C, Gross C, Meropol N, Miksad R. 1558P Biomarker status as a mediator of age-related overall survival (OS) in advanced non-small cell lung cancer (aNSCLC). Annals Of Oncology 2019, 30: v642. DOI: 10.1093/annonc/mdz260.080.
- Bongiovanni T, Jean R, Xu X, Soulos P, Herrin J, Kim A, Gross C. Moving to Bundled Payments: Costs of Lung Cancer Resections. Journal Of The American College Of Surgeons 2019, 229: e209. DOI: 10.1016/j.jamcollsurg.2019.08.1434.
- Kunst N, Long J, Xu X, Busch S, Richman I, Kyanko K, Gross C. Utilization and costs of breast cancer screening for women in their 40s in a privately insured U.S. population. Journal Of Clinical Oncology 2019, 37: 105-105. DOI: 10.1200/jco.2019.37.27_suppl.105.
- Adelson K, Canavan M, Supalla S, Sedghi T, Chaudhry B, Sinanis N, Gross C. Effects of rising drug costs on efforts to control overall cost at a large academic cancer center. Journal Of Clinical Oncology 2019, 37: 2-2. DOI: 10.1200/jco.2019.37.27_suppl.2.
- Mahal A, Mahal B, Kim S, Singh R, Green A, Nguyen P, Gross C, Yu J. The Effect of Race and Decision Aids on Provider Recommendation for Prostate Cancer Treatment Planning: A Randomized Study. International Journal Of Radiation Oncology • Biology • Physics 2019, 105: s220. DOI: 10.1016/j.ijrobp.2019.06.306.
- Chang E, Decker R, Hu X, Yu J, Gross C, Lester-Coll N. Predictors of Toxicity from Stereotactic Body Radiotherapy (SBRT) for Lung Tumors Ultra-Central or Central to Heart, Esophagus, or Proximal Bronchial Tree. International Journal Of Radiation Oncology • Biology • Physics 2019, 105: e499-e500. DOI: 10.1016/j.ijrobp.2019.06.1413.
- Gao S, Kann B, Dosoretz A, Shafman T, Gross C, Yu J, Decker R. An Externally Validated Nomogram to Predict Distant Metastases after Stereotactic Body Radiation Therapy in Early Stage Non-Small Cell Lung Cancer Patients. International Journal Of Radiation Oncology • Biology • Physics 2019, 105: s145-s146. DOI: 10.1016/j.ijrobp.2019.06.146.
- Richman IB, Hoag JR, Xu X, Forman HP, Hooley R, Busch SH, Gross CP. Adoption of Digital Breast Tomosynthesis in Clinical Practice. JAMA Internal Medicine 2019, 179: 1292-1295. PMID: 31233086, PMCID: PMC6593646, DOI: 10.1001/jamainternmed.2019.1058.
- Adamson B, Cohen A, Estevez M, Magee K, Williams E, Gross C, Meropol N, Davidoff A. Affordable Care Act (ACA) Medicaid expansion impact on racial disparities in time to cancer treatment. Journal Of Clinical Oncology 2019, 37: lba1-lba1. DOI: 10.1200/jco.2019.37.18_suppl.lba1.
- Yang D, Makarov D, Gross C, Yu J. Contemporary changes in localized and metastatic prostate cancer incidence by geographic area following decreased PSA screening. Journal Of Clinical Oncology 2019, 37: 1567-1567. DOI: 10.1200/jco.2019.37.15_suppl.1567.
- Abandonment trajectories of conventionally fractionated adjuvant radiotherapy in breast cancer care.Xu X, Soulos P, Herrin J, Wang S, Pollack C, Evans S, Gross C, Yu J. Abandonment trajectories of conventionally fractionated adjuvant radiotherapy in breast cancer care. Journal Of Clinical Oncology 2019, 37: 531-531. DOI: 10.1200/jco.2019.37.15_suppl.531.
- Leapman M, Presley C, Zhu W, Soulos P, Adelson K, Boffa D, Gross C. Real-world practice patterns and impact of PD-L1 expression testing in patients with advanced non-small cell lung cancer. Journal Of Clinical Oncology 2019, 37: 9059-9059. DOI: 10.1200/jco.2019.37.15_suppl.9059.
- Giri S, Huntington S, Wang R, Zeidan A, Podoltsev N, Gore S, Ma X, Gross C, Davidoff A, Neparidze N. Chromosome 1 abnormalities and clinical outcomes in multiple myeloma in the era of novel agents. Journal Of Clinical Oncology 2019, 37: 8044-8044. DOI: 10.1200/jco.2019.37.15_suppl.8044.
- Canavan M, Sedghi T, Gross C, Lane S, Bogdan J, Adelson K. Understanding cancer care coordination: Opening the black box. Journal Of Clinical Oncology 2019, 37: e18310-e18310. DOI: 10.1200/jco.2019.37.15_suppl.e18310.
- Sedghi T, Canavan M, Gross C, Davidoff A, Gould Rothberg BE, Strait M, Sinanis N, Adelson K. Impact of an oncology urgent care clinic on emergency department rates. Journal Of Clinical Oncology 2019, 37: 6615-6615. DOI: 10.1200/jco.2019.37.15_suppl.6615.
- Hooley I, Cohen A, Gross C, Williams E, Adamson B. PCN200 MEDICAID EXPANSION AND RACIAL INEQUITIES IN NEXT GENERATION SEQUENCING TESTING IN ONCOLOGY. Value In Health 2019, 22: s93. DOI: 10.1016/j.jval.2019.04.322.
- Johnson S, Park H, Gross C, Yu J. Complementary Medicine, Refusal of Conventional Cancer Therapy, and Survival Among Patients With Curable Cancers. Obstetrical & Gynecological Survey 2019, 74: 217-219. DOI: 10.1097/01.ogx.0000554438.70661.56.
- Hsiang W, Jemal A, Nguyen K, Shuch B, Park H, Yu J, Gross C, Davidoff A, Leapman* M. MP29-16 THE ASSOCIATION BETWEEN THE AFFORDABLE CARE ACT, INSURANCE STATUS, AND TREATMENT AMONG PATIENTS WITH TESTICULAR CANCER. Journal Of Urology 2019, 201 DOI: 10.1097/01.ju.0000557551.36748.5c.
- Jairam V, Lee V, Park H, Thomas C, Melnick E, Gross C, Presley C, Adelson K, Yu J. P78 Treatment-Related Complications of Chemotherapy and Radiotherapy: An Analysis of the Nationwide Emergency Department Sample. International Journal Of Radiation Oncology • Biology • Physics 2019, 103: e51-e52. DOI: 10.1016/s0360-3016(19)30528-0.
- Desai VB, Wright J, Gross C, Lin H, Boscoe F, Schwartz P, Xu X. Risk of unexpected uterine Cancer in women undergoing myomectomy: A population-based study. European Journal Of Obstetrics & Gynecology And Reproductive Biology 2019, 238: 188-190. PMID: 31103353, DOI: 10.1016/j.ejogrb.2019.03.021.
- Parikh R, Galsky M, Gyawali B, Riaz F, Kaufmann T, Cohen A, Adamson B, Gross C, Meropol N, Mamtani R. Trends in checkpoint inhibitor therapy for advanced urothelial cell carcinoma (aUC) at the end of life: Insights from real-world practice. Journal Of Clinical Oncology 2019, 37: 395-395. DOI: 10.1200/jco.2019.37.7_suppl.395.
- Schulman-Green D, Cherlin E, Capasso R, Mougalian S, Wang S, Gross C, Bajaj P, Eakle K, Adelson K, Patel S. Finding the Path: Incorporating Patient Preferences into an Interactive Clinical Pathway Platform (S867). Journal Of Pain And Symptom Management 2019, 57: 517. DOI: 10.1016/j.jpainsymman.2018.12.317.
- Huntington S, Zhu W, Hoag J, Wang R, Zeidan A, Giri S, Podoltsev N, Gore S, Ma X, Gross C, Davidoff A. Association between Oncologist Ownership of Imaging Facilities and Utilization: An Analysis of Positron-Emission Tomography (PET) Use in Lymphoma Settings with Variable PET Utility. Blood 2018, 132: 3538. DOI: 10.1182/blood-2018-99-115140.
- Yu J, Pollack C, Herrin J, Zhu W, Soulos P, Xu X, Gross C. Persistent Use of Extended Fractionation Palliative Radiation Therapy for Medicare Beneficiaries with Metastatic Breast Cancer: 2011-2014. International Journal Of Radiation Oncology • Biology • Physics 2018, 102: e425. DOI: 10.1016/j.ijrobp.2018.07.1241.
- Kann B, Miccio J, Stahl J, Verma V, Dosoretz A, Park H, Shafman T, Gross C, Yu J, Decker R. Systemic Therapy with Stereotactic Body Radiation Therapy (SBRT) for Early-Stage Non-Small Cell Lung Carcinoma (NSCLC): A Multi-institutional Analysis. International Journal Of Radiation Oncology • Biology • Physics 2018, 102: s10-s11. DOI: 10.1016/j.ijrobp.2018.06.119.
- Johnson S, Park H, Gross C, Yu J. Complementary Medicine, Refusal of Conventional Cancer Therapy, and Survival among Patients with Curable Cancers. International Journal Of Radiation Oncology • Biology • Physics 2018, 102: e399-e400. DOI: 10.1016/j.ijrobp.2018.07.1180.
- O’Connor J, Sedghi T, Dhodapkar M, Kane MJ, Gross CP. Factors Associated With Cancer Disparities Among Low-, Medium-, and High-Income US Counties. JAMA Network Open 2018, 1: e183146. PMID: 30646225, PMCID: PMC6324449, DOI: 10.1001/jamanetworkopen.2018.3146.
- Zhou Y, Abel G, Hamilton W, Pritchard-Jones K, Gross C, Walter F, Renzi C, Johnson S, McPhail S, Elliss-Brookes L, Lyratzopoulos G. Defining, Measuring and Preventing the Diagnosis of Cancer as an Emergency: A Critical Review of Current Evidence. Journal Of Global Oncology 2018, 4: 48s-48s. DOI: 10.1200/jgo.18.45300.
- Wang S, Lin Y, Lin C, Sedghi T, Hsu S, Kim H, Chou T, Chiu Y, Gross C, Wang J. Treatment patterns and survival for hepatocellular carcinoma in USA and Taiwan. Journal Of Clinical Oncology 2018, 36: e16120-e16120. DOI: 10.1200/jco.2018.36.15_suppl.e16120.
- Wang S, Hung P, Killelea B, Mougalian S, Evans S, Sedghi T, Gross C. Comparative effectiveness of sentinel lymph node biopsy for patients with ductal carcinoma in situ. Journal Of Clinical Oncology 2018, 36: e12602-e12602. DOI: 10.1200/jco.2018.36.15_suppl.e12602.
- Richman I, Hoag J, Busch S, Gross C. Early adoption of digital breast tomosynthesis in the United States. Journal Of Clinical Oncology 2018, 36: e13543-e13543. DOI: 10.1200/jco.2018.36.15_suppl.e13543.
- Gross C, Hoag J, Xu X, Richman I, Aminawung J, Soulos P, Busch S. State breast density inform mandate laws and utilization of adjunctive screening tests and cancer detection following screening mammography. Journal Of Clinical Oncology 2018, 36: 6579-6579. DOI: 10.1200/jco.2018.36.15_suppl.6579.
- Pariser A, Mougalian S, Sedghi T, Gross C, Killelea B. Treatment effect of neoadjuvant endocrine therapy compared to neoadjuvant chemotherapy on breast cancer outcomes. Journal Of Clinical Oncology 2018, 36: e12630-e12630. DOI: 10.1200/jco.2018.36.15_suppl.e12630.
- Huntington S, Von Keudell G, Davidoff A, Gross C, Prasad S. Cost-effectiveness analysis of brentuximab vedotin with chemotherapy in newly diagnosed stage III/IV Hodgkin lymphoma. Journal Of Clinical Oncology 2018, 36: 6609-6609. DOI: 10.1200/jco.2018.36.15_suppl.6609.
- Ruddy KJ, Sangaralingham L, Freedman RA, Mougalian S, Neuman H, Greenberg C, Jemal A, Duma N, Haddad TC, Lemaine V, Ghosh K, Hieken TJ, Hunt K, Vachon C, Gross C, Shah ND. Adherence to Guidelines for Breast Surveillance in Breast Cancer Survivors. Journal Of The National Comprehensive Cancer Network 2018, 16: 526-534. PMID: 29752327, DOI: 10.6004/jnccn.2018.7001.
- Kim S, Karnes J, Bukavina L, Van Houten H, Gross C, Mwangi R, Shah N. MP12-15 NATIONAL TRENDS IN THE MANAGEMENT OF LOCALIZED PROSTATE CANCER FROM A POPULATION-BASED COHORT OF PRIVATELY INSURED PATIENTS. Journal Of Urology 2018, 199: e141-e142. DOI: 10.1016/j.juro.2018.02.402.
- Leapman M, Wang R, Park H, Yu J, Gross C, Ma X. MP53-08 USE OF PROSTATE MAGNETIC RESONANCE IMAGING AMONG MEDICARE BENEFICIARIES WITH LOW-RISK PROSTATE CANCER IS ASSOCIATED WITH A HIGHER LIKELIHOOD OF DEFINITIVE TREATMENT. Journal Of Urology 2018, 199: e707. DOI: 10.1016/j.juro.2018.02.1679.
- Andreano A, Peake M, Valsecchi M, Janes S, Pritchard-Jones K, Hoag J, Gross C. 128 The care and outcomes of older persons with lung cancer in England and US, 2008–2012. Lung Cancer 2018, 115: s54-s55. DOI: 10.1016/s0169-5002(18)30154-5.
- Bui D, Magnuson W, Lester-Coll N, Qian J, Ross R, Soulos P, Shafman T, Dosoretz A, Evans S, Yu J, Gross C, Decker R. Stereotactic Body Radiation Therapy for Oligometastatic Disease: A Multi-Institutional Retrospective Survival Analysis. International Journal Of Radiation Oncology • Biology • Physics 2017, 99: e443. DOI: 10.1016/j.ijrobp.2017.06.1664.
- Johnson S, Park H, Gross C, Yu J. Use of Alternative Medicine for Cancer and Its Impact on Survival. International Journal Of Radiation Oncology • Biology • Physics 2017, 99: e401. DOI: 10.1016/j.ijrobp.2017.06.1562.
- Johnson SB, Park HS, Gross CP, Yu JB. Use of Alternative Medicine for Cancer and Its Impact on Survival. Journal Of The National Cancer Institute 2017, 110: djx145. PMID: 28922780, DOI: 10.1093/jnci/djx145.
- Presley C, Han L, O'leary J, Chao H, Shamas T, Kerin A, Rose M, Gross C. Concurrent Care and Aggressive End-of-Life Lung Cancer Care. Journal Of Thoracic Oncology 2017, 12: s1545. DOI: 10.1016/j.jtho.2017.06.058.
- Li D, Sun C, Levi A, Klepin H, Elias R, Mohile S, Tew W, Lim D, Chung V, Chao J, Owusu C, Muss H, Lichtman S, Gross C, Chapman A, Gajra A, Cohen H, Katheria V, Hurria A. Risk factors for hospitalizations (HOS) among older adults with gastrointestinal (GI) cancers receiving chemotherapy. Journal Of Clinical Oncology 2017, 35: e21523-e21523. DOI: 10.1200/jco.2017.35.15_suppl.e21523.
- Soto Perez De Celis E, Sun C, Tew W, Mohile S, Gajra A, Klepin H, Owusu C, Gross C, Muss H, Lichtman S, Chapman A, Cohen H, Dale W, Kim H, Katheria V, Hurria A. Impact of hearing and visual impairment in older adults with cancer. Journal Of Clinical Oncology 2017, 35: 10036-10036. DOI: 10.1200/jco.2017.35.15_suppl.10036.
- O'Connor J, Seidl-Rathkopf K, You P, Nussbaum N, Torres A, Fessele K, Darius K, Adelson K, Yin E, Presley C, Chiang A, Ross J, Abernethy A, Gross C. Adoption of immunotherapy into real-world practice: Insights from the use of checkpoint inhibitors. Journal Of Clinical Oncology 2017, 35: e14583-e14583. DOI: 10.1200/jco.2017.35.15_suppl.e14583.
- Presley C, Soulos P, Chiang A, Longtine J, Adelson K, Herbst R, Nussbaum N, Sorg R, Abernethy A, Agarwala V, Gross C. Disparities in next generation sequencing in a population-based community cohort of patients with advanced non-small cell lung cancer. Journal Of Clinical Oncology 2017, 35: 6563-6563. DOI: 10.1200/jco.2017.35.15_suppl.6563.
- O'Connor J, Seidl-Rathkopf K, Torres A, You P, Nussbaum N, Fessele K, Darius K, Adelson K, Yin E, Presley C, Chiang A, Ross J, Abernethy A, Gross C. Racial disparities in the use of programmed death-1 checkpoint inhibitors. Journal Of Clinical Oncology 2017, 35: 3068-3068. DOI: 10.1200/jco.2017.35.15_suppl.3068.
- Ruddy K, Sangaralingham L, Neuman H, Greenberg C, Freedman R, Jemal A, Mougalian S, Hunt K, Haddad T, Lemaine V, Ghosh K, Hieken T, Vachon C, Gross C, Shah N. Mammography use in breast cancer survivors: An administrative claims study. Journal Of Clinical Oncology 2017, 35: 6531-6531. DOI: 10.1200/jco.2017.35.15_suppl.6531.
- Johnson S, Gross C, Park H, Yu J. Use of alternative medicine for cancer and its impact on survival. Journal Of Clinical Oncology 2017, 35: e18175-e18175. DOI: 10.1200/jco.2017.35.15_suppl.e18175.
- Huntington S, Long J, Hoag J, Wang R, Zeidan A, Giri S, Gore S, Ma X, Gross C, Davidoff A. Physician volume and discontinuation of rituximab during lymphoma treatment. Journal Of Clinical Oncology 2017, 35: 6593-6593. DOI: 10.1200/jco.2017.35.15_suppl.6593.
- Mougalian S, Soulos P, Lannin D, Pusztai L, Gross C, Killelea B. Duration of neoadjuvant endocrine therapy and breast cancer outcomes. Journal Of Clinical Oncology 2017, 35: e12129-e12129. DOI: 10.1200/jco.2017.35.15_suppl.e12129.
- Scarberry K, Scarberry K, Abouassaly R, Gonzalez C, Gross C, Shah N, Meropol N, Psutka S, Prasad S, Bukavina L, Kim S. PD09-02 RACIAL VARIATION IN THE REFUSAL OF INITIAL TREATMENT PLAN AMONG MEN DIAGNOSED WITH LOCALIZED PROSTATE CANCER. Journal Of Urology 2017, 197: e194. DOI: 10.1016/j.juro.2017.02.552.
- Nguyen K, Gross C, Cooperberg M, Katz M, Hittelman A, Syed J, Schulam P, Leapman M. MP69-07 HASHTAG PEER-REVIEW: DOES EARLY SOCIAL MEDIA SUCCESS CORRELATE WITH CONVENTIONAL METRICS OF PUBLICATION IMPACT? Journal Of Urology 2017, 197: e928-e929. DOI: 10.1016/j.juro.2017.02.2303.
- Pollack CE, Soulos PR, Herrin J, Xu X, Christakis NA, Forman HP, Yu JB, Killelea BK, Wang SY, Gross CP. The Impact of Social Contagion on Physician Adoption of Advanced Imaging Tests in Breast Cancer. Journal Of The National Cancer Institute 2017, 109: djw330. PMID: 28376191, PMCID: PMC6059114, DOI: 10.1093/jnci/djw330.
- Davis BA, Aminawung JA, Abu-Khalaf MM, Evans SB, Su K, Mehta R, Wang SY, Gross CP. Racial and Ethnic Disparities in Oncotype DX Test Receipt in a Statewide Population-Based Study. Journal Of The National Comprehensive Cancer Network 2017, 15: 346-354. PMID: 28275035, DOI: 10.6004/jnccn.2017.0034.
- Wang S, Cramer L, Pollack C, Gross C. Primary care physician continuity and end-of-life care intensity among Medicare cancer decedents. Journal Of Clinical Oncology 2017, 35: 38-38. DOI: 10.1200/jco.2017.35.5_suppl.38.
- Bongiovanni T, Kim S, Gross C, Kim A, Killelea B. Variation in Private Payer Payments to Cancer Surgeons. Journal Of The American College Of Surgeons 2016, 223: s121-s122. DOI: 10.1016/j.jamcollsurg.2016.06.252.
- Stahl J, Ross R, Harder E, Mancini B, Soulos P, Dosoretz A, Finkelstein S, Shafman T, Husain Z, Evans S, Yu J, Gross C, Decker R. A Biologically Effective Dose of ≥105 Gy Is Associated With Improved Overall Survival in Stage I Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy. International Journal Of Radiation Oncology • Biology • Physics 2016, 96: s174-s175. DOI: 10.1016/j.ijrobp.2016.06.438.
- Jairam V, Gross C, Yu J. Examining Trends in the CMS Medicare Provider Utilization and Payment Database for Radiation Oncologists. International Journal Of Radiation Oncology • Biology • Physics 2016, 96: e404-e405. DOI: 10.1016/j.ijrobp.2016.06.1646.
- Johnson S, Soulos P, Shafman T, Mantz C, Dosoretz A, Ross R, Finkelstein S, Collins S, Suy S, Brower J, Ritter M, King C, Kupelian P, Horwitz E, Pollack A, Abramowitz M, Hallman M, Faria S, Gross C, Yu J. Patient-Reported Quality of Life After Stereotactic Body Radiation Therapy Versus Moderate Hypofractionation for Clinically Localized Prostate Cancer. International Journal Of Radiation Oncology • Biology • Physics 2016, 96: e242. DOI: 10.1016/j.ijrobp.2016.06.1232.
- Hong J, Gross C, Shafman T, Hu X, Yu J, Ross R, Dosoretz A, Park H, Finkelstein S, Soulos P, Evans S. Modern Radiation Therapy for Left-Sided Breast Cancer: An Analysis of Mean Heart Dose Within Diverse Practice Settings. International Journal Of Radiation Oncology • Biology • Physics 2016, 96: s209. DOI: 10.1016/j.ijrobp.2016.06.520.
- Wang E, Wang S, Soulos P, Chen R, Kim S, Gross C, Yu J. Changes in quality of life after radiation therapy for localized prostate cancer after dissemination of intensity modulated radiation therapy. Journal Of Radiation Oncology 2016, 6: 295-300. DOI: 10.1007/s13566-016-0269-0.
- Klepin H, Sun C, Smith D, Elias R, Trevino K, Bryant A, Nelson C, Tew W, Mohile S, Owusu C, Gross C, Gajra A, Lichtman S, Katheria V, Hurria A. Predictors of unplanned hospitalizations among older adults receiving cancer chemotherapy. Journal Of Clinical Oncology 2016, 34: 10057-10057. DOI: 10.1200/jco.2016.34.15_suppl.10057.
- Shahrokni A, Sun C, Tew W, Mohile S, Owusu C, Klepin H, Gross C, Lichtman S, Gajra A, Katheria V, Cohen H, Hurria A. Complex association between social support and chemotherapy-related toxicities in older cancer patients. Journal Of Clinical Oncology 2016, 34: 10036-10036. DOI: 10.1200/jco.2016.34.15_suppl.10036.
- Wang S, Huang S, Hsu S, Gross C. Association of length of hospice enrollment with regional variation in end-of-life care expenditures. Journal Of Clinical Oncology 2016, 34: 10030-10030. DOI: 10.1200/jco.2016.34.15_suppl.10030.
- Epstein L, Jhaveri A, Han G, Abu-Khalaf M, Hofstatter E, Sanft T, DiGiovanna M, Silber A, Adelson K, Chung G, Gross C, Pusztai L, Mougalian S. Onset of side effects and adherence to endocrine therapy in the Breast Cancer Endocrine Therapy Adherence (BETA) pilot study. Journal Of Clinical Oncology 2016, 34: e18136-e18136. DOI: 10.1200/jco.2016.34.15_suppl.e18136.
- Ruddy K, Sangaralingham L, Freedman R, Jemal A, Thompson C, Hashmi S, Mougalian S, Gross C, Shah N. Acute care use among women receiving adjuvant chemotherapy for breast cancer. Journal Of Clinical Oncology 2016, 34: 6543-6543. DOI: 10.1200/jco.2016.34.15_suppl.6543.
- Gross C, Ross W, Rotatori J, Mitchell H, Ma X, Kadan-Lottick N. Randomized trial assessing the impact of survivorship care plans on the quality of care for childhood cancer survivors. Journal Of Clinical Oncology 2016, 34: 10007-10007. DOI: 10.1200/jco.2016.34.15_suppl.10007.
- Stratton J, Hu X, Soulos P, Davidoff A, Pusztai L, Gross C, Mougalian S. Bone density screening in postmenopausal women with early-stage breast cancer on aromatase inhibitors. Journal Of Clinical Oncology 2016, 34: 6599-6599. DOI: 10.1200/jco.2016.34.15_suppl.6599.
- Presley C, Harrington E, Gippetti J, Agarwala V, Bowser B, Adelson K, Herbst R, Abernethy A, Gross C. Contemporary management of advanced non-small cell lung cancer (aNSCLC) in a large, real-world cohort. Journal Of Clinical Oncology 2016, 34: e20621-e20621. DOI: 10.1200/jco.2016.34.15_suppl.e20621.
- Mahal A, Cramer L, Wang E, Wang S, Davidoff A, Gross C, Yu J. The benefit of modern cancer therapy for older patients. Journal Of Clinical Oncology 2016, 34: e18141-e18141. DOI: 10.1200/jco.2016.34.15_suppl.e18141.
- Doan K, Levy B, Gross C, Wang S. Associations of pre- and post-cancer depression with end-of-life cancer care intensity. Journal Of Clinical Oncology 2016, 34: 10031-10031. DOI: 10.1200/jco.2016.34.15_suppl.10031.
- Thomas G, Cartmel B, Harrigan M, Fiellin M, Capozza S, Zhou Y, Ercolano E, Gross C, Hershman D, Ligibel J, Schmitz K, Li F, Sanft T, Irwin M. Randomized Trial Of Exercise On Body Composition In Breast Cancer Survivors Taking Aromatase Inhibitors. Medicine & Science In Sports & Exercise 2016, 48: 334. DOI: 10.1249/01.mss.0000486010.57056.60.
- Zeidan A, Long J, Hall J, Wang R, Huntington S, Abel G, Prebet T, Podoltsev N, Gross C, Gore S, Ma X, Davidoff A. Comparative Effectiveness of Azacitidine Versus Decitabine Among Older Adults Diagnosed with Higher-Risk Myelodysplastic Syndromes (HR-MDS). Blood 2015, 126: 3285. DOI: 10.1182/blood.v126.23.3285.3285.
- Zeidan A, Long J, Wang R, Yu J, Hall J, Abel G, Gore S, Gross C, Ma X, Davidoff A. Secondary Myeloid Neoplasms in Older Women with Breast Cancer after Radiotherapy: A Population-Based Study. Blood 2015, 126: 1676. DOI: 10.1182/blood.v126.23.1676.1676.
- Wang R, Zeidan A, Soulos P, Yu J, Davidoff A, Gore S, Gross C, Ma X. Myelodysplastic Syndromes and Acute Myeloid Leukemia in Prostate Cancer Patients after Radiotherapy, a Population-Based Study. Blood 2015, 126: 3295. DOI: 10.1182/blood.v126.23.3295.3295.
- Zeidan A, Wang R, Davidoff A, Gore S, Soulos P, Huntington S, Gross C, Ma X. Lack of Association Between Costs of Care and Overall Survival (OS) Among Medicare Beneficiaries with Myelodysplastic Syndromes (MDS) in the United States (US). Blood 2015, 126: 873. DOI: 10.1182/blood.v126.23.873.873.
- Aneja S, Smith B, Gross C, Haffty B, Wilson L, Yu J. Trends in Hospital Owned Practices Within Radiation Oncology. International Journal Of Radiation Oncology • Biology • Physics 2015, 93: e371-e372. DOI: 10.1016/j.ijrobp.2015.07.1495.
- Park H, Wang E, Corso C, Rutter C, Wilson L, Kim A, Gross C, Yu J, Decker R. Higher Facility Case Volume of Stereotactic Body Radiation Therapy Is Associated With Improved Overall Survival in Clinical Stage I Non-Small Cell Lung Cancer. International Journal Of Radiation Oncology • Biology • Physics 2015, 93: s186-s187. DOI: 10.1016/j.ijrobp.2015.07.447.
- Aneja S, Gross C, Glazer P, Yu J. Genomic Predictors of Biochemical Failure Following Radical Prostatectomy. International Journal Of Radiation Oncology • Biology • Physics 2015, 93: e251-e252. DOI: 10.1016/j.ijrobp.2015.07.1180.
- Bledsoe T, Rutter C, Corso C, Aneja S, Lester-Coll N, Wang E, Potosky A, Gross C, Yu J, Park H. Stereotactic Body Radiation Therapy for Prostate Cancer: Adoption in the United States From 2005 to 2012. International Journal Of Radiation Oncology • Biology • Physics 2015, 93: e359. DOI: 10.1016/j.ijrobp.2015.07.1462.
- Lester-Coll N, Park H, Rutter C, Corso C, Mancini B, Yeboa D, Kim S, Gross C, Yu J. Evaluation at Academic Centers Increases the Likelihood of Active Surveillance in Low-Risk Prostate Cancer. International Journal Of Radiation Oncology • Biology • Physics 2015, 93: s118. DOI: 10.1016/j.ijrobp.2015.07.281.
- Fox J, Bauder A, Gross C, Killelea B, Butler P, Kovach S. The Relationship Between Geographic Access to Plastic Surgeons and Immediate Breast Reconstruction Rates Among Women Undergoing Mastectomy for Cancer. Plastic & Reconstructive Surgery 2015, 136: 91-92. DOI: 10.1097/01.prs.0000472391.73232.70.
- Zeidan A, Wang R, Davidoff A, Gore S, Gross C, Ma X. Disease-specific costs of care and survival among Medicare-enrolled patients with myelodysplastic syndromes (MDS). Clinical Lymphoma Myeloma & Leukemia 2015, 15: s44-s45. DOI: 10.1016/j.clml.2015.07.094.
- Wildes T, Tew W, Maggiore R, Edwards B, Cohen H, Smith D, Mohile S, Owusu C, Klepin H, Gross C, Lichtman S, Gajra A, Katheria V, Akiba C, Hurria A. Association of geriatric assessment factors with falls in older adults initiating chemotherapy. Journal Of Clinical Oncology 2015, 33: 9542-9542. DOI: 10.1200/jco.2015.33.15_suppl.9542.
- Peterson L, Hurria A, Feng T, Mohile S, Owusu C, Klepin H, Gross C, Lichtman S, Gajra A, Glezerman I, Katheria V, Zavala L, Smith D, Tew W. Association between renal function and chemotherapy-related toxicity in older adults with cancer. Journal Of Clinical Oncology 2015, 33: 9509-9509. DOI: 10.1200/jco.2015.33.15_suppl.9509.
- Presley C, Soulos P, Yu J, Gross C. “The burden upon me”: The complexity of healthcare utilization among Medicare patients undergoing curative lung cancer treatment. Journal Of Clinical Oncology 2015, 33: 7533-7533. DOI: 10.1200/jco.2015.33.15_suppl.7533.
- Bongiovanni T, Kim A, Killelea B, Kim S, Gross C. Variation in surgeon payment for cancer resection. Journal Of Clinical Oncology 2015, 33: e17802-e17802. DOI: 10.1200/jco.2015.33.15_suppl.e17802.
- Kim S, Karnes J, Gross C, Meropol N, Van Houten H, Abouassaly R, Shah N. Contemporary national trends of prostate cancer screening among privately insured patients in the United States. Journal Of Clinical Oncology 2015, 33: 5065-5065. DOI: 10.1200/jco.2015.33.15_suppl.5065.
- Su K, Yu J, Shafman T, Evans S, Decker R, Dosoretz A, Dosoretz D, Ross R, Salenius S, Finkelstein S, Hall J, Soulos P, Gross C. Changes in prostate cancer presentation for radiation oncology care after USPSTF recommendations, 2007-2013. Journal Of Clinical Oncology 2015, 33: e16070-e16070. DOI: 10.1200/jco.2015.33.15_suppl.e16070.
- Mougalian S, Long J, Hall J, Adelson K, Abu-Khalaf M, Pusztai L, Gross C. Outcomes of adjuvant ACT vs. TC chemotherapy in older women with breast cancer. Journal Of Clinical Oncology 2015, 33: 1009-1009. DOI: 10.1200/jco.2015.33.15_suppl.1009.
- Wang S, Hall J, Long J, Pollack C, Bradley E, Adelson K, Gross C. Trends and regional variation of end-of-life cancer care in the Medicare program. Journal Of Clinical Oncology 2015, 33: 9526-9526. DOI: 10.1200/jco.2015.33.15_suppl.9526.
- Makarov DV, Soulos PR, Gold HT, Yu JB, Sen S, Ross JS, Gross CP. Regional-Level Correlations in Inappropriate Imaging Rates for Prostate and Breast Cancers: Potential Implications for the Choosing Wisely Campaign. JAMA Oncology 2015, 1: 185-194. PMID: 26181021, PMCID: PMC4707944, DOI: 10.1001/jamaoncol.2015.37.
- Kiechle J, Wang E, Yu J, Gross C, Abouassaly R, Cherullo E, Smaldone M, Shah N, Trinh Q, Sun M, Kim S. MP56-06 ASSOCIATION BETWEEN PROVIDER-LEVEL FACTORS AND LYMPH NODE DISSECTION OUTCOMES DURING RADICAL PROSTATECTOMY: A NATIONAL CANCER DATABASE ANALYSIS. Journal Of Urology 2015, 193: e683. DOI: 10.1016/j.juro.2015.02.2070.
- Makarov D, Gold H, Walter D, Eugenio E, Sherman S, Gross C, Zeliadt S. MP9-03 THE EFFECT OF HEALTHCARE SYSTEM ON APPROPRIATENESS OF PROSTATE CANCER IMAGING: DO PATIENTS GET BETTER CARE IN VA OR FEE-FOR-SERVICE MEDICARE? Journal Of Urology 2015, 193: e102-e103. DOI: 10.1016/j.juro.2015.02.363.
- Wane R, Zeidan A, Soulos P, Yu J, Davidoff A, Gore S, Gross C, Ma X. 80 SUBSEQUENT MYELODYSPLASTIC SYNDROMES IN PROSTATE CANCER PATIENTS AFTER RADIOTHERAPY, A POPULATION-BASED STUDY. Leukemia Research 2015, 39: s39. DOI: 10.1016/s0145-2126(15)30081-3.
- Han Y, Wietsma A, Gross C, Shah N, Abouassaly R, Smaldone M, Boorjian S, Hoimes C, Cooney M, Kim S. MP69-08 SYSTEMATIC REVIEW AND META-ANALYSIS OF TARGETED THERAPY FOR OVERALL SURVIVAL, COMPLETE RESPONSE AND QUALITY OF LIFE FOR METASTATIC RENAL CELL CARCINOMA. Journal Of Urology 2015, 193: e869-e870. DOI: 10.1016/j.juro.2015.02.2512.
- Kim S, Karnes R, Gross C, Van Houten H, Abouassaly R, Shah N. PD44-05 CONTEMPORARY NATIONAL TRENDS OF PROSTATE CANCER SCREENING AMONG PRIVATELY INSURED PATIENTS IN THE UNITED STATES. Journal Of Urology 2015, 193: e899. DOI: 10.1016/j.juro.2015.02.2551.
- Kiechle J, Abouassaly R, Tabayoyong W, Dong S, Smaldone M, Cherullo E, Gross C, Shah N, Zhu H, Kim S. MP84-05 VARIATION IN SURGICAL MARGIN STATUS BY SURGICAL APPROACH AMONG PATIENTS UNDERGOING PARTIAL NEPHRECTOMY FOR SMALL RENAL MASSES. Journal Of Urology 2015, 193: e1059. DOI: 10.1016/j.juro.2015.02.1972.
- Dong S, Kiechle J, Kim S, Abouassaly R, Cherullo E, Ponsky L, Gross C, Shah N, Zhu H. MP44-10 TREATMENT TRENDS OF SMALL RENAL MASSES IN PATIENTS OF ADVANCED AGE. Journal Of Urology 2015, 193: e530. DOI: 10.1016/j.juro.2015.02.1552.
- Kiechle J, Wang E, Yu J, Gross C, Abouassaly R, Cherullo E, Smaldone M, Shah N, Trinh Q, Sun M, Kim S. Association between provider-level factors and lymph node dissection outcomes during radical prostatectomy: A national cancer database analysis. Journal Of Clinical Oncology 2015, 33: 89-89. DOI: 10.1200/jco.2015.33.7_suppl.89.
- Gajra A, Feng T, CARG, Mohile S, Owusu C, Klepin H, Gross C, Katheria V, Tew W, Hurria A, Group C. Assessing the validity of the CARG (Cancer and Aging Research Group) chemotherapy toxicity score for reduced models. Journal Of Geriatric Oncology 2014, 5: s64. DOI: 10.1016/j.jgo.2014.09.116.
- Erb C, Soulos P, Tanoue L, Gross C. Surveillance Practice Patterns After Curative Intent Therapy for Stage I Non-small Cell Lung Cancer in the Medicare Population. CHEST Journal 2014, 146: 607a. DOI: 10.1378/chest.1992085.
- Lott J, Soulos P, Aminawung J, Gross C. PS1-44: Time to Surgery for Melanoma. Clinical Medicine & Research 2014, 12: 78-78. PMCID: PMC4453318, DOI: 10.3121/cmr.2014.1250.ps1-44.
- Yu J, Soulos P, Cramer L, Decker R, Kim A, Gross C. Comparative Effectiveness of Stereotactic Body Radiation Therapy Versus Surgery for Stage I Non-small Cell Lung Cancer. International Journal Of Radiation Oncology • Biology • Physics 2014, 90: s138. DOI: 10.1016/j.ijrobp.2014.05.596.
- Yang D, Pamela S, Brigette D, Gross C, Yu J. Impact of 3 Decades of Screening on Racial Disparities in Cervical Cancer Incidence. International Journal Of Radiation Oncology • Biology • Physics 2014, 90: s579-s580. DOI: 10.1016/j.ijrobp.2014.05.1745.
- Killelea BK, Long JB, Chagpar AB, Ma X, Wang R, Ross JS, Gross CP. Evolution of Breast Cancer Screening in the Medicare Population: Clinical and Economic Implications. Journal Of The National Cancer Institute 2014, 106: dju159. PMID: 25031307, PMCID: PMC4155428, DOI: 10.1093/jnci/dju159.
- Kim S, Gross C, Abouassaly R, Psutka S, Van Houten H, Thompson R, Smaldone M, Trinh Q, Sun M, Han L, Shah N. Out-of-pockets costs for patients receiving targeted agents for metastatic renal cell carcinoma. Journal Of Clinical Oncology 2014, 32: e15598-e15598. DOI: 10.1200/jco.2014.32.15_suppl.e15598.
- Yang D, Soulos P, Davis B, Gross C, Yu J. Estimating the impact of screening on three decades of cervical cancer incidence. Journal Of Clinical Oncology 2014, 32: 1518-1518. DOI: 10.1200/jco.2014.32.15_suppl.1518.
- Yu J, Soulos P, Cramer L, Decker R, Kim A, Gross C. Diffusion of stereotactic body radiotherapy (SBRT) for early-stage non-small cell lung cancer (NSCLC) in the Medicare population, 2007-2009. Journal Of Clinical Oncology 2014, 32: 7575-7575. DOI: 10.1200/jco.2014.32.15_suppl.7575.
- Graham-Steed T, Soulos P, Dearing N, Concato J, Tinetti M, Gross C. Development and validation of a prognostic index for fracture risk in older men undergoing prostate cancer treatment. Journal Of Clinical Oncology 2014, 32: 5056-5056. DOI: 10.1200/jco.2014.32.15_suppl.5056.
- Kim S, Gross C, Nguyen P, Smaldone M, Thompson R, Shah N, Kutikov A, Han L, Karnes R, Ziegenfuss J, Tilburt J. Erratum: Specialty bias in treatment recommendations and quality of life among radiation oncologists and urologists for localized prostate cancer. Prostate Cancer And Prostatic Diseases 2014, 17: 212-212. DOI: 10.1038/pcan.2014.14.
- Sivarajan G, Taksler G, Walter D, Bjurlin M, Gross C, Makarov D. PD17-08 THE EFFECT OF THE SURGICAL ROBOT ON THE HOSPITAL-LEVEL UTILIZATION OF PARTIAL NEPHRECTOMY. Journal Of Urology 2014, 191: e543. DOI: 10.1016/j.juro.2014.02.1515.
- Psutka S, Kim S, Gross C, Van Houten H, Thompson R, Abouassaly R, Weight C, Leibovich B, Shah N. MP6-06 POPULATION-LEVEL TRENDS IN THE ADOPTION OF NOVEL TARGETED AGENTS FOR SYSTEMIC THERAPY AND IMPACT ON RATES OF CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA. Journal Of Urology 2014, 191: e58. DOI: 10.1016/j.juro.2014.02.240.
- Delpe S, Shah N, Tilburt J, Karnes R, Nguyen P, Shuch B, Gross C, Schulam P, Yu J, Ziegenfuss J, Kim S. Perceptions of radiation oncologists and urologists on the type of evidence that informs and changes the clinical practice of prostate cancer. Journal Of Clinical Oncology 2014, 32: 167-167. DOI: 10.1200/jco.2014.32.4_suppl.167.
- Yu J, Cramer L, Herrin J, Soulos P, Potosky A, Gross C. Stereotactic body radiosurgery versus intensity modulated radiotherapy for prostate cancer: Comparison of toxicity. Journal Of Clinical Oncology 2014, 32: 89-89. DOI: 10.1200/jco.2014.32.4_suppl.89.
- Presley C, Gross C. Trends in Radiotherapy After Breast-Conserving Surgery in Elderly Patients with Early-Stage Breast Cancer Luu C, Goldstein L, Goldner B, et al (Harbor-UCLA Med Ctr, Torrance, CA; City of Hope Natl Cancer Ctr, Duarte, CA) Ann Surg Oncol 20:3266-3273, 2013§. Breast Diseases A Year Book Quarterly 2014, 25: 85-87. DOI: 10.1016/j.breastdis.2014.01.005.
- Gavankar C, Gross C, Lilenbaum R, Chagpar A. Factors associated with unplanned breast cancer readmissions. Journal Of Clinical Oncology 2013, 31: 131-131. DOI: 10.1200/jco.2013.31.31_suppl.131.
- Raldow A, Presley C, Yu J, Cramer L, Soulos P, Long J, Makarov D, Gross C. The Dissemination of New Technologies and Temporal Trends in Curative Therapy for Prostate Cancer Patients With Low Likelihood of Clinical Benefit. International Journal Of Radiation Oncology • Biology • Physics 2013, 87: s177-s178. DOI: 10.1016/j.ijrobp.2013.06.459.
- Yu J, Cramer L, Herrin J, Soulos P, Potosky A, Gross C. Stereotactic Radiosurgery Versus Intensity Modulated Radiation Therapy for Prostate Cancer: Comparison of Early Toxicity. International Journal Of Radiation Oncology • Biology • Physics 2013, 87: s153-s154. DOI: 10.1016/j.ijrobp.2013.06.396.
- Herbst M, Rosenberg G, Daniels B, Gross C, Singh D, Molinaro A, Luty S, Moore C. Accuracy of Point-of-Care Ultrasound for Hydronephrosis in Patients With Suspected Renal Colic: A Look at Emergency Providers With Variable Ultrasound Experience. Annals Of Emergency Medicine 2013, 62: s32-s33. DOI: 10.1016/j.annemergmed.2013.07.369.
- Yang D, Gross C, Yu J. Changes in Early- and Late-Stage Colorectal Cancer Incidence During the Era of Screening: 1976-2009. International Journal Of Radiation Oncology • Biology • Physics 2013, 87: s331. DOI: 10.1016/j.ijrobp.2013.06.872.
- Maggiore R, Feng T, Dale W, Gross C, Tew W, Mohile S, Owusu C, Klepin H, Lichtman S, Gajra A, McKoy J, Katheria V, Ramani R, Jayani R, Brown J, Hurria A. Measures of polypharmacy and chemotherapy toxicity in older adults with cancer. Journal Of Clinical Oncology 2013, 31: 9545-9545. DOI: 10.1200/jco.2013.31.15_suppl.9545.
- Changes in early- and late-stage colorectal cancer incidence during the era of screening: 1976-2009.Yang D, Gross C, Yu J. Changes in early- and late-stage colorectal cancer incidence during the era of screening: 1976-2009. Journal Of Clinical Oncology 2013, 31: 1522-1522. DOI: 10.1200/jco.2013.31.15_suppl.1522.
- Iyer N, Mitchell H, Gross C, Ma X, Kadan-Lottick N. Health practices and behaviors of childhood cancer survivors not attending a comprehensive survivor clinic. Journal Of Clinical Oncology 2013, 31: 10063-10063. DOI: 10.1200/jco.2013.31.15_suppl.10063.
- Gross CP, Long JB, Ross JS, Abu-Khalaf MM, Wang R, Killelea BK, Gold HT, Chagpar AB, Ma X. The Cost of Breast Cancer Screening in the Medicare Population. JAMA Internal Medicine 2013, 173: 220-226. PMID: 23303200, PMCID: PMC3638736, DOI: 10.1001/jamainternmed.2013.1397.
- Vashi AA, Fox JP, Carr BG, D’Onofrio G, Pines JM, Ross JS, Gross CP. Use of Hospital-Based Acute Care Among Patients Recently Discharged From the Hospital. JAMA 2013, 309: 364-371. PMID: 23340638, PMCID: PMC3598620, DOI: 10.1001/jama.2012.216219.
- Yu JB, Soulos PR, Herrin J, Cramer LD, Potosky AL, Roberts KB, Gross CP. Proton Versus Intensity-Modulated Radiotherapy for Prostate Cancer: Patterns of Care and Early Toxicity. Journal Of The National Cancer Institute 2012, 105: 25-32. PMID: 23243199, PMCID: PMC3536640, DOI: 10.1093/jnci/djs463.
- Yu J, Soulos P, Herrin J, Cramer L, Potosky A, Roberts K, Gross C. Proton Radiation Therapy for Prostate Cancer in the Medicare Population: Patterns of Care and Comparison of Early Toxicity With Intensity Modulated Radiation Therapy. International Journal Of Radiation Oncology • Biology • Physics 2012, 84: s13. DOI: 10.1016/j.ijrobp.2012.07.040.
- Lloyd S, Buscariollo D, Gross C, Makarov D, Yu J, Aneja S. The Funding of Phase III Clinical Trials Examining Radiation Compared With That of Other Modalities. International Journal Of Radiation Oncology • Biology • Physics 2012, 84: s44-s45. DOI: 10.1016/j.ijrobp.2012.07.326.
- Buscariollo D, Lloyd S, Gross C, Makarov D, Yu J. Comparison of the Level of Evidence Supporting Practice Guidelines in Cancer Care Between Therapeutic Modalities. International Journal Of Radiation Oncology • Biology • Physics 2012, 84: s43. DOI: 10.1016/j.ijrobp.2012.07.324.
- Roberts K, Soulos P, Yu J, Evans S, Long J, Gross C. Temporal Trends in Radiation Modalities Among Older Women With Favorable Risk Breast Cancer. International Journal Of Radiation Oncology • Biology • Physics 2012, 84: s34. DOI: 10.1016/j.ijrobp.2012.07.093.
- Sen S, Soulos P, Frick K, Long J, Roberts K, Yu J, Evans S, Chagpar A, Gross C. Understanding Costs and Value of Newer Radiation Modalities Among Older Women With Breast Cancer. International Journal Of Radiation Oncology • Biology • Physics 2012, 84: s35. DOI: 10.1016/j.ijrobp.2012.07.096.
- Hansen D, Fox J, Gross C, Bruun J. Laparoscopic colon resection for cancer is not associated with fewer hospital-based encounters following discharge. Journal Of The American College Of Surgeons 2012, 215: s99. DOI: 10.1016/j.jamcollsurg.2012.06.264.
- Gajra A, Tew W, Hardt M, Mohile S, Owusu C, Klepin H, Gross C, Lichtman S, Katheria V, Hurria A. Predictors of early discontinuation of chemotherapy (EDC) in patients (pts) age 65 or older with stage IV non-small cell lung cancer (NSCLC). Journal Of Clinical Oncology 2012, 30: e18133-e18133. DOI: 10.1200/jco.2012.30.15_suppl.e18133.
- Quon J, Yu J, Soulos P, Gross C. The relations between age and androgen deprivation therapy use among men receiving radiation therapy for prostate cancer in the Medicare population. Journal Of Clinical Oncology 2012, 30: e15150-e15150. DOI: 10.1200/jco.2012.30.15_suppl.e15150.
- Weiss T, Nelson C, Tew W, Hardt M, Mohile S, Owusu C, Klepin H, Gross C, Gajra A, Lichtman S, Ramani R, Katheria V, Zavala L, Hurria A. The relationship among age, anxiety, and depression in older adults with cancer. Journal Of Clinical Oncology 2012, 30: 9123-9123. DOI: 10.1200/jco.2012.30.15_suppl.9123.
- Owusu C, Tew W, Hardt M, Mohile S, Klepin H, Gross C, Gajra A, Lichtman S, Ramani R, Katheria V, Zavala L, Hurria A. Anemia and functional disability in older adults with cancer. Journal Of Clinical Oncology 2012, 30: 9109-9109. DOI: 10.1200/jco.2012.30.15_suppl.9109.
- Hurria A, Hardt M, Tew W, Mohile S, Owusu C, Gross C, Gajra A, Lichtman S, Katheria V, Ramani R, Zavala L, Klepin H. Factors associated with life expectancy (LE) < 3 months (mo) among older adults receiving palliative chemotherapy (chemo). Journal Of Clinical Oncology 2012, 30: 9034-9034. DOI: 10.1200/jco.2012.30.15_suppl.9034.
- Lloyd S, Buscariollo D, Gross C, Makarov D, Yu J. An assessment of the collective efforts of clinical trials to provide evidence-based practice guidelines in cancer care. Journal Of Clinical Oncology 2012, 30: 6019-6019. DOI: 10.1200/jco.2012.30.15_suppl.6019.
- Yu J, Soulos P, Cramer L, Roberts K, Herrin J, Potosky A, Gross C. Proton radiotherapy for prostate cancer in the Medicare population: Patterns of care and comparison of early toxicity with IMRT. Journal Of Clinical Oncology 2012, 30: 4651-4651. DOI: 10.1200/jco.2012.30.15_suppl.4651.
- Presley C, Soulos P, Herrin J, Roberts K, Yu J, Killelea B, Lesnikoski B, Long J, Gross C. Short-term complications and use of breast brachytherapy in the national Medicare population in 2008-2009. Journal Of Clinical Oncology 2012, 30: 1030-1030. DOI: 10.1200/jco.2012.30.15_suppl.1030.
- Makarov D, Li H, Yu J, Makary M, Braithwaite S, Sherman S, Taneja S, Penson D, Lepor H, Desai R, Blustein J, Gross C. 419 FACTORS ASSOCIATED WITH THE EARLY ACQUISITION OF THE SURGICAL ROBOT BY HOSPITALS IN THE UNITED STATES. Journal Of Urology 2012, 187: e172. DOI: 10.1016/j.juro.2012.02.485.
- Soulos PR, Yu JB, Roberts KB, Raldow AC, Herrin J, Long JB, Gross CP. Assessing the Impact of a Cooperative Group Trial on Breast Cancer Care in the Medicare Population. Journal Of Clinical Oncology 2012, 30: 1601-1607. PMID: 22393088, PMCID: PMC3383112, DOI: 10.1200/jco.2011.39.4890.
- Chen J, Long J, Steingart R, Gross C. RISK OF HEART FAILURE OR CARDIOMYOPATHY ASSOCIATED WITH ADJUVANT TRASTUZUMAB OR CHEMOTHERAPY IN OLDER WOMEN WITH BREAST CANCER. Journal Of The American College Of Cardiology 2012, 59: e996. DOI: 10.1016/s0735-1097(12)60997-8.
- Hurria A, Togawa K, Mohile S, Owusu C, Klepin H, Gross C, Lichtman S, Gajra A, Bhatia S, Katheria V, Klapper S, Hansen K, Ramani R, Lachs M, Wong F, Tew W. Reply to J. Lagro et al. Journal Of Clinical Oncology 2012, 30: 561-562. DOI: 10.1200/jco.2011.39.5319.
- Yu J, Aneja S, Makarov D, Roberts K, Gross C. The influence of regional radiation oncologist and urologist capacities on treatment choice for prostate cancer management. Journal Of Clinical Oncology 2012, 30: 108-108. DOI: 10.1200/jco.2012.30.5_suppl.108.
- Yu J, Aneja S, Makarov D, Roberts K, Gross C. The influence of physician densities and patient characteristics on the decision to treat prostate cancer patients with varying clinical benefit. Journal Of Clinical Oncology 2012, 30: 19-19. DOI: 10.1200/jco.2012.30.5_suppl.19.
- Aneja S, Makarov D, Gross C, Roberts K, Yu J. The Influence of Physician Densities and Patient Characteristics on the Decision to Treat Prostate Cancer Patients with Varying Clinical Benefit. International Journal Of Radiation Oncology • Biology • Physics 2011, 81: s553. DOI: 10.1016/j.ijrobp.2011.06.871.
- Lloyd S, Gross C, Makarov D, Yu J. Are the Efforts of Current Clinical Trials Involving Radiation Therapy Focused on the Evidence Gaps in Cancer Treatment? International Journal Of Radiation Oncology • Biology • Physics 2011, 81: s139-s140. DOI: 10.1016/j.ijrobp.2011.06.286.
- Aneja S, Gross C, Makarov D, Roberts K, Yu J. The Influence of Regional Radiation Oncologist and Urologist Capacities on Treatment Choice for Prostate Cancer. International Journal Of Radiation Oncology • Biology • Physics 2011, 81: s552. DOI: 10.1016/j.ijrobp.2011.06.869.
- Maggiore R, Gross C, Hardt M, Tew W, Mohile S, Klepin H, Lichtman S, Owusu C, Gajra A, Ramani R, Katheria V, Brown J, Jayani R, Hurria A. Polypharmacy, potentially inappropriate medications, and chemotherapy-related adverse events among older adults with cancer. Journal Of Clinical Oncology 2011, 29: e19501-e19501. DOI: 10.1200/jco.2011.29.15_suppl.e19501.
- Gajra A, Hardt M, Tew W, Mohile S, Owusu C, Klepin H, Gross C, Lichtman S, Ramani R, Brown J, Katheria V, Jayani R, Hansen K, Togawa K, Klapper S, Hurria A. Primary dose reduction (PDR) of chemotherapy (chemo) in patients (Pts) older than age 65 with advanced cancer (Ca) and toxicity outcomes. Journal Of Clinical Oncology 2011, 29: 9037-9037. DOI: 10.1200/jco.2011.29.15_suppl.9037.
- Klepin H, Gajra A, Hardt M, Tew W, Mohile S, Owusu C, Gross C, Lichtman S, Ramani R, Katheria V, Brown J, Jayani R, Hansen K, Togawa K, Klapper S, Wong F, Hurria A. Predictors of primary dose reduction (PDR) among patients (pts) age 65 and older receiving adjuvant chemotherapy (chemo). Journal Of Clinical Oncology 2011, 29: 9003-9003. DOI: 10.1200/jco.2011.29.15_suppl.9003.
- Presley C, Raldow A, Cramer L, Soulos P, Long J, Makarov D, Yu J, Gross C. Racial disparities in prostate cancer treatment: The contribution of inappropriate care. Journal Of Clinical Oncology 2011, 29: 4544-4544. DOI: 10.1200/jco.2011.29.15_suppl.4544.
- Chagpar A, Sanft T, Gross C. Do cancer survivors follow screening guidelines better? Journal Of Clinical Oncology 2011, 29: 1597-1597. DOI: 10.1200/jco.2011.29.15_suppl.1597.
- Vest M, Tanoue L, Soulos P, Kim A, Gross C. Adoption Of Invasive Clinical Staging Techniques In Stage IIIA Non-Small Cell Lung Cancer Lags Adoption Of Positron Emission Tomography. 2011, a5380-a5380. DOI: 10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a5380.
- Hemani M, Huang W, Blustein J, Braithwaite S, Sherman S, Gross C, Taneja S, Penson D, Desai R, Makarov D. 443 REGIONAL VARIATION IN THE COST OF RADICAL CYSTECTOMY: EVIDENCE FROM THE HEALTHCARE COST AND UTILIZATION PROJECT NATIONWIDE INPATIENT SAMPLE. Journal Of Urology 2011, 185: e180-e181. DOI: 10.1016/j.juro.2011.02.534.
- Makarov D, Yu J, Desai R, Penson D, Gross C. 439 THE ASSOCIATION BETWEEN DIFFUSION OF THE SURGICAL ROBOT AND RADICAL PROSTATECTOMY RATES. Journal Of Urology 2011, 185: e178-e179. DOI: 10.1016/j.juro.2011.02.530.
- Yu J, Soulos P, Sharma R, Makarov D, Decker R, Smith B, Desai R, Cramer L, Gross C. Head and Neck Cancer (HNC) Patients Undergoing Primary Radiation with Intensity Modulated Radiation Therapy (IMRT) Demonstrate Improved Overall Survival (OS) Compared to Those Undergoing Conventional Radiation Therapy (CRT) in the SEER-Medicare Linked Database. International Journal Of Radiation Oncology • Biology • Physics 2010, 78: s459. DOI: 10.1016/j.ijrobp.2010.07.1077.
- Gross C, Soulos P, Sharma R, Makarov D, Decker R, Smith B, Desai R, Cramer L, Yu J. Head and Neck Cancer (HNC) Patients Undergoing Intensity Modulated Radiation Therapy (IMRT) Have Fewer Subsequent Days of Hospitalization (DOH) than Do Patients Undergoing Conventional Radiation Therapy (CRT) in the SEER-Medicare Linked Database. International Journal Of Radiation Oncology • Biology • Physics 2010, 78: s445. DOI: 10.1016/j.ijrobp.2010.07.1045.
- Raldow A, Sharma R, Presley C, Cramer L, Yu J, Soulos P, Gross C. Temporal Trends in the Treatment of Elderly Men with Low and Moderate Risk Prostate Cancer: The Effect of Life Expectancy on the Administration of Curative Therapy. International Journal Of Radiation Oncology • Biology • Physics 2010, 78: s562. DOI: 10.1016/j.ijrobp.2010.07.1312.
- Rao M, Lerro C, Gross C. 221: Current Strategies and Future Solutions to On-Call Care Shortages. Annals Of Emergency Medicine 2010, 56: s73. DOI: 10.1016/j.annemergmed.2010.06.269.
- Gibney G, Elfiky A, Hoimes C, Burns A, Rowen E, McDonough J, Lampert R, Gross C, Kelly W. Assessing cardiac risk using heart rate variability in a phase II study of androgen-deprivation therapy and bevacizumab in noncastrate metastatic prostate cancer patients. Journal Of Clinical Oncology 2010, 28: tps244-tps244. DOI: 10.1200/jco.2010.28.15_suppl.tps244.
- Hurria A, Togawa K, Mohile S, Owusu C, Klepin H, Gross C, Lichtman S, Katheria V, Klapper S, Tew W. Predicting chemotherapy toxicity in older adults with cancer: A prospective 500 patient multicenter study. Journal Of Clinical Oncology 2010, 28: 9001-9001. DOI: 10.1200/jco.2010.28.15_suppl.9001.
- Makarov D, Sharma R, Yu J, Abraham N, Desai R, Albertsen P, Penson D, Gross C. 270 INAPPROPRIATE USE OF IMAGING TO STAGE INCIDENT PROSTATE CANCER IN THE MEDICARE POPULATION. Journal Of Urology 2010, 183: e106-e107. DOI: 10.1016/j.juro.2010.02.330.
- Yu J, Makarov D, Gross C. Predicting the Extent of Prostate Cancer. International Journal Of Radiation Oncology • Biology • Physics 2009, 75: s313-s314. DOI: 10.1016/j.ijrobp.2009.07.719.
- Geriatric assessment of older adults with cancer: Baseline data from a 500 patient multicenter studyHurria A, Mohile S, Lichtman S, Owusu C, Klepin H, Gross C, Hansen K, Klapper S, Togawa K, Tew W. Geriatric assessment of older adults with cancer: Baseline data from a 500 patient multicenter study. Journal Of Clinical Oncology 2009, 27: 9546-9546. DOI: 10.1200/jco.2009.27.15_suppl.9546.
- Yu J, Makarov D, Sharma R, Peschel R, Partin A, Gross C. VALIDATING THE PARTIN TABLES USING THE NCI SEER DATABASE. Journal Of Urology 2009, 181: 170. DOI: 10.1016/s0022-5347(09)60487-0.
- Knisely J, Gross C, Castrucci W, Chiang V. Survey of Radiosurgery Practitioner Attitudes on the use of Stereotactic Radiosurgery Alone for Oligometastatic Brain Metastases. International Journal Of Radiation Oncology • Biology • Physics 2008, 72: s241-s242. DOI: 10.1016/j.ijrobp.2008.06.625.
- Gross C, McAvay G, Tinetti M. Life Expectancy and Colorectal Cancer Screening. Annals Of Internal Medicine 2007, 146: 758. DOI: 10.7326/0003-4819-146-10-200705150-00018.
- Gross CP, McAvay GJ, Krumholz HM, Paltiel AD, Bhasin D, Tinetti ME. The effect of age and chronic illness on life expectancy after a diagnosis of colorectal cancer: implications for screening. Annals Of Internal Medicine 2006, 145: 646-53. PMID: 17088577, DOI: 10.7326/0003-4819-145-9-200611070-00006.
- Gross C, Filardo G, Singh H, Freedman A, Farrell M. The relation between projected breast cancer risk, perceived cancer risk, and mammography use. Journal Of General Internal Medicine 2006, 21: 158-164. DOI: 10.1007/s11606-006-0251-4.
- Gross C, Murthy V, Li Y, Kaluzny A, Krumholz H. Cancer Trial Enrollment After State-Mandated Reimbursement. Journal Of Urology 2006, 175: 265. DOI: 10.1016/s0022-5347(05)00074-1.
- Wendler D, Kington R, Madans J, Van Wye G, Christ-Schmidt H, Pratt LA, Brawley OW, Gross CP, Emanuel E. Are Racial and Ethnic Minorities Less Willing to Participate in Health Research? PLOS Medicine 2005, 3: e19. PMID: 16318411, PMCID: PMC1298944, DOI: 10.1371/journal.pmed.0030019.
- Murthy V, Krumholz H, Gross C. Disparities in Participation in Cancer Clinical Trials—Reply. JAMA 2004, 292: 922-922. DOI: 10.1001/jama.292.8.922-b.
- Murthy VH, Krumholz HM, Gross CP. Participation in Cancer Clinical Trials: Race-, Sex-, and Age-Based Disparities. JAMA 2004, 291: 2720-2726. PMID: 15187053, DOI: 10.1001/jama.291.22.2720.
- Masoudi F, Gross C, Wang Y, Havranek E, Rathore S, Foody J, Krumholz H. 838-1 National patterns of spironolactone prescription for older patients with heart failure and left ventricular systolic dysfunction before and after RALES. Journal Of The American College Of Cardiology 2004, 43: a415. DOI: 10.1016/s0735-1097(04)91750-0.
- Bekelman JE, Li Y, Gross CP. Scope and Impact of Financial Conflicts of Interest in Biomedical Research: A Systematic Review. JAMA 2003, 289: 454-465. PMID: 12533125, DOI: 10.1001/jama.289.4.454.
- Cruz-Correa M, Gross C, F M, McNeil C, R N. The impact of practice guidelines on management of Barrett's esophagus: a prospective cohort. The American Journal Of Gastroenterology 2000, 95: 2627. DOI: 10.1111/j.1572-0241.2000.03106.x.
- Gross C, Nicholson W, Powe N. Factors Affecting Prophylactic Oophorectomy in Postmenopausal Women. Obstetrical & Gynecological Survey 2000, 55: 147-148. DOI: 10.1097/00006254-200003000-00015.
- Management of Barrett's esophagus: a national study of practice patterns and their cost implicationsGross C, Canto M, Hixson J, Powe N. Management of Barrett's esophagus: a national study of practice patterns and their cost implications. The American Journal Of Gastroenterology 1999, 94: ajg1999806. PMID: 10606300, DOI: 10.1111/j.1572-0241.1999.01606.x.
- GROSS C, NICHOLSON W, POWE N. Factors Affecting Prophylactic Oophorectomy in Postmenopausal Women. Obstetrics And Gynecology 1999, 94: 962-968. DOI: 10.1097/00006250-199912000-00011.
- Gross C, Anderson G, Powe N. The Relation between Funding by the National Institutes of Health and the Burden of Disease. New England Journal Of Medicine 1999, 340: 1881-1887. PMID: 10369852, DOI: 10.1056/nejm199906173402406.
- Gross C, Sepkowitz K. The myth of the medical breakthrough: Smallpox, vaccination, and Jenner reconsidered. International Journal Of Infectious Diseases 1998, 3: 54-60. PMID: 9831677, DOI: 10.1016/s1201-9712(98)90096-0.
- Gross C, Reisman A, Schwartz M. The Physician as Ambivalent Samaritan. Journal Of General Internal Medicine 1998, 13: 491-494. PMID: 9686718, PMCID: PMC1496980, DOI: 10.1046/j.1525-1497.1998.00141.x.
- Gross C, Callahan M, Mele J. Will Commercial Managed Care Patients Accept Residents as Their Primary Care Providers? Journal Of General Internal Medicine 1998, 13: 331-334. PMID: 9613890, PMCID: PMC1496953, DOI: 10.1046/j.1525-1497.1998.00100.x.
Departments and Programs
Locations
Primary Care Center, Yale New Haven Hospital
789 Howard Avenue
New Haven, CT 06519
- Primary Care Center, Yale New Haven Hospital789 Howard AvenueNew Haven, CT 06519
Primary Care Center, Yale New Haven Hospital
789 Howard Avenue
New Haven, CT 06519
- Primary Care Center, Yale New Haven Hospital789 Howard AvenueNew Haven, CT 06519